Studies on the protein components of Biotin Synthase by McIver, Lisa
Studies on the Protein 
Components of Biotin Synthase 
Lisa McIver 
PhD 




I. Lisa McIver, hereby certify that this thesis has been composed by myself, that it is a record 
of my work, and that it has not been accepted in partial or complete fulfilment of any other 
degree or professional qualification. 
Acknowledgements 
Acknowledgements 
1 would like to acknowledge Dr Robert Baxter for the opportunity to carry out this PhD and I 
would like to thank him for his continued support and supervision. I would also like to thank 
both Dr Dominic Campopiano and Dr Andrew Munro for their guidance, encouragement and 
advice during the course of this work. 
Without the following this work would not have been completed and I would like to thank 
them. 
Professor Stephen Chapman for help and advice and in whose laboratory the experiments for 
chapter 3 were acomplished with the help of Dr Simon Daff. 
Dr Scott Webster, Dr Lu Jiang and Brian Whigham who were responsible for the mass 
spectrometry. 
The analytical ultracentrifugation work was done with Dr Olwyn Byron (Glasgow 
University). 
The circular dichroism experiments were carried out with Dr Sharon Kelly (Stirling 
University). 
Nicola Preston was responsible for the DNA sequencing and Andrew Cronshaw the N-
terminal protein sequencing. 
Dr Rhodri Thomas for the ICP-AES. 
Finally, the Baxter group, the Chemistry department and KBH (past and present) especially 




The genes encoding the E. coli flavodoxin NADP oxidoreductase (FLDR) and Ilavodoxin 
(FLD) have been overexpressed in E. co/i and the gene products purified to homogeneity. 
Physical characterisation of both proteins was carried out using steady-state and stopped 
flow kinetics, circular dichroism and fluorimetric studies. The molecular masses of the 
apoproteins were determined as 2764813a and 19606Da and the isolectric points as 4.8 and 
3.5, respectively. The midpoint reduction potentials of the oxidisedlsemiquinone and 
semiquinone/hydroquinone couples of both FLDR (-308mV and -268mV) and FLD (-
254mV and -433mV) were measured using redox potentiometry. This confirms the electron-
transfer route as NADPH -). FLDR -* FLD. Binding of 2' adenosine monophosphate 
increases the midpoint reduction potentials for both FLDR couples. These data highlight the 
strong stabilization of the flavodoxiri semiquinone with respect to the hydroquinone state and 
indicate that FLD must act as a single electron shuttle from the semiquinone form in its 
support of cellular functions. FLDR and FLD were covalently crosslinked using I-ethyl-
3(dimethylamino-propyl) carodiimide. A single species was formed with an apparent 
molecular weight of 47kD. This complex was catalytically active in that it could reduce 
cytochrome c and potassium ferricyanide almost as efficiently as the individual proteins. 
The gene encoding E. coil biotin synthase (bloB) has been expressed as a histidine-fusion 
protein and the protein purified in a single step using IMAC. The His 6-tagged protein was 
fully functional in in vitro and in vivo biotin production assays. Analysis of all the published 
bloB sequences identified a number of conserved residues. Single point mutations, to either 
serine or threonine, were carried out on the four conserved (Cys-53, Cys-57, Cys-60 and 
Cys- I 88) and one non-conserved (Cys-288) cysteine residues and the purified mutant 
proteins tested both for ability to reconstitute the [2Fe-2S] clusters of the native (oxidised) 
dimer and enzymatic activity. The CI 88S mutant was insoluble. The wild-type and four of 
the mutant proteins were characterised by UV-visible spectroscopy, metal and sulfide 
analysis and both in vitro and in vivo biotin production assays. The molecular masses of all 
proteins were verified using electrospray mass spectrometry. The results indicate that the 
His6-tag and the C288T mutation have no effect on the activity of biotin synthase when 
compared to the wild-type protein. We conclude that three of the conserved cysteine residues 
(Cys-53, Cys-57 and Cys-60), all of which lie in the highly conserved cysteine-box' motif, 
are absolutely crucial for Fe-S cluster binding whereas Cys-188 plays a unknown structural 
role in biotin synthase. 
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Chapter 1: Introduction 
Chanter 1: Introduction 
1.1 An introduction to biotin 
In 1901 Wildiers discovered that a substance obtained from beer wort, which he termed bios, 
stimulated the growth of yeasts (I). Over thirty years later Williams found that bios was a 
mixture of biotin, alanine, myoinositol and pantothenic acid (2). Biotin itself was found to be 
identical to "protective factor x" and "vitamin H" which had been previously isolated from 
mammalian livers (3). This factor was found to protect rats from the pathological effects of 
the ingestion of dried egg whites. Pure biotin was finally isolated, as its methyl ester from 
dried egg yolks by Kogl. Biotin has since been found to be an essential vitamin for all animals 
and humans. It is produced in minute quantities by bacteria, plants and yeast. Although, it is 
found in minute quantities in the majority of foodstuffs (egg yolk being the exception 
containing -50tgI100g) and the recommended daily amount (Ca. 300j.ig/day) is normally in a 
balanced diet and synthesised by intestinal microfiora. Biotin has an extremely important role 
in animal nutrition and also in biotechnology. 
1.1.1 Structure and properties 
Kogt (4) established the empirical formula of biotin methyl ester as C 11 H 1803N 2S in 1936 but 
it was not until 1942 that the structure of biotin was elucidated by du Vigneaud el al. (5). The 
first of many chemical syntheses of the vitamin was described by Harris a year later (6). 
Biotin is a water soluble vitamin which X-ray studies have shown consists of an 
imidazolidone ring fused in the cis confirmation to a tetrahydrothiophene ring with a valeryl 
side chain (Figure 1-1). The molecule contains 3 asymmetric carbons and so has eight 
optically active forms. Only one form, D-(+)-biotin, is biologically active. Currently biotin is 
made using an expensive, laborious twelve step chemical synthesis originally developed by 
Roche (7) although significant improvements have been made by workers at Lonza AG (8). 
Demand for the vitamin is such that there is currently intense effort to develop a 





D-(+)-biotin consists of an imidazolidone ring fused in the cis configuration to a 
tetrahydrothiophene ring with a valeryl side chain. 
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1.1.2 The role of biotin as a coenzyme 
Biotin is the cofactor in a number of enzymatic carboxylation reactions where it acts as a 
carrier of activated CO, (9). Enzymes which use biotin are involved in a variety of 
physiological processes such as fatty acid synthesis and gluconeogenesis. These enzymes fall 
into three categories shown in Table I-I. Class I enzymes are carboxylases which transfer 
carbon dioxide as derived from hydrogen carbonate to acceptors. The substrate is 
carboxylated in two reversible steps. First, a carboxybiotin intermediate is formed at the 
expense of an adenosine 5 '-triphosphate(ATP) molecule. The fact that N-I was carboxylated 
in the enzyme-biotin complex presented an interesting mechanistic problem. A stepwise 
mechanism has been proposed where bicarbonate is phosphorylated by ATP to form 
carboxyphosp hate. This is then attacked by the N-I nitrogen to yield carboxybiotin (10) (11). 
The activated CO 2 is then transferred to the substrate to form the product (12). Substrates bind 
to the enzyme and are released in a specific sequence. The mechanism is "ping-pong", where 
one or more of the products are released before all the substrates are bound. Enzymes in class 
II are transcarboxy lases and class Ill enzymes are decarboxylases which decarboxylate 13-keto 
esters and their thioesters (13). In class II and Ill reactions ATP is not required and active CO 2 
is transferred from either an acyl derivative or an a or 13  keto ester to the biotin enzyme (14). 
Pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase and 3-
methylmalonyl-CoA carboxylase are the only biotin enzymes so far found in human, animal 
and higher plant tissues. 
Acetyl-00A carboxylase from E. co/i has been studied in detail and it has been found to 
consist of three subunits that catalyse the partial reactions (Figure 1-2)(15). 
Subunit 1: The biotin carboxyl carrier protein (BCCP) is a 22kDa monomeric protein which 
contains the biotin molecule covalently linked to the c-nitrogen atom of a lysine residue 
through an amide bond (16). This linkage has been found in all biotin enzymes studied to 
date. 
Subunit 2: The lOOkDa biotin carboxylase subunit catalyses the first step which is the ATP-
dependent carboxylation of the NI nitrogen atom of biotin to form carboxybiotin. 
Subunit 3: The carboxy-transferase subunit (90kDa) which takes the carboxyl group from 
biotin to acetyl Coenzyme-A. 
The length and flexibility of the link between biotin and its carrier protein enables the 
activated CO2  group to move from one active site to another in the enzyme complex (15). 
2 
Table 1.1 The enzymes that use biotin 
Class Enzyme Reaction catalysed Biochemical role 
I Carboxylases Pyruvate carboxylase Pyruvate to oxaloacetate Gluconeogenesis, lipogenesis 
Acetyl Co-A carboxylase Acetyl CoA to malonyl CoA Fatty acid biosynthesis 
Propionyl-CoA carboxylase Propionyl 	CoA 	to 	methylmalonyl Proprionate metabolism 
CoA 
3-Methylcrotonyl-CoA carboxylase 3-Methyicrotonyl 	CoA 	to 	3- Catabolism of leucine 
methylglutaconyl CoA 
Geranyl-CoA carboxylase Geranyl CoA to carboxygeranyl CoA Microbial catabolism of isoprenoid compounds 
Urea carboxylase Urea to N-carboxyurea Bacterial catabolism of urea in microbes that 
lack urease and grow on urea as a sole source of 
carbon 
II. Trancarboxylases Methylmalonyl-CoA carboxyltransferase Methylmalonyl CoA and pyruvate to Fermentation 	of 	certain 	carbohydrates 	to 
oxaloacetate and propionyl CoA propionate in prop ion ibacteria 
Ill. Decarboxylases Methylmalonyl-00A decarboxylase Methylmalonyl 	CoA 	to 	propionyl Last step in lactate fermentation in Micrococcus 
CoA and CO2 lacus 
Oxaloacetate decarboxylase Oxaloacetate to pyruvate a and CO2 Inducible 	enzyme 	in Aerobacter aerogenes 
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E.coli acetyl-00A carboxylase consists of three subunits; the biotin carboxyl carrier protein 
subunit (22kDa) which links to the biotin molecule, the biotin carboxylase (lOOkDa) subunit 
which carboxylates biotin and the carboxyl-transferase (90kDa) subunit which transfers the 
carboxyl group from biotin to acetyl CoA (15). 
1.1.3 Biotin binding proteins 
Several proteins which bind to biotin have been identified with the most well known being the 
egg white glycoprotein, avidin (17) and streptavidin which has been isolated from 
Streptomyces avidinii (18). Avidin and streptavidin are 70kDa proteins which are tetramers of 
identical (17.5kDa) subunits, each of which is folded into an eight-stranded antiparallel 3-
barrel. Biotin binds at one end of this barrel in a pocket between two tryptophan residues (19). 
The interaction of biotin with avidin is one of the strongest protein-ligand complexes known 
with a Kd = I0 15M. The binding is highly specific and can withstand extremes of pH, buffer 
salts and chaotrophic agents and has thus provided researchers with a unique tool for use in 
receptor studies, drug delivery, immunological staining and protein isolation. Avidin and 
streptavidin may also act as inhibitors of biotin uptake and of biotin requiring enzymes since 
they can complex both free and enzyme-bound biotin in vivo (3). 
4 
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1.1.4 The biochemical and pathological effects of the deficiency of biotin 
Biotin deficiency can result from long term antibiotic therapy which destroys the gut 
microflora leading to insufficient biotin being produced (20) and also from the excessive 
ingestion of raw eggs. A lack of biotin causes a reduction in all activites of biotin-dependent 
enzymes. Indirect effects include impairment of protein synthesis and inhibition of RNA 
synthesis. The resultant physiological effects in mammals include progressive ataxia, 
dermatitis, alopecia, skin lesions, nausea and metabolic acidosis. These symptoms can be 
readily relieved by supplementing the diet with biotin. 
1.2 The Biosynthesis of Biotin 
Current evidence suggests that the biosynthesis of biotin occurs by similar pathways in both 
microorganisms and higher plants (21) . However the majority of studies have been carried 
out in Bacillus sphaericus and E. coli. 
1.2.1 The biotin operon 
The biotin (bio) operon of E. coil has been extensively studied. Early work by del Campillo 
Campbell and Rolfe led to the discovery of the genes it encodes (22, 23). The 5.8 kilobase bio 
operon is located at 17 minutes on the E. coli genetic map between the attachment site of X 
prophage (auX) and the uvrB gene (24). Complementation analysis of biotin mutants 
indicated that the operon was composed of five genes bioA, bloB, bloC, bioD and bioF which 
code for the principal enzymes of biotin biosynthesis (25, 26). An unlinked gene bioH has 
also been discovered but as yet its function is unknown (27). Although current evidence 
suggests that it may be an acyl carrier protein (ACP) (28). Eisenberg subsequently identified 
two addition biotin genes; bioP, a permeability gene and bioR, a regulatory gene (29). Barker 
and Campbell also identified a gene known as birA and it is now known that this is the same 
as bioR which had previously been described by Eisenberg (30). The function of birA, now 
known to encode the E. coil biotin holoenzyme is described in section 1.2.2. Deletion 
mapping was used to determine the gene order of the operon (Figure 1-3)(25, 31). Guha et al. 
(32) determined the positions of the operator and the promoter and concluded that the operon 
was divergently transcribed. The four genes bioB, F, C and D are transcribed as a unit from 
left to right and the bioA gene from right to left, from a complex promoter/operator region 
located between bioA and bloB. Sequencing of this regulatory region has shown that the bioA 
and bloB promoters overlap and are situated face to face. An unusually large imperfect 
palindrome was identified as the single operator site and it was found to overlap the two 
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promoters. Both promoters have the typical Pribnow box and -35 sequences similar to those 
in other bacterial promoter sequences (33). 
0kb 
	 F6kb]  
A 
Figure 1-3 
The E.coli bio operon is divergently transcribed with the BloB, BioF, BioC and BioD genes 
being transcribed from left to right and the BioA gene from right to left; the function of ORF1 is 
not known. 
Another biotin gene has been described in Sinorhizobium meffloti which is a N 2-fixing root 
bacteria. BioS is a biotin-inducible gene which encodes a 35kDa protein. The BioS protein 
has predicted structural motifs similar to that of the LysR- type regulators and this indicates 
that it may have a regulatory role (34). 
1.2.2 Regulation of biotin biosynthesis 
The earliest evidence for control of biotin biosynthesis in E. co/i was discovered by Pai and 
Lichstein who noted that biotin production decreased with the increased biotin concentration 
in the growth media (35). The nature of this inhibition was found to be repression rather than 
feedback inhibition (36). Thus, the classic model of Jacob and Monod for regulation of an 
operon by repression can be applied to the biotin operon (37). Regulation of gene expression 
is now known to involve the protein BirA which is a 321 amino acid protein with a molecular 
weight of ca. 35.3kDa. BirA is a bifunctional protein serving both as the biotin activating 
enzyme and as a transcriptional regulator (38). It converts biotin to biotinoyl-AMP (using 
ATP) and biotinoyl-AMP is the activated form required for ligation of biotin to the BCCP. 
The intermediate in this reaction, the BirA-biotinoyl-AMP complex functions as a co-
repressor. It binds to the 40 base pair bio operator, repressing transcription of the biotin 
biosynthetic genes. Thus BirA synthesises its own co-repressor ligand, a unique property 
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among DNA binding proteins. Howard et al. sequenced the birA gene and suggested that it 
has a helix-loop-helix domain similar to other DNA binding proteins (39). The crystal 
structure of BirA was published in 1992 by Wilson et a! (40) and confirmed this proposal. 
The expression of biosynthetic enzymes and the de novo synthesis of biotin is thus dependant 
on the intracellular biotin concentration and the concentration of unbiotinylated carrier 
protein. When the concentration of biotin in the cell is low, no BirA-biotinoyl-AMP can 
accumulate because biotinoyl-AMP is being consumed in the biotinylation of the acceptor 
protein. In this case transcription of the biotin genes is maximal. When the cellular 
concentration of biotin is high, the BirA-biotinoyl-AMP complex concentration is increased 
and this binds to the operator preventing transcription. 
1.3 The Biotin Biosynthetic Pathway in Eukaryotes 
Biotin is synthesised in higher plants and the pathway appears to involve similar enzymes to 
those found in bacteria. Baldet has described the presence of free and bound plant derived 
biotin in green peas (41). The bound biotin appears to be associated with the soluble fractions 
of the chloroplasts and mitochondria as would be expected from its function as a "CO 2 
carrier". Baldet et al. also investigated and identified the intermediates of biotin biosynthesis 
in lavender cells (21). They found that an unknown stable intermediate accumulated and 
when this was analysed it was found to coelute with 9-mercaptodethiobiotin on HPLC. They 
suggest that dethiobiotin (DTB) may be converted to biotin via this intermediate. Baldet and 
Weaver (42) have isolated the cDNA which encodes the Arabadopsis thaliana bioB gene. The 
predicted bioB gene product (from cDNA sequencing) shows specific homology with the 
bioB gene products of numerous bacteria. In 1997 this protein was overexpressed and 
purified. It was found to be reddish in colour, dimeric (lOOkDa) and had the spectral 
characteristics of a 2Fe-2S protein (43). Although this data and the recent identification of the 
bioB gene in Saccharomyces cerevisiae (44) indicates that a functional eukaryotic pathway 
similar to the bacterial pathway exists, little more is known of the eukaryotic synthesis of 
biotin. 
1.4 The Biotin Biosynthetic Pathway in Prokaryotes 
The currently accepted pathway for the biosynthesis of biotin in E. co/i was proposed by 
Eisenberg (13) (Figure 1-4). It now appears that the main steps in this pathway are ubiquitous 
in bacteria (45). 
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1.4.1 The first step 
Pimelic acid was identified as the first biotin precursor and in B. sphaericus this is converted 
to pimeloyl CoA by pimeloyl-CoA synthase in the presence of HSCoA, ATP and Mg 2 (46). 
This is not the case in E. coil where 13C  labelling studies by the groups of Ifuku and Sanyal 
have suggested that pimeloyl-CoA is produced directly from a malonyl-CoA starter unit by a 
pathway similar to that of fatty acid and polyketide synthesis (47, 48). Lemoine et al. have 
suggested that in E. coil BloC catalyses the stepwise condensation of the malonyl-CoA starter 
by the addition of acetate units from malonyl groups in a similar way to that of chalcone 
synthase (49). They also propose a role for BioH in that it can transfer pimeloyl from the 
active cysteinyl residue of BioC directly to CoA, preventing the accumulation of free 
pimelate inside the cells. Studies in our laboratory have found that when BioH is 
overexpressed and purified 99% of the protein has the expected molecular weight of 28505Da 
and 1% has a molecular weight that is 340Da higher. We think that this is a 
phosphopantothein molecule that has been added as a post translational modification (28). 
However, the function of the E. coil bioC gene, thought to encode a pimeloyl CoA synthase, 
is unknown. Attempts to express this protein give only insoluble products. 
1.4.2 8-Amino-7-oxononanoate synthase 
The next step in the pathway is the condensation of L-alanine with pimeloyl-CoA to give 8-
amino-7-oxononanoate (AON). This reaction is catalysed by 8-amino-7-oxononanoate 
synthase (AONS) which is the product of the bioF gene. The predicted size of the E. coil 
enzyme is 4159913a (384 amino acids). This enzyme has an absolute requirement for 
pyridoxal phosphate (PLP) as a cofactor. The bioF gene from B. sphaericus has been cloned 
and the AONS overexpressed in E. coil (50). Recently the structure of E.coii AONS (PDB 
IBSO) has been determined by Alexeev etal. (Figure I-5)(51). The enzyme is a homodimer 
and its structure is typical of a type II aminotransferase. The dimer has two active sites whose 
identical residues are contributed from each monomer. Each monomeric unit has three 
domains, the N-terminal domain which wraps around the opposing monomers, a large central 
domain and the C-terminal domain. The active site is a cleft between the two latter domains 
with PLP attached to lysine 236. 
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The E.coli biotin biosynthetic pathway; 8-Amino-7-oxononanoate (41 599Da) is the product of 
the BioF gene, 7,8-diaminononanoate (47403Da) is the BioA gene product, dethiobiotin 
synthase (23917k0a) is the BioD gene product and biotin synthase (38648Da) is the BloB 
gene product. 
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Figure 1-5 
The structure of 8-amino-7-oxononanoate synthase (PBD 1 BSO). The enzyme fold (dimer 
shown) is similar to that of a type II aminotransferase. The N-terminal domain (turquoise) 
wraps around the opposing monomer. The active site cleft is between the large domain 
(purple) and the C-terminal domain (yellow) (51). 
1.4.3 7,8-Dia mono nanoate synthase 
Transamination of AON by the enzyme 7,8-diamononanoate synthase (DANS), the product of 
the bioA gene, then leads to the formation of 7,8-diamononanoate (DAN). Studies by Pai 
showed that ATP, Mg 24  and PLP are required for this reaction. Methionine was originally 
suggested to be the amino donor (52) but it was subsequently shown that S-adenosyl 
rnethionine (SAM) is the actual substrate. DANS has been purified and has been shown to be 
a dimer with each subunit being 430 amino acids (47403Da) and it is unique in its absolute 
requirement for SAM as an amino donor. The structure of DANS has recently been solved 
both by Lindqvist (53) and Alexeev (54) at the University of Edinburgh (Figure 1-6). The 
10 
Chapter 1: Introduction 
structure of DANS is very similar to that of AONS in that it is also similar to a type II 
aminotransferase with three domains in each monomer. The PLP is attached to lysine 274 and 
there are two structural sodium atoms on the surface of each monmer. 
Figure 1-6 
The atomic structure of 7,8-diaminononanoate synthase. The enzyme structure (dimer 
shown) is typical of that of a type II aminotransferase. The N-terminal domain (turquoise) 
wraps around the opposing monomer. The active site cleft is between the large domain 
(purple) and the C-terminal domain (yellow). Two structural sodium atoms are present in each 
monomer (shown in blue). The structure shown is that determined by Alexeev (54). 
1.4.4 Dethiobiotin synthetase 
The next step in the biosynthesis involves CO 2 insertion into DAN catalysed by the bioD gene 
product, DTB synthetase (DTBS), to produce DTB. This reaction requires ATP and Mg 2 
(55). Paradoxically, DTBS is a virtually unique CO 2 utilising enzyme in that it does not 
involve biotin as a prosthetic group. The gene sequence was first deduced by Otsuka el al. 
1: Introduction 
(56) and was later corrected by Alexeev et al. (57). This encodes a 224 amino acid protein, 
the N-terminal methionine being cleaved by a post-translational process. The sequence has 
now been verified by C- and N-terminal sequencing of the protein and confirmed by laser 
desorption mass spectrometry. The native enzyme has been purified and has been shown to be 
a homodimer with a monomeric molecular weight of 23891713a (55). DTBS shows little 
homology with other proteins with the exception of the related proteins from Serratia 
marcescens (58) and B. sphaericus (59) with which it shares 70.2% and 49% amino acid 
sequence identity respectively, assuming conservative substitutions. The crystallisation and 
structure of cloned E. co/i DTBS has been reported (Figure I-7)(60, 61). The 3D structure of 
the enzyme has been solved to 1.6 A resolution (PDB I DAD). Each monomer subunit has a 
seven stranded parallel 3-sheet surrounde by helices. This sheet contains the classic 
mononucleotide binding motif with the fingerprint peptide Gly. X, Gly, Lys, Thr. The 
sequence of steps in its catalytic mechanism have been examined in depth by both 
mechanistic and structural studies (62-64) and the roles of catalytic residues examined by 
mutation studies. 
1.4.5 The final step 
The final step in the biotin biosynthetic pathway is the insertion of sulfur into the carbon 
skeleton of DTB to yield biotin. Little is known about the reaction mechanism or the actual 
source of the sulfur atom. Sequence similarity searches reveal that there are twenty six known 
species of bacteria, yeast and plants which contain genes encoding amino acid sequences 
similar to that of E.coli biotin synthase. The entire sequences of twenty four species are 
known and only the first five N-terminal residues are known for the Citrobaclerfreundii and 
Salmonella typhimurium proteins. To date, biotin synthase from B. sphaericus (65), A. 
thaliana (43), S. cerevisiae (44), and E. co/i (66) have been cloned, overexpressed and 
purified. However, sufficient complementation analysis has been carried out on 
Methylobacillus, B. flavum (67), B. subtilis (68) E. herbicola (69) and S. marcescens (70) to 
verify that these genes encode active biotin synthases. The alignment of all the sequences 
shows that there are a number of highly conserved regions of the protein. Four residues in the 
known proteins are completely conserved and a number of others are almost completely 
conserved. Three of these residues are cysteine which occur in the following motif Cys, X 3 , 
Cys, X 2, Cys. This motif is also found in anaerobic ribonucleotide reductase activating 
enzyme (ARR-AE, Swissprot accession number P39329) (71), benzylsuccinate synthase 
activating enzyme (CAA05050) (72), lipoic acid synthase (P25845) (73), lysine aminomutase 
LAM (74), the nitrogen fixation B gene product (P1 1067) (75), FNR protein (P03019) (76), 
pyrrolo-quinoline-quinone synthase (Q01060) (77), pyruvate formate lyase activating protein 
(PFL-AE) (P09374) (78), spore photoproduct lyase (P37956) (79), molybdenum cofactor 
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synthase (MOAA) (027593) (80), NARA protein (P39757) (81) and the thiH gene product 
(P30140) (79). It has been speculated that this motif is involved in the binding of iron as all of 




Dethiobiotin synthase 1.6A (PBD 1 DAD). The seven stranded parallel 3-sheet (blue) is surrounded 
by six helices (yellow). 
1.5 The Components of the E.coii Biotin Synthase System 
Prior to 1992 little was known about the conversion of DTB to biotin. The reaction was 
originally thought to be catalysed solely by the bioB gene product, biotin synthase. It is now 
known that the reaction is extremely complex and involves a number of other proteins along 
with biotin synthase. In this work we will refer to the bioB gene product as biotin synthase. 
1.5.1 E. coil biotin synthase is an Fe-S protein 
Fe-S clusters are found in numerous proteins where they perform a number of important roles. 
However, the mechanism by which they are formed in vivo is not yet fully understood. In 
catalytic reactions Fe-S clusters can act as Lewis acids during dehydration. They are also 
involved in electron tranport, the stabilisation of protein structure, the formation of protein-
bound radicals. DNA recognition and in the regulation of metabolic pathways. A further 
function of Fe-S clusters is that they can act as biological sensors of oxygen and iron (82). 
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The E. coil biotin synthase protein is a 346 amino acid protein with a predicted weight of 
3866513a (56) which contains a Fe-S cluster (48). Sanyal et al. cloned, overexpressed and 
purified the bloB gene product from E. coil (66). Two protein species were found which had 
molecular weights of Ca. 82kDa and Ca. 104kDa based on native gel electrophoresis. Both 
species ran on SDS gels with the expected molecular weight of ca.39kDa. The 82kDa protein 
was found to be a homodimer which contains one [2Fe-2S] cluster per protein monomer and 
the 104kDa species a homodimer that contains a single [2Fe-2S] cluster per dimer. The 104 
kDa species can be converted to the 82kDa species (one [2Fe-2S] cluster per monomer) on 
incubation with Fe 31,  S 2 and 2-mercaptoethanol. Both proteins species are red in colour and 
have UV-visible absorbance spectra typical of that of other Fe-S proteins with peaks at 
324nm and 419nm. Anaerobic dithionite reduction of the protein resulted in a gradual 
bleaching of colour indicating some degradation of the Fe-S cluster. Three years later it was 
reported that during the purification of biotin synthase, yet another species of biotin synthase 
which had a molecular weight of Ca. i 6OkD had been discovered during purification (44). 
Flint et al. have reported EPR work on the Fe-S cluster of the 82kDa protein (83). Their 
results confirm the presence of one [2Fe-2S] cluster in each subunit of the homodimer in 
aerobically purified samples. One iron ion has two sulfur ligands while the other has one 
cysteine ligand and an oxygenic terminal ligand. In contrast after anaerobic dithionite 
reduction it appears that the two [2Fe-2S] clusters in each monomer convert to form a single 
[4Fe-4S] cluster at the subunit interface via reductive dimerisation (Figure 1-8). This form of 
the Fe-S cluster has each iron ion coordinated to a cysteine. Reoxidisation of the reduced 
sample leads to a degradation of the [4Fe-4S] cluster and a partial reformation of the [2Fe-2S] 
cluster. It is thought that the formation of the [2Fe-2S] cluster is a consequence of aerobic 
purification. 
A redox role for the cluster seems unlikely and a more likely role for the [4Fe-4S] cluster lies 
in the initiation of the radical mechanism by facilitating reductive one-electron cleavage of 
SAM to form methionine and a 5'-deoxyadenosyl radical (DOA*) (Figure 1-9). It has also 
been suggested that the [4Fe-4S]-[2Fe-2S] cluster interconversion may play a further role in 
vivo in radical enzymes by providing a method of regulating enzyme activity in response to 
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[4Fe + 4S] dimer 
Figure 1-8 
Proposed scheme for the reductive dimensation of two [2Fe-2S] dusters to form a single 
[4Fe-4S] cluster at the dimer interface. Reproduced from Johnson et a! (83). 
Figure 1-9 
Proposed mechanism for the reductive cleavage of SAM by a [4Fe-4S] cluster. Reproduced 
from Johnson, M. K. et a! (83). 
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1.5.2 The stimulatory cofactors 
In 1992 it was reported that in crude cell free extracts of E. co/i clones which carried a 
plasmid encoding the bioB gene, the convertion of DTB to biotin was stimulated by certain 
stimulatory cofactors (85). The cofactors reported by these authors were fructose-1,6-
bisphosphate, SAM, Fe 2 , reduced nicotinamide adenine dinucleotide phosphate (NADPI-I) 
and potassium chloride. The function of fructose-1,6-bisphosphate, which is a glycolytic 
intermediate, is unknown but it has been postulated that it could be a cofactor, although a role 
as an enzyme activator seems likely. It was also suggested that other as yet unidentified 
enzymes may be required and within the next two years it was discovered that E. co/i 
flavodoxin (FLD) (86) and E. co/i fiavodoxin NADP*  oxidoreductase (FLDR) (87) were 
necessary for the reaction. The purified biotin synthase alone is unable to convert DTB to 
biotin. Only when fructose- 1,6-bisphosphate. SAM, Fe 2 , NADPH and potassium chloride, 
dithiothreitol (DTT) and the cell free extract of a bioB strain, were added did biotin 
production occur. The turnover number was very low (ca. Ih') possibly due to the fact that 
the concentration of biotin synthase was greater than all the other required cofactors. Sanyal 
eta/also reported a Km for DTB of 21.tM and a kcag/K,. equal to 103M 1 s based on the 82kDa 
species (48). Several other authors have also tried to define the absolute requirements for 
biotin synthase activity. Birch et al. have suggested that there is a thiamine pyrophosphate-
dependent protein required for the reaction and also one of the following amino acids: 
asparagine, aspartate, glutamine or serine (88). They also developed a more sensitive assay 
system which is based on the conversion of radiochemical DTB to produced labelled biotin. 
The reaction products are then separated using thin layer chromatography and analysed using 
HPLC and autoradiography. It should be noted that in their experiments they were not 
working with pure samples of biotin synthase. The most recent (and most complete) cocktail 
of ingredients required for biotin synthase activity is derived from the work of Sanyal et al. 
(89). They report that pure biotin synthase was only active if the following cofactors were 
added - FLD, FLDR, SAM, Fe 2 , fructose-1,6-bisphosphate, cysteine and DTT. They also 
noted that the addition of a labile low molecular weight product from the DANS reaction 
stimulated the biotin reaction. A further finding was that fructose-1,6-bisphosphate can be 
replaced by asparagine (44). However, the biotin synthase preparations still have a poor 
turnover with an upper limit of 2 molecules of biotin per monomer. It seems likely that the 
reaction mixtures still do not contain all the physiological factors needed as the enzyme is 
obviously not functioning very efficiently. It is also possible that the biotin synthase may 
become modified after one turnover to an unactive form or that only a small fraction of the 
pure biotin synthase is active. 
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Biotin synthase from B. sphaericus has been found to be able to transform DTB to biotin, in 
the presence of SAM and photoreduced deazaflavin which substitutes for FLD, FLDR and 
NADPH (90). 
1.5.3 The cysteine desulfurase protein NifS 
In 1991 Jacobson et a!, discovered the nitrogenase gene cluster of Azolobacter vinelandii (A. 
vine/andii) (91). Two years later it was found that the protein product of the nzjS gene, N1fS, 
was able to catalyse the desulfuration of cysteine to alanine and sulfide. The physiological 
role of this reaction appears to be the production of S 2 for the regeneration of the Fe-S cluster 
of the nitrogenase Fe-protein. The NifS protein is a homodimer, with a monomeric weight of 
44kDa, which utilises PLP as a cofactor. The mechanism of the NifS reaction starts with the 
formation of a cysteine-PLP Schiffs' base adduct and H-2 abstraction to form a quinioid. 
Nucleophilic attack then occurs by an enzyme thiolate anion at the sulfur of the substrate 
cysteine (Cys 325). This results in the cleavage of the C-S bond to form a PLP-bound alanine 
enamine and formation of an enzyme-bound cysteinyl persulfide, which is a likely candidate 
for a sulfur donor (92). In vitro experiments to confirm the role of NifS have been carried out. 
In the nitrogenase Fe-protein the [4Fe-4S] cluster was removed via a metal chelator and and 
the apo-protein was then incubated with NifS, cysteine, DTT, Fe and MgATP. The [4Fe-4S] 
cluster was found to have been reformed (93). 
This experiment has also been carried out on SoxR a dimeric transcription factor of the soxrs 
regulon of E. coli which contains two [2Fe-2S] clusters per monomer which were chemically 
removed with EDTA. The Fe-S was regenerated in two ways both non-enzymatically (six 
hours) using Fe, S and a reducing system, and enzymatically using NifS from A.vinelandii 
(two minutes). A mutant SoxR protein, which had one out of its four cysteine residues 
substituted for an alanine residue did not have cluster reformation (94). 
In 1996 Flint reported that he had found a protein in E. co/i with a similar sequence and 
molecular weight to NifS. He called this protein the E. co/i NIfS-like protein, as it contains 
PLP and can catalyse the conversion of cysteine to alanine and sulfur (95). He speculated that 
this protein could be involved in the regeneration of Fe-S cluster in E. co/i Fe-S-proteins but 
so far this has not been verified. 
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1.6 The Flavoprotein Components of the Biotin Synthase System 
Flavoproteins are proteins which contain a flavin as a prosthetic group. The name derives 
from the Latin flavus meaning yellow and this refers to the chromophore of the water soluble 
vitamin, riboflavin (vitamin B 2). Riboflavin is the precursor for flavin mononucleotide (FMN) 
and flavin adenine dinucleotide (FAD). In the production of FMN, riboflavin is 
phosphorylated by ATP. FMN is then derivatised by ATP to yield FAD (Figure 1-10). 
Flavoproteins catalyse redox reactions and the reactive part of the flavin molecule is the 
isoalloxazine ring which can accept two electrons, and in doing so it can take up a proton and 
a hydride ion. When the flavin accepts one electron it is converted from its oxidised form to 
its semiquinone. When another electron is added to the semiquinone, the flavin is in its 
hydroquinone or fully reduced state. There are two types of semiquinones observed in 
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Figure 1-10 
The structure of the oxidised fon'n of flavin adenine dinucleotide (FAD). This made up of flavin 
mononucleotide (FMN) unit (shown in blue) and AMP (shown in red). 
18 
Chapter 1: Introduction 
1.6.1 Escherichia coil flavodoxin 
E. coli FLD was discovered in 1971 where it was described as an acidic protein with a 
molecular weight of around 20 kDa (96). Three years later it was discovered that two 
flavoproteins, R and F, were required to activate cobalamin-dependent methionine synthase, 
which catayses the formation of methionine from homocysteine and met hy ltetrahydrofolate. 
The reaction involves two methyl transfers where cobalamin is both the methyl donor and 
acceptor. The reaction requires FLDR, FLD and SAM (97). The enzyme contains zinc which 
becomes ligated to the homocysteine (98). 
Both of these E.coli proteins, R and F, were purified and it was found that they needed a 
reduced triphosphate nucleotide to facilitate electron transfer (99). Protein R proved to be a 
FAD-containing protein with a molecular weight of Ca. 27kDa. When it was incubated with 
NADPH. the FAD was rapidly reduced to its hydroquinone form, with no serniquione species 
being observed. Protein F contained FMN and had a molecular weight of Ca. I 9.4kDa, it was 
inert to NADPH but on reduction with dithionite a neutral blue semiquinone was formed 
(100). 
In 1982 Blachowski reported that both FLD and ferredoxins became reduced in E. co/i by 
oxidoreductase reactions, and that this reduced FLD was required to activate pyruvate 
formate-lyase (PFL) (101). PFL catalyses the C0A-dependent formation of pyruvate from 
acetyl-CoA and formate (102). In 1991 Rowena Matthews' group in Michigan discovered that 
the R and F factors which were needed for the activation of cobalamin-dependent methionine 
synthase were in fact FLDR and FLD. They cloned, expressed, purified and determined the 
amino acid sequence of FLD from E.coli. They found that it had a molecular weight of 19606 
Da after N-terminal methionine removal and its amino acid sequence was similar to that of 
other flavodoxins (103). 
In 1993 they found that FLD was required to activate anaerobic ribonucleotide reductase 
(ARR), which is the enzyme responsible for the production of deoxyribonucleotides for 
anaerobic DNA synthesis (104). Subsequently they cloned and crystallised E. coil FLD and 
using Aspergillus nidulans FLD as a model, they were able to solve the three dimensional 
structure to 10A. FLD has five parallel 13-sheets which are flanked by helices, this is similar 
to other flavodoxins (PDB IAG9). Four tyrosine residues (Y58, Y59, Y94, Y97) and a single 
tryptophan residue (W57) form a box which surrounds the flavin. with residues W57 and Y94 
as the top and bottom of this box (105). Two years later they had managed to refine the 
structure to 1.8A (Figure 1-1 l)(106, 107). 
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Figure 1-12 
The 3-D structure of E.coli Flavodoxin at 1.8 A (PDB 1AG9) 
FLO has five parallel 13-sheets (blue) which are flanked by helices (red), the flavin (yellow) is 
surrounded by tyrosines (Y58, Y59, Y94, Y97) and a tryptophan (W57). 
1.6.2 Eschenchia coil flavodoxin NADP oxidoreductase 
In E.coli FLDR can use either FLD or ferredoxin as an electron acceptor but it appears to 
favour FLD as its redox partner. NADPH is FLDR's electron donor and FAD mediates 
electron transfer to FLD. In 1993 the FLDR gene was cloned and the protein overexpressed 
for use in the activation of ARR (108). The synthesis of FLDR was found to be under the 
control of the soxrs regulon, which may be an adaptive response against superoxide. Thus, 
FLDR may be involved in the protection of bacteria from damage by oxygen radicals since 
the absence of FLDR does not affect anaerobic growth. In bacteria, pyruvate:ferredoxin 
oxidoreductase can substitute for FLDR and mutants which lack FLDR have an increased 
sensitivity to paraquat (109). In 1997 the structure of FLDR was solved to 1.7A resolution 
(Figure 1-12) (PDB IFDR) (110). The structure was found to be similar to other reductases 
such as nitrate reductase and cytochrome b 5 reductase. It contains two distinct domains which 
are joined by a single covalent connection. The FAD-binding domain is a double sandwich 
structure with six strands. The NADPI-I-binding region is an open a/3 structure with a central 
parallel pleated sheet and six strands surrounded by helices. The E.coli FLDR has not been 
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co-crystallised with NADPH or FLD, so the residues involved in substrate binding and 
protein-protein interaction are unknown. However, the structure of other reductases with the 
NADPH mimic 2-AMP have been solved. By analogy with these three arginine residues 
(R144. R174 and R184) are thought to interact with NADPH. In all these reductases residue 
R174 is completely conserved and R144 is conserved in four out of five structures. The 
results of site-directed mutagenesis studies in our laboratory where each arginine was 
changed to alanine, indicates that all three residues are definitely involved in the binding of 
NADPH (ill). 
In the atomic structure it can be clearly seen that there is a depression in FLDR where it 
seems logical to assume that FLD would bind, in modelling studies, FLD from Anabena sp 
was successfully docked into this depression. In this region there are also three arginine 
residues (R236. R237 and R238) and work in our laboratory to investigate their role in FLD 
binding is currently underway. 
In 1998 we reported on the biophysical studies of E. co/i FLD and FLDR, analysing the 
interactions between these two proteins, and determined the redox properties of the fiavin 
cofactors (112). in 1994 it was discovered that FLD and FLDR could support the function of 
17u—hydroxylase activities of bovine cytochrome P-450 (113). It has also been shown that 
FLD and FLDR support the activity of cytochrome P-450BM3 and that the reduction 
mechanism is a 'ping pong', with FLD acting as a shuttle rather than participating in a ternary 
complex between the FLD, FLDR and the P-450 (112). 
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The atomic structure of E.coli ferredoxin (flavodoxin) NADP oxidoreductase at 1.7 A (PDB 
1 FDR). The FAD(red) binds in a double sandwich domain with six strands surrounded by 
helices (blue). The NADPH-binding region is an open oL/P structure with a central parallel P-
sheet (green). 
1.7 The Mechanism of the Biotin Synthase Reaction 
The biotin synthase reaction has proven to be extremely complex and efforts to elucidate its 
mechanism have led to complex and confusing results. The first problem is the source of the 
sulfur atom which is inserted into two saturated carbon atoms of dethiobiotin to form the 
thiophene ring of biotin. Early work on the identity of the sulfur donor proved inconclusive 
and it has only recently that evidence has shown it to be derived from cysteine. In B. 
sphaericus crude cell free extracts, sulfur from [35S] cysteine was incorporated into biotin. 
However, this was not the case in the asssay where pure biotin synthase was activated by 
deazaflavin (90). In E. co/i crude cell-free extracts incorporation of 35S from [35S]cysteine and 
[35S]cystine have been reported (88). In defined mixtures, there is no evidence of 
incorporation of 35S from either [ 35S] cysteine or [35S] SAM (89). The fact that there is no 
sulfur incorporation in defined mixtures but incorporation occurs in cell free extracts points to 
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there being a component in cell free extracts which can convert the sulfur atom from cysteine 
into a form that can eventually be incorporated into biotin. In the currently defined cell free 
catalytic mixtures there are three possible sources of sulfur; the Fe-S cluster, an as yet 
unidentified sulfur-containing species associated with biotin synthase, (although this has 
never been observed, it would be consistent with the one turnover) and DTT. If DTT was the 
sulfur donor in vitro then the lack of the correct physiological donor would again explain the 
above results (44). 
Shaw et al. found that sulfur from [ 35S]-cysteine was incorporated into a reaction intermediate 
which could then produce labelled biotin and this strengthens the case for cysteine being the 
sulfur donor or a precursor to the sulfur donor (114). Whether it was just the sulfur atom or 
the entire amino acid that was attached to the intermediate remains to be verified. 
Marquet and coworkers found that biotin production in B.sphaericus increased 3-4 fold when 
FeC 1 3 and Na2S were added to the assay mixture. They proposed that this was due to the 
reconstitution of the Fe-S cluster. They repeated the experiment using Na 234S and found that 
34S-biotin was produced indicating that the sulfide could be utilised by the enzyme and 
incorporated into biotin. To verify whether or not the Fe-S cluster is involved in sulfur 
donation they reconstituted the apoenzyme with FeCI 3 and Na234S. When this enzyme was 
used in the assay 34S-biotin was produced indicating that the Fe-S cluster is the sulfur donor. 
They repeated the experiment with E.coli biotin synthase (without the addition of cysteine to 
the assay medium) and got very similar results. This appears to be a function for Fe-S clusters 
in that they can in fact provide sulfide for use in reactions. The most recent work on the sulfur 
donor has been carried out by Gibson in collaboration with Flint. In their assays however they 
had gone back to working with impure biotin synthase as further purification of the enzyme 
reduces its activity. They suggest that the biotin synthase acts as an "assay reagent" rather 
than a catalyst. In in vitro experiments using 35S cysteine and 35S methionine they produced 
35S biotin only when the labelled cysteine was present in the reaction mixture. They suggest 
that the sulfur is from either the Fe-S cluster or from a cysteine residue on the protein. They 
carried out mass spectrometry analyses on the enzyme looking for covalent interations and 
detected two species which they termed "naïve" and "experienced". The "naïve" enzyme gave 
a narrow peak with a mass of 38514.413a and the "experienced" enzyme gave a broad peak 
with a mass of 385 18.413a. They suggest that if sulfur was lost from the "experienced" 
enzyme then something must be gained to account for the increase in mass. They make no 
suggestions as to the nature of the chemical change (115). 
The second problem of the biotin synthase reaction is the mechanism of C-H to C-S bond 
formation. Many groups have investigated this and as early as 1968 Wright ci al. fed 
randomly tritiated DTB to cells of Aspergillus niger (116). Their results indicated that there 
was a loss of 4 hydrogen atoms. Eight years later Parry fed specifically titrated DTB to A. 
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niger and his results showed that only two hydrogens were lost - one from C6 and the other 
from C9. There was no loss of hydrogen at C5, C6 or C7 (117). Parry produced results, again 
using A. niger, that indicated that there was loss of the 6-pro-S-hydrogen at C6 (but not the 6-
pro-R hydrogen). Since the absolute configuration at C6 is S then sulfur is inserted with 
retention of configuration (118). Arigoni and Marti investigated the stereochemistry at the C9 
methyl group of DTB. They chirally labelled the methyl group with tritium, deuterium and 
hydrogen and it was found that "scrambling" of chirality occurred. The logical conclusion to 
this is that there is an intermediate between DTB and biotin that has a labile methylene radical 
(119). A number of authors have speculated as to whether there is a thiol intermediate 
involved in the reaction. Marquet (120) and Baxter (121) have both suggested that 9-
mercaptodethiobiotin could be this intermediate but they also note that 9-mercaptoDTB could 
be an abnormal precursor of DTB in vitro. 
Recent work by Shaw el al. has proved that SAM is directly involved in the biotin synthase 
reaction (114). Radiochemical assays involving [' 4C]-DTB resulted in the formation of an 
enzyme-generated intermediate. Formation of this intermediate was SAM-dependent and it 
was definitely derived from DTB, as it was radioactively labelled. The [' 4C]-intermediate was 
purified and then assayed. It in turn produced labelled biotin by a mechanism which again 
required SAM. Characterisation of this intermediate was not possible due to the fact that only 
nanogram quantities were produced. It is known however that it is not 9-
mercaptodethiobiotin, as it does not coelute with this compound on I-IPLC. It is possible that 
this intermediate is 9-hydroxydethiobiotin (capture of H 20 or 02) or arises by reaction of a 
DTB radical with cysteine to give the thioether adduct although 9-OH DTB was shown not to 
be an intermediate in whole cell work. In assays using [ 14C-methyfl-SAM a labelled product 
was formed which was found to be [' 4C]-methionine. This result supports the hypothesis that 
SAM is cleaved to produce methionine and a 5 '-deoxyadenosyl radical (DOA). Shaw and 
co-workers have proposed a mechanism where two molecules of SAM are required for each 
molecule of biotin produced. In this they propose that the conversion of DTB to the 
intermediate involves the generation of either a substrate-bound or enzyme-bound radical 
from the reductive cleavage of SAM, as does the intermediate to biotin step. If the radicals are 
both formed on the substrate, then one molecule of SAM would be needed to activate the 
methyl carbon and another to activate the methylene carbon of DTB. They did note however 
that over time it appeared that almost three molecules of SAM were used per biotin molecule 
produced and this has been supported by the work Guianvarc'h and co-workers on 
B.sphaericus biotin synthase who report a stoichiometry of 3:1 for SAM : biotin and that 
methionine and DOA are produced in equal amounts (122). In the case of enzyme radicals 
such as lysine 2,3-aminomutase (LAM) SAM consumption is catalytic with respect to 
substrate, although it can be increased during the reaction due to abortive processes. 
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However, for a direct radical formation on DTB SAM would be a substrate infering a 2:1 
stoichiometry. 
Studies on the biotin synthase reaction are in their infancy, but the fact that it cleaves SAM 
and probably uses a radical mechanism means that is could be a member of a group of 
enzymes which use SAM to form enzyme-bound (ARR, PFL) or substrate-bound radicals 
(LAM) which uses a B 12  -like mechanism where the homolytic cleavage of a C-H bond on the 
substrate lysine is mediated by DOA, as shown by the reversible transfer of 3H from the 
substrate to DOA (123). It should also be noted that the glycyl radical amino acid sequence 
(RVS(C)GY) which is found in ARR-AE and PFL-AE is not present in biotin synthase (84) 
Recent work by the Marquet group has further examined the role of SAM in the biotin 
synthase reaction. In order to find out if DOA directly abstracts the substrate hydrogen as in 
the LAM reaction they synthesised 6,9-[ 2 H 5]DTB, 9-[ 2H 3]DTB, 6(S)-[ 2H 1 ],9-[ 2 H 1 ]DTB and 
6(R)-[ 2 1-1 1 ],9-[2H 1 ]DTB and incubated them in the biotin synthase reaction. Mass spectrometry 
analysis of the products revealed that 2H from both the 9-methyl and the 6-pro-R position are 
definitely transferred from DTB to DOA (84). Mass spectrometry results reveal that 
deuterium transferred to DOA but whether it is at position 4' or 5' is unknown. The results 
also confirmed that in fact two molecules of SAM are required for the reaction (124) 
While the results are not entirely unambiguous in that mass spectrometry analysis of the 
mono deuterated DOA formed did not enable distinction between 5' and 4' deuterated species 
a point which may be immaterial since Frey (Southampton Biochemical Society meeting) has 
pointed out that C4 to C5 hydrogen transfer can occur in DOA radicals. This data strongly 
supports the DOA radical hypothesis and the proposals of the Marquet and Shaw groups are 
consistant enough to be combined in the scheme shown in Figure 1-13. 
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Figure 1-13 
The proposed mechanism for the conversion of DTB to biotin. 
1.8 Fe-S cluster enzymes 
The fact that biotin synthase is based on a core [2Fe-2S] protein with a requirement for 
NADPH. a FLD/FLDR redox couple and SAM as a radical generator suggests that it belongs 
to a growing family of enzymes which use Fe-S clusters. Four of these, anaerobic 
ribonucleotide reductase activating enzyme (ARR-AE) lipoic acid synthase (LIPA), lysine 
2,3-aminomutase (LAM) and pyruvate formate lyase activating enzyme (PFL-AE) have been 
studied in recents years. However, even within this small group there appears to be subtle 
differences with regard to subunit composition and chemical function. 
ARR was discovered in 1989 and was found to be an a 2 heterotetramer (125, 126). Like 
biotin synthase it also requires potassium, SAM and DTT, FLD and FLDR (104). Its reaction 
involves formation of a glycyl radical on the a subunit of the enzyme and is oxygen-sensitive. 
The 1E subunit is required for catalytic activity and contains a [4Fe-4S] cluster which joins the 
two P subunits together (127). SAM binds to the 3 subunits with a stoichiometry of 1:1 and it 
then is reduced by the Fe-S cluster during enzyme activation (128, 129). In 1993 a mechanism 
was proposed where FLDR is reduced by NADPH and this reduced FLDR then reduces FLD. 
The Fe-S cluster is in turn reduced by FLD. SAM then binds to the Fe-S cluster and is 
reduced. After this it dismutates into methionine and a primary DOA radical. The glycyl 
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work on characterisation of this cluster reveals that the P2 protein actually contains two [2Fe-
2S] clusters per chain which are converted to a single [4Fe-4S] cluster on reduction with 
dithionite (131). 
LAM from Clostridium substerminale catalyses the interconversion of L-lysine and L--
lysine and it is a hexameric Fe-S protein with a molecular weight of 285kDa (subunit weight 
is 47kDa). It is a PLP-containing enzyme which requires SAM. The Fe-S cluster of LAM 
exists as three different forms, one of which directly interacts with SAM. It is proposed that 
SAM is cleaved by reaction at the Fe-S centre to reversibly form methionine and a 
(hypothetical) DOA radical at the enzymes active site. This radical could then initiate the 
formation of a radical on the substrate. lysine (132). 
Lipoic acid synthase, the lipA gene product, inserts a sulfur atom into octanoic acid to form 
lipoic acid. Lipoic acid is a cofactor in oxidative carboxylations of cx-keto acids and in glycine 
cleavage. In these reactions lipoic acid is, like biotin, joined to the enzymes via an amide 
bond to a c-amino group of a lysine residue. The E. co/i lipA gene has been cloned and 
sequenced and it has a 36% sequence similarity to the E. coli biotin synthase (133) (134). The 
enzyme has been shown to be a dimer which contains a [2Fe-2S] cluster in each monomer. 
On reduction these two cluster converts to a single [4Fe-4S] cluster (73). Both lipoic acid 
synthase and biotin synthase contain a Y (F) N H N motif that may be part of the enzymes 
active site. The similarity in the chemistry of the dithiolane ring of lipoic acid and the 
tetrahydrothiophene ring of biotin suggests that the two enzymes may have similar 
mechanisms of action (135). This type of oxidative cluster rearrangement has only been 
observed for the subunit bridging [4Fe-4S] cluster in the nitrogenase Fe-protein, ARR lipoic 
acid synthase and in biotin synthase (83). 
PFL is a homodimer with a monomeric weight of 85kDa whose structure has recently been 
solved (136. 137). It has many similarities to ARR in that it also requires an Fe-dependent 
activating enzyme (a monomer of 28kDa) which contains a [4Fe-4S] cluster (PFL-AE) and 
SAM, DTT, NADPI-I and the FLD/FLDR couple (101) for activation (138. 139). In its active 
form, PFL contains a single stable glycyl radical (Gly-734) which is necessary for catalysis 
(140). The radical is thought to be produced by a mechanism similar to that of ARR. Single 
point cysteine to serine mutants in the PFL-AE have proven that three cysteine residues are 
absolutely essential for activity (Cys 29, 33 and 36). Direct interaction of SAM with the Fe-S 
cluster is possible (141). The spectroscopic data shows that the [4Fe-4S] cluster in the PFL-
AE cluster undergoes facile oxidative degradation to [2Fe-2S1 clusters as a result of exposure 
to oxygen during isolation (78). 
Other enzymes which are involved in sulfur incorporation such as the enzymes of thiamine 
and molydopterin biosynthesis have been documented in the literature. In the E. co/i thiamine 
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biosynthetic pathway, a thiazole and a pyrimidine are synthesised and then coupled to give 
thiamine. The mechanism of sulfur insertion to form the thiazole is not fully understood, but it 
is conjectured that the source of sulfur is cysteine and that the thiS gene product is the sulfur 
carrier (142. 143). Little is known about molbydopterin biosynthesis other than it requires a 
three enzyme system for sulfur transfer (143). The enzymes which insert sulfur into into 
amino acids in E.coli are serine acetyl transferase which activates serine and acetyl-CoA and 
forms O-acetyl-L-serine and O-acetyl-L-serine (thiol) lyase which converts this to cysteine 
(144). 
The mechanism of biotin synthase remains an enigma and before a mechanistic understanding 
can be reached a large number of questions still have to be answered with respect to the biotin 
synthase reaction. The factors limiting catalysis by biotin synthase need to be identified. The 
mechanism of sulfur transfer from the Fe-S cluster to the dethiobiotin radical needs to be 
investigated. The mechanism of the reductive cleavage of SAM by reduced Fe-S clusters 
needs to be elucidated. 
1.9 Aims 
The main aim of this work was to characterise the protein components of the E. co/i biotin 
synthase system. The electron transfer proteins FLD and FLDR were characterised and then 
mutational analysis of the Fe-S cluster of biotin synthase was carried out. In normal cells 
these proteins are expressed at low levels so expression systems had to be developed which 
would allow the large scale production of milligram quantities. 
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2.1 General Reagents 
Chemicals and solvents were of the appropriate quality and were purchased from Pharmacia, 
Promega. Sigma, Biorad, Gibco BRL. Amicon, New England Biolabs, Waters Millipore or 
Invitrogen unless otherwise stated. 
2.2 Solutions and Buffers 
AB buffer - ammonium bicarbonate (50mM, pH7.9) and zwittergent 3-16 (0.05%) 
Ampicillin - a stock solution (100mg/mi) was sterilised by filtration (0.45 tM) and used at a 
final concentration of 100ig/mI. The solution was stored at 4°C. 
Buffer A - Tris-1-ICI (50mM, pH 7.5) 
Buffer B - Sodium phosphate (100mM. pH 7.5) 
Buffer C - Sodium acetate (100mM, pH 5.0) 
Buffer D - Imidazole (5mM), sodium chloride (0.5M), Tris-HCI (20mM, pH 7.9) 
Buffer E - imidazole (IM), sodium chloride (0.5M), Tris-HCI (20mM, pH 7.9) 
Electroblot buffer - 3-[cyclohexiamino]-1-propanesulfonic acid (10mM, pHI 1.0), methanol 
(10%) 
Ethidium bromide - a stock solution (10mg/mi) was made and used at a final concentration 
of 5 .tg/ml. The solution was stored at 4°C in a dark bottle. 
LPTG - a stock solution of isopropyl - 3, D - thiogalactopyranoside (100mM) was sterilised 
by filtration (0.45 tM filter) and stored at 4°C. 
SDS running buffer- Tris-HCI (25mM, p1-18.3), glycine (192mM), SDS (I % (w/v)) 
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SDS sample buffer - Tris-HC1 (0.5 M, p1-I 6.8, 1.Oml), Glycerol (2.Oml), SDS (10% (wlv), 
1.6 ml), 2-13-mercaptoethanol (0.4 ml), bromophenol blue (0.05% (w/v), 2.0ml) 
TAE - Tris-HCI (40mM, pH8.0), acetic acid (57.1 ml), EDTA (0.5 M, pH 8.0, 1 OOml) 
Tetracycline - a stock solution (12.5mg/mi) was used at a final concentration of 12.5ig/m1. 
The solution was stored at -20°C. 
Transformation buffer (TB) - Calcium chloride (50mM). Tris-HCI (10mM, p1-I 8.0) 
2.3 Media 
Agar plates - bacto-agar (1 5g/1) was added to specified media to prepare agar plates. 
MRS modified - proteose peptone (15g), yeast extract (5g), sodium acetate (5g), ammonium 
citrate (2g). tween 80(1 ml), di-potassium hydrogen orthophosphate (2.4g), magnesium 
sulphate (0.2g), manganese sulphate (0.02g), the pH of the solution was adjusted to 6.4 with 
acetic acid, made up to 900ml and then autoclaved (12 1°C, l5psi, 15mm). Glucose (20g) was 
dissolved in water (I 00m]) and filter sterilised into the medium once it had cooled. 
Resuspension medium - 12% reconstituted milk solution (5 ml), MRS modified medium 
(2.5ml) and glycerol (2.5m1). This media was then autoclaved (12 1°C, 15 mm, 15 psi). 
Luria Bertani (LB) - bacto - tryptone (lOg), bacto - yeast extract (5 g), sodium chloride 
(lOg) were dissolved in distilled water (1 litre) and then adjusted to pH 7.5 with sodium 
hydroxide. 
Minimal (M9) - di-sodium orthophosphate (6 g), potassium di-hydrogen orthophosphate (3 
g), sodium chloride (0.5 g), ammonium hydrogen chloride (1 g). This was adjusted to pH 7.4, 
made up to 11 with distilled water and autoclaved (121°C, 15 min,15 psi). The media was 
allowed to cool and then the following filtered (0.45 riM) solutions were added - magnesium 
sulphate (IM, 2m1), glucose (20%, lOmI) and calcium chloride (IM, 0.1ml). 
Minimal casamino acids (M9 CA)- Identical to M9 but with casamino acids (2 gIl). 
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2YT - bacto - tryptone (16 g), bacto - yeast extract (lOg), sodium chloride (5 g) were 
dissolved in distilled water (1 litre) and then adjusted to pH 7.5 with sodium hydroxide. 
2.4 Bacterial Cell Lines 
JMIOI. JMI09 and TOP 1OTM cell lines were used for the storage of genes and also for the 
initial transformation of ligation products. PCOi was used to prepare a bio cell free extract. 
1-lyperproduction of proteins was carried out using B834 (DE3) HMS 174 (DE3) DHSaF' and 
JMIOI. Lactobacillus plantarum (ATCC 8014) was used in the microbial biotin assay. 
Cell Line Genotype Reference 
JMIOI F traD36 lacl' 	(lacZ) MIS proABV supE thi A(lac- (145) 
proAB) 
JMIO9 F' traD36 laclq A(lacZ) MIS proA 	B /e14 (McrK) A(Iac-  
proAB) thi gyrA96 (NaIr)  endAl 	hsdRI7 (rkmk) relAl 
supE44 recAl 
Top IOTM F'mcrA D(mrr-hsdRMS-mcrBC) 	t801acZAM15 AlacX74  
deoR 	recAl 	araDI39 A(ara-leu)7697 gal/U gal/K 	rpsL 
endAl nupG 
PCOi bioA(attX, 	bio 	uvrB) 	thr, 	leu, 	thi, 	placi 	which 	confers 
tetracycline resistance 
B834 (DE3) F ompT hsdS (rm; an E. coli B strain) gal dcm met with  
DE3, a X prophage carrying the 17 RNA polymerase gene 
HMS 174 (DE3) F, recA, hsdR [rKI2mKI2] Rif' with DE3, a ). prophage (147) 
carrying the T7 RNA polymerase gene 
Dl-l5czF' F/endAl hsdRI7 (r k mk) supE44 thil recAl gyrA (Nal')  
reIAIA9IacIZYA-argF) u169 deoR (80dlacA (lacZ) MIS) 
2.5 DNA Vectors and Plasmids 
Vectors used for the initial cloning and storage of genes were pUC I 8/RBS. a derivative of 
pUCI8 that contains a Ncol cloning site, and pEEI010. Plasmids used for the cloning and 
overexpression of proteins were pET16b, pET6H (his-tagged proteins), pCL2I (FLDR). 
pD551 (NIFS). pDl-ll (FLD), pET16b/bioB (wild-type biotin synthase), pHis 613 (l-lis6-tagged 
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biotin synthase), pC53S, pC57S, pC60S, pCI88S and pC288T (His 6-tagged biotin synthase 
mutants). 
2.6 Oligonucleotide Primers 
The following oligonucleotide primers were used (restriction sites are in bold and codon 
changes are underlined). 
BLOB PCR 	5' - GGTAAAACCATGGCTCACCGCCCA -3' 
BMUTFOR 5' - GTAAAAGCGATGGGGCTCGAGGCGTGTATG -3' 
BXHO 1 	5' - CGCCGACTCGAGCACCTG -3' 
C53S 	5' - AAGACCGGAGCTTCCCCGGAA -3' 
C57S 	5' - CCGGAAGATTCTAAATACTGCCCG -3' 
C60S 	5' - AAATACTCTCCGCAAACGTCGCGC -3' 
C 188 	5'- GGGATCAAAGTCTCTTCTGGC -3' 
C288T 	5' - GGTCAGCAGTTTGGTACCGTA -3' 
M13 	5'- CGCCAGGGTTTTCCCAGTCACG -3' 
NEW REV 5' - GTTGTGTGGAATTGTGAGCGG -3' 
RED FOR 	5' - CAGGAGAATTCCATGGCTGATTGGGTAACAGGC -3' 
RED REV 	5' - ATAAGGATCCGCTTACCAGTAATGCTCCGCTGTCAT -3' 
BLOB PCR contains an Ncol site and it was used for sequencing and amplification of the bioB 
gene. BMUT FOR and BXI-IO I incorporated a Xhol site in the bioB gene by changing a 
single base pair at two different sites (G375C and G246C). C53S. C57S, C60S, C188S and 
C288T caused single point, cysteine to either serine or threonine, mutations in the bioB gene. 
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M 13 and NEW REV are pUC 18 vector primers and were used for the PCR and sequencing of 
genes cloned into pUC 18. RED FOR and RED REV were used to PCR the fldr gene from 
pEE 1010. 
2.7 Equipment 
Electrophoresis was carried out using a Biorad Protean 11 minigel system (protein) and a 
Gibco BRL H5 system (DNA). Denley BR401. Sorvall RC-513 and DuPont Micrcospin 12 
centrifuges were used for centrifugations A Pharmacia FPLC system and various columns 
were used for chromatographic separations of proteins. 
2.8 Storage of Bacterial Stocks 
LB or 2YT medium containing the appropriate antibiotics were used for the short-term 
storage of E. co/i. Colonies of bacteria were stored on inverted parafilm sealed agar plates at 
4°C for up to four weeks. For long term storage strains were frozen (-80°C) in LB or 2YT 
media containing glycerol (15%) (149). 
2.9 Preparation of E. coil Competent Cells 
LB or 2YT media (lOmI) was inoculated with a single bacterial colony from a fresh agar plate 
or from frozen stocks and grown overnight (37°C, shaking at 250rpm). Fresh LB or 2YT 
(lOmi) containing magnesium chloride (IM, 0.2ml) was seeded with some of the overnight 
culture (0.2m1). The cells were grown to OD 6wn,, = 0.2 and then chilled on ice (5mm). 
Centrifugation (3000rpm, 1 5mm, 4°C) was used to pellet the cells. The supernatant was 
discarded and the pellet resuspended in cold TB (4 ml). The cells were then placed on ice and 
agitated gently (30mm). Centrifugation was carried out to pellet the cells (3000rpm, 1 5mm, 
4°C). The supernatant was discarded and the cells were resuspended in cold TB (0.4ml). The 
competent cells were left on ice for 2h prior to use (149). 
2.10 Transformation of E. coil Competent Cells with Recombinant DNA 
The competent cells were gently resuspended and 100tl of the suspension transferred to a 
sterile Eppendorf tube. This was then left on ice (15mm) and DNA was added (up to 40ng). 
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The tube was tapped gently and left on ice (30mm). The cells were then heat shocked (37°C, 
5mm) and warm LB (37 °C, 1 ml) was added. The tube was then incubated (37°C, 1h), 
centrifuged (15000rpm, 15mm, RI) to pellet the cells, the supernatant discarded and the 
pellet resuspended in LB (501tl). The suspension was spread to dryness on selective agar 
plates and incubated (37 °C, 16h) (149). Ready-made competent cells were transformed 
according to the manufacturers instructions. 
2.11 Preparation of Plasmid DNA 
Plasmid DNA was prepared using the Promega WizardiM  Plus Minipreps DNA purification 
system (Promega). 
2 12 Digestion of DNA with Restriction Endonucleases 
Typically the required amount of DNA (0.5-1,ug) was treated with the appropriate amount of 
enzyme and buffer and the sample was then placed at the appropriate temperature for the 
required amount of time (buffer and temperature conditions for each enzyme were as advised 
by the manufacturers). Blue/orange loading dye (Promega), typically 2iL/10tl of incubation 
mixture was added and the samples were subjected to electrophoresis on agarose. The gels 
were then viewed and photographed under ultraviolet light (149). 
2 13 Electrophoresis of DNA 
The required amount of agarose was added to TAE buffer and heated at 100°C until it 
dissolved. The solution was allowed to cool to 55°C and ethidium bromide was added to a 
final concentration of 0.5j.tg/ml . The gel was then poured into the casting mould and allowed 
to set at room temperature (149). 
2.14 Purification of DNA 
DNA was purified from either agarose or from solution using the Prep A Gene® kit from 
Biorad. 
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2.15 Amplification and Mutagenesis of DNA 
PCR and sequencing reactions were done using a Perkin Elmer 480 thermal cycler. The 
following were placed in a PCR tube (0.5ml) - 2 Ready to Go PCR Th' beads (Pharmacia), DNA 
template (1il), primer 1 (forward) (5tl), primer 2 (reverse) (5.tl) and distilled water (39tl). 
These were then overlayed with PCR oil and cycled 30 times at 95°C for I mm, 54°C for I 
min and 72°C for 2 mm. Heating at 72°C for 5 min terminated the reaction. The PCR product 
was then subjected to agarose gel electrophoresis and the required band was excised and the 
DNA purified as described in section 2.14. In mutagenic PCR reactions the resulting PCR 
product (megaprimer) was used as primer 2 in the second reaction (1 50). 
2.16 PCR Screen 
A single colony was picked from a plate and gently touched on a fresh agar plate before being 
resuspended in water (50tl). The cell suspension was boiled (5 mm) and then the debris 
centrifuged (13000rpm, 5 mm ). A sample was removed (5 xI) and used in a PCR reaction to 
amplify the gene using the appropriate primers. The PCR conditions are described in section 
2.15. 
2.17 Automated DNA Sequencing 
Automated DNA sequencing was carried out on an ABI prism 377 DNA sequencer using the 
Sanger dideoxy chain termination method. The following were placed in a PCR tube (0.5ml) 
DNA template (-5 pmol) (101il), primer (Itl). distilled water (l d) and DNA sequencing pre-
mix (Amersham) (8.tl). The reaction mixture was overlayed with oil and cycled 30 times at 
96°C for 30sec, 45°C for 15 sec and 60 °C for 4 mm. Sequencing data was analysed using the 
ABI Prism editview software. 
2.18 Precipitation of DNA 
To the DNA sample ammonium acetate (7.5M, 1/3 vol) and ethanol (100%, 4 vol) were 
added. The solution was left on ice (2h) and then centrifuged (15 mm. 13000rpm). The 
supernatant was discarded, the pellet washed with ethanol (70%, 250tl), centrifuged (15mm, 
1 3 000rpm), the supernatant discarded and the pellet dried under vacuum. 
35 
Chaøter 2: Materials and Methods 
2.19 Cloning into Plasmid Vectors 
The DNA fragment (or PCR product) cut with suitable restriction enzymes (13 p1), the host 
vector cut with suitable restriction enzymes (3 tl), lOX T4 DNA ligase buffer (2 .tl) and T4 
DNA ligase (2 pi) were placed in an Eppendorf. A control with water (13 tl) instead of the 
gene or PCR product was also set up. The reaction was left at room temperature for 24-48h 
and then transformed into a suitable cell line (as section 2. JO). 
2.20 SDS Polyacrylamide Gel Electrophoresis (SDS PAGE) 
SDS PAGE was used to analyse proteins on the basis of their molecular weight. The 
technique used was the discontinuous buffer system of Laemmeli (151). 
2.21 Protein Concentration Assays 
The protein concentration was determined according to Bradford using bovine serum albumin 
as a reference (152). Alternatively, protein concentration was measured using the following 
extinction coefficients. Biotin synthase (c 274 = 3.3 x 10 4M' cm', 6 330nn, = 1.4 x 
104M- I  cm 
420nm = 6.Ox 103M 1 cm 1 , C 453nm = 7.1 x 10 3M' cm t , C 540nm = 3.5 x 
103M- I  cm' )(66). 
FLDR ( = 7100M' cm - ') (I 11). FLD (c 4mnm = 8250M 1 cm -1 FLD has a ratio of A 2741 I 
A4661 = 5.8) (104). 
2 22 Mini Induction of Proteins 
A single colony from a freshly transformed plate was placed in LB or 2YT (2rn1 - lOmI) 
containing ampicillin. The cells were grown to an OD 600 , = 1.0 and divided equally into two 
aliquots. One sample was induced with IPTG (1mM) while the other served as a control. Both 
samples were then allowed to grow for a further three hours prior to being centrifuged 
(13000rpm, 30s). The supernatants were discarded and the pellets were resuspended in SDS 
sample buffer (I 00p1), boiled (5mm) and loaded (15p1) onto a SDS gel (15%). 
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2.23 Preparation of a bio Cell Free Extract 
LB (lOmI) containing tetracycline (10tg/ml) was inoculated with PCOi from either frozen 
stock or a fresh agar plate. The culture was grown overnight (37 °C, shaking 250rpm) before 
being subcultured into fresh LB containing tetracycline (2.5 ml into 250m1 x 4). The cells 
were grown as before for 6h. Centrifugation (5000g. 1 0mm, 4 °C) was carried out to harvest 
the cells and the cell pellet was washed and resuspended in buffer A (I ml of buffer per 0.25 g 
of cells). The cell suspension was sonicated for 15 mm (30s on with 30s rest, 4 °C) and the 
sonicated sample was then centrifuged (10000rpm, 20mm, 4 °C) to get rid of cellular debris. 
The supernatant cell free extract was aliquoted into Eppendorf tubes and stored frozen (-80°C) 
in glycerol (15 %). 
2.24 Large Scale Preparation of E.coIi Flavodoxin 
Transformant JMIO1/pDH1 was grown in 2 - 10 litres of LB containing ampicillin 
(lOOp.g/ml) to OD 600,. = 1.0 and production of FLD was induced by the addition of IPTG 
(100.iM). Riboflavin (5mg/I) was also added to the culture at the time of induction. The cells 
were harvested 6 hours after induction and then the cells (Ca 1 .5g/l wet weight) were washed 
by resuspension in ice-cold buffer B, broken by intermittent sonication (30s on, 30s off for 15 
mm) and the cell lysate collected after centrifugation. Protamine sulfate was added to a final 
concentration of 0.1% (w/v)to the extract and the mixture centrifuged (15000g for 30minutes, 
4°C). The filtered (0.45tM) supernatant was loaded directly on a Q-Sepharose 26/10 Hi-Load 
anion exchange column (2.6cm x 10cm) which had been pre-washed in buffer C and FLD 
was eluted from the column in a gradient of NaCl (0- IM, IOCV) in buffer C, between 375 
and 425mM NaCl. The pH of the bright orange FLD-containing fractions was increased to pH 
7.5 immediately following elution by dialysis against buffer B. This single-step procedure 
resulted in a fraction in which >90% of the protein was FLD. Further purification was 
achieved by a second anion exchange chromatography step using a Resource Q column 
(0.64cm x 3cm). Protein was loaded in buffer B and eluted using a linear gradient of NaCl (0 
- I M, IOCV) in buffer B. Pure FLD was eluted between 350 and 400mM NaCl. The final 
FLD fraction was dialysed against buffer B, concentrated by ultrafiltration (Amicon, 10000Da 
cut-off) to ca 5mg/mI and stored frozen at -20 °C. 
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2.25 Large Scale Preparation of E. coil Flavodoxin (ferredoxin) NADP 
oxidored uctase 
Transformant HMSI74 (DE3)/pCL2I was grown in 2 - 10 litres of LB media containing 
ampicillin (lOOjig/mI) to an OD6nm = 1.0 and production of FLDR was induced by the 
addition of IPTG (100iM). Thereafter, growth was continued for 3 hours and the cells (ca 
2.5g/l wet weight) were harvested by centrifugation (7500rpm for 10 minutes, 4 °C), washed 
by resuspension in ice cold buffer B and lysed by intermittent sonication (30s on, 30s off) for 
15 minutes. Cellular debris was removed by centrifugation (10000 rpm for 30 minutes, 4 °C) 
and the filtered (0.45tM) supernatant was loaded directly on a Q-Sepharose 26/10 Hi-Load 
anion exchange column (2.6cm x 10cm) which had been pre-washed in buffer B. Protein was 
eluted with a gradient of NaCI (0-IM, IOCV) in buffer B. Yellow FLDR-containing fractions 
were collected from 130 to 150mM NaCl. These were combined and loaded on a 2, 5'-ADP 
Sepharose column (1cm x 20cm), pre-equilibrated with buffer B containing 150mM NaCl. 
Pure FLDR was eluted using buffer B containing 500mM NaCl. The purified enzyme was 
dialysed against buffer B, concentrated by ultrafiltration (Amicon, I000013a cut-off) to ca 
5mg/mi and stored frozen at -20°C. 
2.26 Preparation of Biotin Synthase Cell Free Extracts 
Wild-type 	biotin 	synthase 	(from 	HMS 174 	(DE3)/pET16b/bioB 	or 	B834 
(DE3)/pET16b/bioB), His 6-tagged biotin synthase (from HMSI74 (DE3)/pET6H/bioB) and 
mutant forms (from HMS174 (DE3)/pC53S, pC57S, pC60S, pCI88S and pC288T) were 
prepared from cultures grown in 2 - 10 I of 2YT media containing ampicillin (100 jig/mi). 
Transformed cells were grown at 37°C (shaking 250rpm) until the OD 60onm = 1.0. and 
transcription induced by addition of IPTG to a final concentration of 1mM. Cells (Ca. 2.5g/l 
wet weight) were harvested (5000g for 10 minutes, 4°C) after a further 4 hours of growth. 
The l-lis6-tagged protein pellets and mutant pellets were washed by resuspension in ice cold 
buffer D. The cell pellets from the wild-type biotin synthase clone were washed in buffer B. 
The cell pellets were lysed by intermittent sonication (30s on, 30s off) for 15 minutes, cellular 
debris was removed by centrifugation (15000g for 30 minutes. 4°C) and the supernatants 
were stored frozen (-20°C) in glycerol (15%). 
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2.27 Purification of Wild-type Biotin Synthase 
Protamine sulphate (1%, 0.5ml per lOmI ) was added to the cell free extract to remove nucleic 
acids. Ammonium sulphate (45%) was then added to the supernatnant and centrifuged. The 
protein pellets were resuspended in buffer B and filtered (0.45.tm) prior to being loaded onto 
a Q-Sepharose 26/10 high load anion exchange column (2.6cm x 10cm) which had been 
equilibrated with buffer B. The proteins were eluted with an increasing gradient of potassium 
chloride (0 - IM, IOCV) in buffer B. The fractions containing biotin synthase eluted at ca 
300mM salt and were red in colour. They were combined and ammonium sulphate (10%) was 
added. This was then loaded onto a Phenyl Sepharose hydrophobic interaction column (I cm x 
30cm) which had been equilibrated with buffer B containing ammonium sulphate (10%). 
Biotin synthase was eluted with a decreasing gradient of buffer B containing ammonium 
sulphate (10 - 0%. IOCV). Biotin synthase eluted at the end of the gradient. The fractions 
containing biotin synthase were combined and filtration concentrated (Amicon, 1000013a cut-
off). The concentrated protein was loaded onto a Sephacryl S-200 HR gel filtration column 
(2.6cm x 60cm) and eluted with buffer B. Protein samples were stored frozen (-80°C) in 
glycerol (15%). 
2.28 Purification of His6-tagged Biotin Synthase and Mutants 
Transformant HMSI74 (DE3) pHisB was grown in 2YT containing ampicillin (100pg/ml) 
and incubated overnight (37 °C, shaking 250rpm). The overnight culture was then subcultured 
into fresh 2YT amp and incubated as above until the OD600nn = 1.0. The cells were then 
induced with IPTG (1mM) and grown for a further 3 - 6h. The cells were harvested by 
centrifugation (7500rpm, 1 0mm, 4°C) and then washed with buffer D. The wet weight of the 
cells was determined and they were resuspended in buffer D (0.25g cells/I ml buffer). The 
cells were sonicated on ice (30s on, 30s off, 15mm) and centrifuged (10000rpm, 20mm, 4 °C). 
The supernatant was filtered (0.45p.M filter) and loaded on to a Hitrap chelating affinity 
column (5m1, Pharmacia, 4°C) which had been charged with Ni 2 (NiSO4, 100mM). The 
column was then washed with buffer D and the protein eluted with buffer E. The pure protein 
was immediately dialysed against buffer B and then stored at -20 °C in glycerol (15%). Four of 
the biotin synthase mutants (C53S, C57S, C60S and C288T) were also purified using this 
protocol. 
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2.29 Preparation of Apo- and Holo- Wild-type Biotin Synthase and 
Mutant Proteins 
These experiments were carried out using the methods of both Sanyal (66) and Marquet 
(153). 
2.30 Purification of Azotobacter vinelandil NifS 
The purification and assays were carried out as described by Zheng (92). 
2.31 Chemical Cross-linking of Flavodoxin (ferredoxin) NADP 
oxidoreductase and Flavodoxin 
Purified FLD (40.tM) and FLDR (8.tM) were covalently cross-linked using 1-ethyl-3-
(dimethylamino-propyl) carbodiimide (10mM) in Hepes buffer (10mM, 2 ml, pH 7.0) at room 
temperature. Aliquots were withdrawn from the reaction at 15 minute intervals to assess the 
progress of the reaction by SDS-PAGE. After 1 hour, the reaction was stopped by the addition 
of ammonium acetate (100mM) and the protein mixture concentrated to approximately 0.5m1 
by ultrafiltration (using a lOkDa cut-off Centricon concentrator [Amicon]). The cross-linked 
complex was separated from the FLDR and FLD proteins by gel filtration on FPLC 
(Superdex 75 column, 1.6 x 60cm) in buffer A containing 50mM KCI (154). The protein 
(2mg/mi) was stored at -20°C. 
2.32 In vitro Biotin Production 
The assays were carried out aerobically and anaerobically in buffer B. A typical assay mixture 
contained biotin synthase or mutant protein (51iM), potassium chloride (10mM). dethiobiotin 
(501.tM), SAM (1 50 j.tM), ferrous ammonium sulphate (5mM), NADPH (1mM). fructose 1,6-
bisphosphate (5mM), L-cysteine (5001.tM). DTT (10mM), PCOi cell free extract (1001.d), 
FLD (12.5i.tM) and FLDR (2j.tM). The final reaction volume was typically ImI. The reaction 
was incubated at 37°C for 2 hours and then stopped by adding lOOj.tl of 10% TCA. The 
resulting precipitate was centrifuged and 5jtl of the supernatant was used in the bioassay 
(section 2.34). 
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2.33 In vivo Biotin Production 
Transformants of HMS 174 (DE3) with pET16b, pET6H, pETI6b/bioB, pET6H/bioB, pC53S, 
pC57S, pC60S, pCI88S and pC288T were grown in M9CA media containing dethiobiotin 
(5tgIml), glucose (0.4%), thiamine (0.8.1g/ml), magnesium sulphate (2mM), calcium chloride 
(0.1mM) and ampicillin (100tgIml). At OD 6w. = 1.0 the cells were equally divided and one 
sample was kept as a control while the other was induced with IPTG (1mM). HMS 174 (DE3) 
was used as a control and was grown in the same media minus the ampicillin. Aliquots of the 
medium (I ml) were removed from both control and induced samples at various time intervals 
and held at 4°C. The cells were then pelleted by centrifugation and 5d of the supernatants 
were used in the bioassay (section 2.34). 
2.34 Lactobacillus Bioassay 
In vitro and in vivo biotin production was determined using the Lactobacillus assay (155). 
2.35 Steady-state Kinetics 
UV/Vis spectroscopy and steady-state kinetics were carried out using a Unicam UV4 and 
Shimazdzu 1201 spectrophotmeters. Steady-state kinetic parameters for FLDR and FLD were 
measured at 30 °C in buffer B. Reduction of cytochrorne c (horse heart, type 1) was monitored 
by absorbance increase of the Sorret band 	= 22640M'cm5. Reduction of potassium 
ferricyanide was measured by absorbance decrease at 420nm (c = I01OM 1 cm 1 ). 
Measurements of P-450BM3 haern domain-catalysed arachidonic acid oxidation supported by 
FLDR and FLD were performed as described previously for the catalysis of pregnenolone 
oxidation by P-45007 (113). To determine the mechanistic nature of the FLDR/FLD/P-
450BM3 interactions, a series of oxidation rate measurements were performed in the presence 
of saturating NADPH (1mM), FLD (25MM), FLDR (0.25-10.tM) and the P-450BM3 haem 
domain at 0.76.tM, 2.541.tM or 3.81tM. Reaction rates were determined at 30°C in buffer B 
and the reciprocals of the data plotted against the reciprocals of the concentration of FLDR 
for each concentration. 
2.36 Pre-steady State Kinetics 
Stopped flow kinetic analyses were carried out using an Applied Photophysics SF.17 MV 
spectrophotometer. Reactions were performed anaerobically at 30°C in buffer B. Absorbance 
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changes associated with flavin reduction of FLDR (40j.tM) by NADPLI (4tM - 2mM) were 
monitored at 456nm. The electron transfer from FLDR to FLD was monitored at 583nm 
(formation of FLD blue semiquinone, 6 = 4933Mcm) after mixing reduced FLDR (40tM, 
pre-reduced with 2mM NADPH or sodium dithionite) with FLD (20tM). 
When sodium dithionite was used, FLDR was reduced completely in an anaerobic 
environment with excess reductant, then separated from the dithionite by gel filtration under 
anaerobic conditions. Reoxidation of FLDR was measured by mixing the reduced protein 
(80tM) with a sub-stoichiometric quantity of NADPH (40jtM) and monitoring the 
absorbance increase at 456nm. Reoxidation of the FLD semiquinone (absorbance decrease at 
583nm) was measured after anaerobic reduction of the enzyme with excess sodium dithionite, 
isolation of the reduced enzyme by gel filtration and dilution of reduced FLDR into aerobic 
buffer. Reduction of cytochrome c was measured at 550nm after reaction of reduced FLDR 
(10- 50tM enzyme + 2mM NADPI-I) with cytochrome c (horse heart, type 1;4j.tM). Analysis 
of stopped-flow data were performed using the SF.17 MV software and Origin (Microcal), 
both of which use non-linear least-squares regression analysis. 
2.37 Elemental Analyses 
Inductively coupled plasma atomic emission spectroscopy [ICP-AES] was used for metal 
analyses. All data were interpreted using thermospec/CID software. The R.F. Power was 1150 
watts, the nebulizer flow was 30 psi, the pump rate was 100rpm and the purge time was 90s. 
Fe(NO 3 )3 (0.01-IOOppm; 180nM-1.8mM) and Ni(NO 3)2 (0.0001-1.Oppm; 1.7nM - 17mM) 
solutions were used as standards. All biotin synthase samples (27tM) and standard solutions 
were made up in buffer B (156). 
Chemical analysis for iron was carried out using the Ferrozine assay as described by Stookey 
using the standard described above (157). Labile sulfide analysis was determined as 
previously reported (66). 
2.38 Mass Spectrometry 
Electrospray mass spectrometry was performed on a Micromass Platform II quadrupole mass 
spectrometer equipped with an electrospray ion source. The mass spectrometer cone voltage 
was set to 70V and the source temperature to 65°C. Protein samples were separated on a 
Gilson I-IPLC system using a Aquapure reverse phase C-4 column at a constant TFA 
42 
Chapter 2: Materials and Methods 
concentration of 0.1% using a linear gradient of 10-100% acetonitrile in water over 40 min at 
a flow rate of Imi/min. The total ion count of all the ions in the mlz range 500 to 2000 and the 
UV chromatogram at 280nm were recorded for the revered-phase HPLC separation. The mass 
spectrometer was scanned at intervals of 0. Is, the scans accumulated, the spectra combined 
and the average molecular mass determined using the MaxEnt and Transform algorithms of 
MassLynx software. 
2.39 Electroblotting of Proteins 
Protein samples were run on a SDS gel (15%, 40mm, 200V), and then the gel was soaked in 
electroblot buffer (5 mm). At the same time the problot membrane (same size as gel) was 
soaked in methanol for a few seconds. The electroblot was set up with the membrane closest 
to the anode and the gel closest to the cathode. Transfer was carried out at 50V for 2h at RT. 
The membrane was rinsed with distilled water, stained with Ponceau S (2% in 1% acetic acid, 
I mm) and then rinsed with distilled water. The bands of interest were then excised using a 
scalpel. 
2.40 Tryptic Digest of Proteins 
Protein samples were separated on SDS gels (15%) and stained with Coomassie G-250. The 
protein bands of interest were excised along with a control band of gel that contained no 
detectable protein. The gel strips were allowed to dry before being resuspended in AB buffer 
(20i.tl), chopped into 2-3mm pieces and put into Eppendorf tubes. AB buffer (100t1) and 
modified trypsin (1 ld of 20tgI50j.il) were then added. Samples were incubated overnight (37 
°C, shaking 250rpm), centrifuged (13000rpm, 1 0mm) and the supernatants transferred to fresh 
tubes. AB buffer (1 00111) was added to the pellet which was then left at 37 °C for Ih. Samples 
were centrifuged as before and the supernatants combined. The supernatants were stored at - 
20°C until needed. 
Aqueous acetonitrile (40%) was sometimes used as an alternative to AB in the above digest. 
2.41 Protein Sequencing 
N-terminal sequencing was done using an ABI 477A protein sequencer using the automated 
Edmann degradation method (158). Tryptic digests were separated using an ABI 130A 
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microbore HPLC using solvent A (0.1% TFA in water) and solvent B (0.08% TFA in 70% 
acetonitrile). The proteins were eluted with a linear gradient from 0 to 70% solvent B over I h. 
The flow rate was 1 00j.lImin at 220nm. The collected protein peaks were then sequenced. 
2.42 Potentiometric Titrations 
All redox titrations were conducted within a Belle Technology glove box under a nitrogen 
atmosphere (02 < 5p.p.m). Degassed, concentrated protein samples were passed through an 
anaerobic Sephadex G25 column (I x 20cm) immediately on admission to the glove box. The 
column was equilibrated and proteins were eluted with buffer B. Protein solutions were 
titrated electrochemically according to the method of Dutton using sodium dithionite as 
reductant and potassium ferricyanide as oxidant (159). Mediators were introduced prior to 
titration; typically 2-hydroxy-1,4-napthaquinone (5p.M), benzyl viologen (1 tM) and methyl 
viologen (11.iM) within sample volumes of 5-10ml. After 10-15 minutes equilibration 
following each reductive/oxidative addition, spectra were recorded between 350 and 800nm. 
The electrochemical potential of the sample solutions were monitored using a CD740meter 
(WPA) coupled to either Pt/calomel or PtJAg.AgCI combination electrodes (Russell pH Ltd.) 
at 25 ± 2°C. The electrodes were calibrated using the F&"/Fe 11 EDTA couple as a standard 
(+108mV). The calomel and Ag.AgCI electrodes were corrected by +244 ± 2mV and +198 + 
3mV respectively, both relative to the normal hydrogen electrode. For experiments involving 
FLDR, UV/Vis spectra were affected by the slow formation of a protein precipitate, which 
resulted in a small increase in baseline absorbance with time. This was corrected for by 
transforming each spectrum with a I/k subtraction calculated to return the absorbance at 
800nm back to zero (at this wavelength chromophore absorbance is minimal). All data 
manipulations and non-linear least squares curve fitting of electrochemistry data were 
conducted using Origin (Microcal). 
2.43 Fluorimetry 
All experiments were carried out using a Shimadzu RF530IPC spectrofl uori meter. Excitation 
and emission fluorescence was carried out on free FMN (4N). For excitation spectra the 
emission wavelength was 525nm (slit width l.Snm) and the excitation wavelength was from 
450nm to 700nm (slit width 3nm). For emission spectra the excitation wavelength was 450nm 
(slit width I .5nm) and the emission wavelength from 450nm - 700nm (slit width 3nm). Flavin 
fluorescence was carried out on free FMN (0.7.tM) and FLD (9.8iM) with an excitation 
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wavelength of 450nm (slit width 3nm) and an emission wavelength from 450nm to 700nm 
(slit width 5nm). It was also carried out on both FLD (73p,M) and FLDR (50tM) in the 
presence ofGdni-iCl (between 0 and 6.7M). The excitation was at 450nm (slit width 5nm) and 
the emission was between 500 and 600nm (slit width lOnm). A time course was carried out 
on FLD (240tM) in GdnHCI (63M) where samples were removed at time intervals between 
with the final sample being boiled (5mm). Tryptophan fluorescence was carried out on both 
FLD (480nM) and FLDR (310nM) in the presence of GdnHCI (between 0 and 6.7M). The 
excitation was at 290nm (slit width 5nm) and the emission was between 300nm and 400nm 
(slit width 5nm). All experiments were carried out in buffer B in a 1cm fluorimetry cell. 
2.44 Circular Dichroism 
All CD experiments were carried out on a Jasco Spectropiarimeter. Far UV (190nm-260nm) 
CD of FLD (30jiM). FLDR (20tM) and a one to one mixture of FLD (151.tM) and FLDR 
(10iM) was measured in buffer B at IOnm/min in a 0.02cm cell. Near UV CD (260nm-
320nm) of FLD (75tM), FLDR (50p.M) and a one to one mixture of FLD (37.51.iM) and 
FLDR (50p.M) were measured at lOnm/min in a 0.5cm cell. Visible CD of FLD (751iM), 
FLDR (501tM) and a one to one mixture of FLD (37.5tM) and FLDR (50.tM) were measured 
at 20nmlmin in a 0.5cm cell. Far UV, near UV and visible CD of FLD and FLDR were also 
measured in the presence of varying concentrations of GdnHCI using the same concentrations 
and conditions mentioned above. 
2.45 Analytical Ultracentrifugation 
In order to determine the operational molecular masses of FLDR and FLD (15iM) 
sedimentation equilibrium (SE) and velocity (SV) studies were performed on a Beckman 
Optima XL-A AUC. The AUC was equipped with 6-channel, 1.2 cm pathlength centrepieces 
and scanning optics to measure the equilibrium solute distribution. 
2.46 Crystallisation Trials 
Structure screen I (Molecular Dimensions Ltd) was used and an aliquot of each solution 
(300i.tl) was placed in a well of a Linbro ® multi-well plate. Concentrated protein samples 
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(5mg/mi, 2.tl) and well solution (2.tl) were placed on a siliconised cover slip which was then 
placed upside down over a parrafin wax coated well lip in a hanging drop fashion. 
2.47 Sequence Alignments 
Swissprot (http ://www. expasy.ch/sprot/)  and the Genomes Representation Organisation 
(http://www.ncbi.nim.nih.gov/Entrez/Genome/org.htm)  databases were used to search for 
amino acid sequences which were then aligned using Expasy (http://www.expasy.chl ), Clustal 
W (http://www2.ebi.ac.uklclustalw/)  and Alscript (160). 
2.48 Vector NTI 5 
This programme was used for drawing plasmids, manipulation of both nucleic acid and 
protein sequences and primer design. 
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Chapter 3: Characterisation of FLDR and FLD 
3.1 Introduction 
FLDR is a monomeric (247 amino acids, Mr 27620) enzyme which contains FAD. FLD is a 
small (177 amino acids. M1 19606) acidic f'lavoprotein which contains FMN as its prosthetic 
group. FLD is used in electron transport where it transfers electrons from NADPH via FLDR 
to a variety of systems. Characterisation of these proteins is essential to understand their roles 
in numerous biological pathways. 
The aim of this work was to obtain milligram quantities of homogeneous E. co/i FLDR and 
FLD for characterisation by a number of biophysical techniques, including SDS PAGE, 
electrospray mass spectrometry, potentiometric titrations, AUC, fluorimetry and circular 
dichroism. 
The plasmid. pDH I, was a gift from Rowena Matthews and David Hoover. The plasmid, 
pEEIOIO, was a gift from Elizabeth Haggard Lindquist. Claire Leadbeater and Dominic 
Campopiano did the subcloning and construction ofpCL2I and I would like to thank them for 
allowing me to use their data. 
3.2 Cloning of the fldrand fidA genes 
The fldr gene was amplified from the plasmid pEE101O using the primers RED FOR (5'-
CAG GAG AAT TCC ATG CCT GAT TGG GTA ACA GGC-3') which incorporated a 
Ncol site (5'-CICATGG-3' in bold) and RED REV (5'-ATA AGG ATC CGC TTA CCA 
GTA ATG CTC CGC TGT CAT-3') which incorporated a BamHI site (5'-G/GATCC-3' in 
bold). The PCR product and pET 16b were both digested with Ncol and BamHl. They were 
ligated together and the resulting plasmid was named pCL21 (Figure 3-la). 
FLD was produced from pDHI transformed into E. co/i JMIOI. pDHl is a pTrc99A-
derivative with the fidA gene cloned downstream of a powerful P fr promoter system that is 
IPTG inducible (Figure 3-1b). Plrc  is a hybrid of the !rp and lac -10 and -35 promoters. 
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4pa LI (3246) 
Figure 3-1a 
The plasmid pCL21 (6389bp), which contains the fldr gene inserted using Ncol I BamHl sites, 
was used for the overexpression of FLDR. The gene is under control of the T7 promoter-
driven system. 
.4pa LI (29) 
Nco 1(266, 
Hind 111 (40 1) I (806) 
fldA 
Apa LI(3921) 	 i 1(822) 
Figure 3-1b 
Plasmid pDH1 (4711 bp), that contains the fldA gene, cloned downstream of the P tr, promoter 
and upstream of a strong rmB transcription termination signal. 
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3.3 Overexpression and purification of FLDR 
E. co/i HMS 174 (DE3)/pCL21 was used to overexpress FLDR and the protein was purified 
by sequential chromatography steps on Q-Sepharose and 2'. 5'-ADP Sepharose. Samples 
were analysed at all steps by SDS-PAGE (Figure 3-2) and UV/visible spectroscopy. 
Routinely, approximately 23mg of pure FLDRJlitre of cells were produced. The re-cloning of 
the fldr gene into vector pET l6b (to generate pCL21) along with an improved purification 
scheme (2 steps rather than 4) allowed significantly higher levels of recovery of FLDR 
compared to the original clone in pEE101O, which gave ca 3.5mg/I. Transformants ofpCL2l 
in strain 131-2I (DE3) resulted in even higher expression of fldr (ca 35mg/I); but the specific 
activity of the purified FLDR was considerably lower than that purified from the HMS 174 
(DE3) strain, probably due to low flavin content. 
Figure 3-2 
SDS PAGE of E. coli Flavodoxin NADP oxidoreductase purification steps. Lane 1: Molecular 
weight standards (94000, 67000, 43000, 30000, 20100, 14400 Da), Lane 2: Uninduced intact 
cells, Lane 3: Induced intact cells, Lane 4: Cell lysate, Lane 5: Q-Sepharose, Lane 6: 2', 5'-
ADP Sepharose, Lane 7: Low molecular weight standards (as Lane 1). 
The molecular weight of the expressed FLDR apoprotein was determined as 27648 Da by 
electrospray mass spectroscopy. This is 28 Da higher than the predicted molecular mass of 
27620 Da calculated from the amino acid sequence derived from the database gene sequence 
(less the N-terminal methionine). However, the recent solution of the atomic structure of the 
E. co/i FLDR indicates that an arginine is present at position 126, as opposed to a glutamine 
predicted from the gene sequence. The difference in molecular mass of these two residues is 
exactly 28 Da, corresponding to the apparent discrepancy which is in the DNA sequence and 
not the atomic structure (110). The isoelectric point of FLDR was measured as 4.8 by 
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isoelectric focusing; rather more acidic than the theoretical value of 6.19 (SwissProt). FLDR 
is bright yellow in its oxidised form and it is converted to a neutral blue semiquinone by the 
addition of one reducing equivalent. FLDR has an extinction coefficient of 7100 M'cm' at 
456nm (113). 
Based on the 7.41-fold purification value calculated using flavin absorbance at this 
wavelength, the overexpressed FLDR comprises 13.5% of the total soluble protein in the E. 
co/i extract (Table 3-I). 
Table 3-1 
Purification table for E. co/i NADP flavodoxin oxidoreductase. Total protein was estimated by 
absorbance at 280nm. FLDR was estimated by measurement of absorbance at the peak of 









Abs4 /Abs250 Purification 
fold 
Lysate 55 833.9 18.26 0.0207 
Q-Sepharose 80 119.1 9.28 0.0779 3.77 
2,5'-ADP 
Sepharose 
35 37.5 5.74 0.1531 7.41 
34 Overexpression and purification of FLD 
The purification of FLD was followed by a combination of SDS-PAGE (Figure 3-4) and 
spectroscopic characterisation (Table 3-3) on FLD-containing fractions. SDS-PAGE analysis 
of the purified protein showed a single species which migrated at m = 20 kDa. A molecular 
weight of 19606 Da was recorded by electrospray mass spectrometry. The isoelectric point of 
FLD was measured as 3.5 which was slightly more acidic than the theoretical value of 4.21 
(SwissProt). Typically, between 20 and 30mg of pure FLD per litre was produced from 
JMIOI/pDHI. 
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4" 
AW 	4W -now 
Figure 3-3 
SIDS PAGE of E. co/i flavodoxin purification steps. Lane 1: Low molecular weight standards 
(94000, 67000, 43000, 30000, 20100, 14400 Da). Lane 2: Uninduced cell lysate. Lane 3: 
Induced cell lysate. Lane 4: Empty. Lane 5: Q-Sepharose. Lane 6: Resource-Q. Lane 7: Low 
molecular weight standards (as Lane 1). 
Fractions containing the protein had a distinct bright orange colour that is expected for 
flavodoxin in its oxidised state. Pure FLD has an extinction coefficient of 8250 M'cm' at 
466nm and a ratio of OD7 7IOD 66 of 5.8 (104). Total protein recovery was estimated at 37% 
based on the purity of FLD at the end of the short purification scheme and the assumption that 
the absorbance at 466nm is specific for the overexpressed protein. Clearly, other E. coli 
flavin-containing proteins (as well as those containing e.g. haem or iron-sulfur centres) will 
have absorbance in this region; so this figure is likely to be an underestimate. Based on an 
8.8-fold purification value, the overexpressed flavodoxin comprised 11.4% of the total 
soluble protein in the E. co/i extract. 
Table 3-2 
Purification table for E. coil flavodoxin. Total protein was estimated by absorbance at 274nm. 
FLO was estimated by measurement of absorbance at the peak of the longer wavelength 














Cell Lysate 23 1166.1 21.62 0.0185 I 
Q-Sepharose 120 62.52 7.68 0.123 6.65 
Resource-Q 4.8 46.5 7.54 0.162 8.76 
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3.5 Spectroscopic Characterisation of FLDR and FLD 
FLDR and FLD were examined using UV/visible spectroscopy, fluorescence and CD 
spectroscopy. 
3.5.1 UV/visible spectroscopy of FLDR and FLD 
A visible scan was carried out on FLDR (40p.M), free FMN (341.LM) and on pure oxidised 
FLD (60p.M). The oxidised FLDR had flavin absorbance maxima at 456nm and 400nm, with 
a shoulder on the longer wavelength band at 483nm (Figure 3-4a). 
In the visible region free FMN has absorbance maxima at 373nm (6373 = 10400 M' cm- ') 
and at 445nm (c = 12500 M' cm ). Oxidised pure FLD had flavin absorbance maxima 
at 372nm and 466nm, with a distinct shoulder on the longer wavelength band at ca 495nm 
and a less obvious shoulder at ca 438nm (Figure 3-4b). As can be seen from Figure 3-4b the 
environment of FMN is significantly perturbed when it is bound to FLD. The peak in the 
373nm region is reduced and shifted slightly to a shorter wavelength and the peak at 445nm is 
shifted to the longer 466nm wavelength. 
3.5.2 Fluorimetry 
Fluorimetry is a very useful technique and it can be used to examine many aspects of the 
nature, integrity and kinetic properties of flavoproteins. 
FAD has two absorbance maxima 375nm (9300M'cm 1 ) and 450nm (I 1300M'cm) and an 
emission maximum at 525nm when excited at 450nm. The excitation and emission spectra of 
free FMN (4tM) show that it has absorbance maxima in the visible region at 373nm (F-3'73. = 
10400 M' cm-1 ) and 445nm (€ = 12500 M' cm) and a fluorescence maxima at 525nm 
(Figure 3-5a). 
To examine the fluorescence of FMN when it is bound to FLD, emission spectra of both free 
FMN (0.7.tM) and FLD (9.81.tM) were carried out. It is immediately obvious that the 
fluorescence of the free FMN is greatly reduced when it is bound to FLD (Figure 3-5b). 
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Figure 3-4a 
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Figure 3-4b 
The visible absorption spectra of free FMN (341M, green) and FLD (60iM, red). The 
environment of FMN in FLD significantly perturbs the spectrum. The samples were prepared 
in 100mM sodium phosphate pH7.5. 
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Figure 3-5a 
Fluorescence excitation (red line) and emission (green line) spectra of free FMN (4tM, in 
100mM sodium phosphate pH7.5). For excitation spectra emission was measured at 525nm 
with spectral bands widths at 3nm (excitation) and 1 .5nm (emission). For emission spectra 
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Figure 3-5b 
Fluorescence emission spectra of both free FMN (red, 0.71.LM) and Ecoli FMN-containing FLD 
(green, 9.81.tM). FMN fluorescence is very strongly quenched in FLD and the emission 
intensity is much reduced. Samples were in 100mM sodium phosphate pH7.5 and excitation 
was at 450nm with spectral band widths at 3nm (excitation) and 5nm (emission). 
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Chemical denaturation of FLDR and FLD was carried out using GdnHCI and the loss of the 
protein's tertiary structure was measured. This was achieved by measuring the fluorescence of 
the aromatic amino acid, tryptophan as its indole ring absorbs UV light at 280nm (c505OM 
'cm 1 ) and it has an emission maxima between 320-360nm depending on the protein 
environment. FLDR (31OnM) and FLD (480nM) were incubated with varying concentrations 
of Gdnl-ICI (0 to 6.7M). As can be seen in FLDR the FAD adenine ring causes some 
quenching of the fluorescence from the isoalloxazine system(Figure 3-6a). As the protein 
unfolds, the emission maxima shifts from 320nm to 360nm, and the emission intensity 
increases. 
In a similar study with FLD, fluorescence intensity decreases and the emission maximum 
shifts from 330nm to 350nm as the protein unfolds (Figure 3-6b). 
The flavin environments of FLDR and FLD were also examined under denaturing conditions. 
FLDR (50iM) and FLD (73p.M) were incubated in varying concentrations of GdnHCI (0-
6.7M). Examination of the results of FLDR fluorescence show that GdnHCl induces 
unfolding of the enzyme and releases quenching of the FAD fluorophore by the enzyme 
(Figure 3-7a). The fluorescence is enhanced so much at 6M GdnHCI that the enzyme had to 
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Figure 3-6a 
GdnHCl-induced tryptophan fluorescence of FLDR (31OnM). Excitation was carried out at 
290nm and emission was measured between 300nm to 400nm (spectral band width was 
5nm). All samples were in 100mM sodium phosphate pH7.5. Inset shows molar 
concentrations of GdnHCI. 
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FLD flavin fluorescence is also greatly enhanced as the concentration of GdnHCl increases 
(Figure 3-7b). In both cases, increasing flavin fluorescence may be explained by increased 
solvent exposure of the bound cofactor, disruption of interactions between flavin and aromatic 
amino acids (which lead to quenching of fluorescence) or complete dissociation of the flavin. 
To further examine the FMN environment another experiment was carried out where FLD 
(240jM) was incubated in GdnHCl (6.7M) and samples were taken over time. The final 
sample was boiled for 5 minutes to completely denature the protein. From the results it can be 
seen that the fluorescence increases over time indicating that the protein is very stable and 
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Figure 3-6b 
GdnHCI-induced tryptophan fluorescence of FLD (480nM). Excitation was carried out at 
290nm and emission was measured between 300nm to 400nm (spectral band width was 
5nm). All samples were in 100mM sodium phosphate pH7.5. Inset shows molar 
concentrations of GdnHCI. 
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Figure 3-7a 
GdnHCI-induced flavin fluorescence of FLDR (50tM, 100mM sodium phosphate pH7.5) was 
incubated with GdnHCl (0-6.7M). Excitation was at 450nm and fluorescence spectra were 
recorded between 500nm and 600nm. Spectral band widths were 5nm (excitation) and lOnm 
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Figure 3-7b 
GdnHCI-induced flavin fluorescence of FLD (73M, 100mM sodium phosphate pH7.5) was 
incubated with GdnHCI (0-6.7M). Excitation was at 450nm and fluorescence spectra were 
recorded between 500nm and 600nm. Spectral band widths were 5nm (excitation) and lOnm 
(emission). Only selected spectra shown. Fluorescence was enhanced as GdnHCI 
concentration was increased and the FLD unfolded, exposing the FMN cofactor. Inset shows 
molar concentrations of GdnHCI. 
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Figure 3-7c 
GdnHCI-induced flavin fluorescence in FLD (240iM, 100mM sodium phosphate pH7.5). FLD 
was incubated with GdnHCI (67M) and samples were analysed over time. Excitation was at 
450nm and fluorescence spectra were recorded between 500nm and 600nm. Spectral band 
widths were 5nm (excitation) and lOnm (emission). An increase in fluorescence was 
observed over time indicating that the protein binds its flavin very tightly and long incubations 
in the the powerful denaturant are required to dissoicate the cofactor. 
3.5.3 Circular Dichroism Spectroscopy 
Various CD experiments were carried out on FLDR and FLD both individually and also on a 
mixture of both proteins. CD in the far-UV range (190-260nm) indicates the presence of a 
large amount of secondary structure in both proteins (Figure 3-8a). FLDR and FLD show 
similar CD spectra with negative ellipicity from 202nm to 250nm and positive ellipticity at 
wavelengths lower than the abcissa at 202nm. 
The far-UV CD of the physical mix and the algebraic mix (the combined spectra of the 
individual proteins) of FLDR and FLD show similar spectra (Figure 3-8b). There is no 
significant change in intensity of the signal indicating that there are no large changes in 
secondary structure of either FLDR or FLD when they are physically mixed. 
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Figure 3-8a 
Far-UV CD (190-260nm) of FLDR (201.iM) and FLD (30A) in 50mM Tns-HCI pH7.5, scanned 
at lOnm/min in a 0.5cm cell. The proteins have distinctive CD spectra, reflecting different 
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Figure 3-8b 
Far-UV CD (190-260nm) of both the physical and algebraic mixes of FLDR (101.tM) and FLD 
(15.tM) in 50mM Tns-HCI pH7.5, scanned at 10nmlmin in a 0.5cm cell. The algebraic and 
physical mixtures are essentially identical indicating that FLDRIFLD interactions do not result 
in major structural alterations. 
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The near-UV CD (260 - 320nm) signal of FLDR shows positive ellipticity with a large 
maxima at 274nm. The intensity of the signal may derive from stacking interactions between 
FAD and one or more aromatic residues of FLDR (Figure 3-9a). The spectra of FLD is more 
complex and has negative ellipticity from 260nm to 283nm. It then shows positive ellipticity 
from 283nm to 304nm with peaks at 290nm and 298nm. The spectrum suggests that there are 
contributions from a number of distinct aromatic amino acids in different environments. Near-
UV CD spectra of the algebraic mix of FLDR and FLD shows positive peaks at 270nm. 
283nm and 290nm. This spectra of the physical mix is very similar to that of the algebraic 
mix. However, its intensity is decreased indicating that there is a change in the environment 
of the aromatic amino acids (Figure 3-9b). The spectra also cross the axes at different points 
and cross each other at approximately 295nm. this suggests that FLDR/FLD docking does 
result in alterations in the environments of aromatic amino acids (i.e. tertiary structure 
perturbations). These strong well defined near UV signals indicate that the aromatic amino 
acids of the proteins are in well defined chiral environments. 
Visible CD (300nm - 500nm) shows clear signals for the flavin cofactors. FAD and FMN 
(Figure 3-10a). The visible CD spectra of FLDR shows that it has positive ellipicity in the 
region of the first flavin absorption band (385nm) with a peak at 388nm and a less intense 
band of negative ellipticity in the region of the second flavin absorption band (456nm), 
centered at 454nm. FLD shows negative ellipicity from 300nm to 450nm with a maximum 
CD at 365nm. 
The physical and algebraic mixes show small changes in the spectra in the visible CD region 
with maxima at 350nm and 390nm (Figure 3-10b). The fact that the spectra change slightly 
and cross each other at approximately 355nm indicates that there is a small change in the 
environment of one or both of the flavin cofactors on mixing of the two proteins. 
Incubation of FLDR with increasing amounts of GdnHCl (0 - 7.04M) causes the loss of 
secondary structure as can be seen by changes in the far-UV spectra in the 220nm region 
(Figure 3-1 Ia). The intensity of CD decreases from 210-240nm, consistent with loss of 
secondary structure. There is a major loss of secondary structure at GdnHCl concentrations 
higher than I.5M. 
The far-UV CD spectra of FLD in varying concentrations of Gdnl-lCl show that FLD is very 
stable and shows only very small alterations in secondary structue even at 7M GdnHCl 
(Figure 3-1 Ib). 
Near-UV and visible CD (260 - óOOnm) denaturation studies (0 - 5.6M Gdnl-ICI) show that 
there is a gradual decrease in the overall CD intensity of the FLDR spectra up to 
concentrations of 4M GdnHCI, indicating loss of the FAD cofactor (Figure 3-12a). There is 
no change in the FLD spectra (Figure 3-12b) even at GdnHCI concentrations greater than 6M 
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indicating that the FMN cofactor is still bound. Both proteins are quite stable under strong 
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Figure 3-9a 
Near-UV CD (260 - 320nm) of FLDR (50i.tM) and FLD (751iM) in 50mM Tns-HCI pH7.5. The 
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Figure 3-9b 
Near-UV CD (260 - 320nm) of both the physical mix of FLDR (25.iM) and FLD (37.5.tM) and 
also the algebraic mix. The samples were in 50mM Tns-HCI pH7.5 and were scanned at 
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Figure 3-10a 
Spectra of the visible CD (300 - 500nm) of FLDR (50RM) and FLD (75.tM) in 50mM Tns-HCI 
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Figure 3-10b 
Spectra of the visible CD (300 - 500nm) of both the physical and algebraic mixes of FLDR 
(25tM) and FLD (37.5i.M). The samples were in 50mM Tns-HCI pH7.5 and were scanned at 
20nm/min in a 0.5cm cell. 
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Figure 3-11 a 
Spectra of the far-UV CD (300 - 500nm) of FLDR (25iM) in the presence of varying 
concentrations of GdnHCI (0 - 5.OM). The samples were in 50mM Tns-HCI pH7.5 and were 
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Figure 3-1Ib 
Spectra of the far-UV CD (190 - 260nm) of FLD in varying concentrations of GdnHCI (0 - 
7.04M).Samples were in 50mM Tns-HCI pH7.5 and were scanned at l0nrrilmin in a 0.5cm 
cell. Inset shows molar concentrations of GdnHCI. 
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Figure 3-12a 
Spectra of the near-UV and visible CD (300 - 500nm) of FLDR in varying concentrations of 
GdnHCI. The samples were in 50mM Tns-HCI pH7.5 and were scanned at 20nm/min in a 
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Figure 3-12b 
Spectra of near-UV and visible CD (260 - 600nm) of FLD in varying concentrations of 
GdnHCl (0 - 5.6M). Samples were in 50mM Tris-HCI and were scanned at in a 0.5cm cell. 
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3.6 FLDR-FLD cross-linked complex 
The FLDR-FLD complex was generated using EDC, a water-soluble carbodiimide. as a cross-
linking agent. The time course of the production of the complex is shown in Figure 3-13a. A 
higher molecular weight band appears which is not present in the initial sample. The complex 
was purified from unreacted FLDRIFLD using gel filtration on FPLC (Figure 3-13b). It 
should be noted that during the incubation there was also the appearance of FLD at slightly 
lower M, values so it is possible that covalent modifications of FLD carboxyl groups by EDC 
to N-acylurea derivatives was also taking place (148). It could also be simple degradation. 
It appears that only a single species was produced in the reaction with an apparent molecular 
mass (by SDS-PAGE) of 47kDa. The complex was analysed by electrospray mass 
spectrometry and a molecular weight of 47430Da was obtained. This is close to the predicted 
value for a 1:1 EDC-linked complex of FLDR/FLD (47360Da). There was no evidence for 
self-complexation of FLDR or FLD after EDC treatment - suggesting that the interactions 
between FLDRJFLD are stronger than those between FLD/FLD or FLDRJFLDR. Visible 
spectra of the complex showed absorbance maxima at 379.5nm and 462nm, with shoulders at 
ca 487nm and 404nm (Figure 3-14). These absorbance characteristics are different from those 
of the individual FLDR and FLD, with the absorbance maxima located between the peaks of 
the isolated flavoproteins. Addition of NADPH was seen to induce a decrease in the intensity 
of the flavin spectrum, but not to induce the formation of a species absorbing in the 550-
600nm region which suggests that there was no formation of the neutral blue semiquinone 
form expected for the FMN in FLD. This, in turn, suggests that the cross-linked protein may 
not be oriented suitably for efficient FAD to FMN electron transfer. The spectra is almost 
identical to that obtained for the Desulfovibrio vulgaris FLD and spinach FLDR complex 
(148). 
3.7 Analytical Ultracentrifugation 
Preliminary sedimentation equilibrium (SE) studies were carried out on FLDR and FLD. In 
early experiments sample columns were scanned at 456nm for FLDR and 466nm for FLD but 
these cofactors were found to be too unstable to act as reliable stoichiometric labels for the 
proteins themselves. For this reason, in later experiments the protein wavelength of 280nm 
was used. In solution FLDR appears to be monomeric, giving a whole-cell weight average 
mass at infinite dilution of 29kDa. FLD, on the other hand, appears to exist in a monomer -
dimer equilibrium (at a 0.15itM it has a whole-cell weight average mass of 26kDa) with a Kd 
in the region of 1j.tM. 
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Figure 3-13a 
SIDS PAGE gel of formation of EDC-linked FLDR/FLD complex. Lane 1: pure FLDR and FLD 
proteins; no EDC added. Lane 2: 15min after addition of 10mM EDC. Lane 3: 30mins after 
addition of EDC. Lane 5: lh after addition of EDC. Lane 5: Molecular weight standards 
(94000, 67000, 43000, 30000, 20100, 14400 Da). 
Figure 3-13b 
SDS-PAGE gel showing purification of EDC-linked FLDR/FLD complex using FPLC 
(Superdex 75). Lane 1: Molecular weight standards (94000, 67000, 43000, 30000, 20100, 
14400 Da). Lane 2: CompIexIFLDRIFLD mixture prior to gel filtration. Lane 3: FPLC fraction 
containing complex. Lane 4: FPLC fraction containing FLDR/FLD. Lane 5: as Lane 1. 
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Figure 3-14 
The visible absorption spectra of the EDC-linked FLDRIFLD complex. The samples were 
prepared in 100mM sodium phosphate pH7.5. 
3.8 Enzyme activities 
Purified FLDR has NADPH-dependent reductase activity towards a variety of electron 
acceptors. Using cytochrome c as the acceptor, a k. of 141.3 ± 5.3 mol/minlmol and a K m of 
17.6 ± 2.15tM were measured. With saturating cytochrome c, the K m  for NADPI-1 was 
estimated at 3.85 ± 0.5.tM. Under similar conditions, potassium ferricyanide was reduced 
with a Km  of 23.6 + 3.2.tM and a k of 1610.3 + 50.1 mol/minlmol. Purified FLD acts as a 
single electron shuttle and it is able to stimulate the rate of FLDR-dependent cytochrome c 
reduction approximately 6-fold. With saturating cytochrome c (100tM) and FLDR at 
16.65nM, a Michaelis curve was obtained for the stimulation of cytochrome c reductase 
activity by FLD indicating an apparent Vm of 272 ± 11.5 mol/minlmol and an apparent K u., 
of the FLD for the FLDR of 6.84 ± 0.68MM (Table 3-3). 
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Table 3-3 
Steady-state kinetic parameters for FLOR. Rates of reduction of artificial electron acceptors 
were measured at 550nm for cytochrome c (22640 M 1 cm 1 ) and 420nm for potassium 
ferricyanide (1010 M 1 crr1 1 ). Rates were measured at 30 °C in 100mM sodium phosphate 
buffer (pH 7.5) with saturating (200tM) NADPH. The Km for NADPH was determined under 
conditions of saturating cytochrome c (1 501.tM). The Km for the FLD was determined under 
conditions of saturating cytochrome c and NADPH, with the FLDR at 16.65nM. 




Cytochromec 141.3+5.3 17.6±2.15 
NADPH ---- 3.85 ± 0.5 
FLD ---- 6.84 + 0.68 
The purified EDC-linked complex of FLDRIFLD was also catalytically active. With 
cytochrome c as the acceptor, a k of 109 ± 4.5 mol/min/mol and a K m  of 87 ± 8.21.LM were 
measured. Using potassium ferricyanide, under similar conditions, a k of 782 ± 3.5 
mol/minlmol and a K m  of 33 ± 6.4 M were measured. Both the rate of reduction and the 
affinity of these substrates for the complex were lower than those for FLDR on its own (Table 
3-4). 
Table 3-4 
Steady-state kinetic parameters for the EDC-linked complex of FLDR/FLD. 
Substrate k at (moI/min/mol) K m  (j.iM) 
Potassium 
ferricyanide 
782.0+ 35 33.2 +6.4 
Cytochrome c 109.2 ± 4.5 87.4 + 8.2 
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Rates of FLDR-catalysed cytochrome c reduction were measured in buffer B containing 
various concentrations of GdnHCI, and also in fresh buffer B following dilution from 
GdnHCI-containing solutions. In both cases 15mm pre-incubation with the denaturant at 30°C 
were performed prior to enzyme assays. FLDR assayed in the presence of Gdnl-ICl shows a 
decline in activity at concentrations of GdnHCI greater than I .OM (Figure I 5a).However, 
there is a large increase in activity between 0-IM Gdnl-ICI. The stimulation of activity may be 
due to minor structural changes in FLDR that enhance binding of cytochrome c, or electron 
transfer to cytochrome c. The continuous decrease in ferricyanide reduction activity with 
increasing GdnHCl shows that the effect is specific for cytochrone c. Following dilution of 
GdnI-IC I-treated samples to fresh assay buffer, assays of both cytochrome c and ferricyanide 
indicate that activity decreased at concentrations higher than I .OM GdnHCl and declined to 
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Figure 3-15a 
Effect of GdnHCI on the enzymatic activity of cytochrome c reduction by FLDR. Prior to 
measurements being taken the samples were incubated for 15min at 30°C in 100mM sodium 
phosphate pH7.5 at the indicated concentrations of GdnHCI. 
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Figure 3-15b 
Cytochrome c reductase activity was measured following dilution of FLDR in GdnHCI-free 
assay buffer at 30°C. Prior to measurements being taken, the samples were incubated for 
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Figure 3-15c 
Ferricyanide reductase activity was measured following dilution of FLDR into GdnHCI-free 
assay buffer. Prior to measurements being taken, the samples were incubated for 15min at 
30°C in 100mM sodium phosphate pH7.5 and the indicated concentrations of GdnHCI. 
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3.9 Stopped-flow characterisation 
Investigations of the rates of reduction of FLDR (40MM) with NADPH (4iM - 2mM) were 
performed with measurement of the rate of decrease in absorbance at 456nm. the oxidised 
FLDR absorbance maximum. The rate observed was 15 * 2 s, regardless of the 
concentration of NADPH. A similar value was obtained when the concentration of FLDR was 
altered. Attempts to measure the rate of electron transfer between NADPH-reduced FLDR 
and FLD (following the formation of FLD semiquinone at 583nm) proved difficult under 
aerobic conditions due to the slow rate of this process and the relatively rapid reoxidation of 
the FLDR. To solve this problem, solutions were degassed and made up anaerobically prior to 
performing the stopped-flow experiments. The rate of formation of FLD semiquinone was 
seen to be very slow when reduced FLDR (40.tM) was mixed with FLD (20p.M), regardless 
of whether NADPH (500 jiM - 2mM) or sodium dithionite was used as the reductant. Over the 
first 60 seconds, a single exponential rate of only (3.4 ± 0.2) x 10-2 s -I  was recorded in the 
presence of 2mM NADPI-I. 
To compare the reduction of an artificial electron acceptor on stopped flow/steady state time 
scales, the reduction of cytochrome c by FLDR was investigated. NADPH (2mM)-reduced 
FLDR (10-50tM) was mixed with cytochrome c (4tM) and absorbance monitored at 550nm. 
A of 29 + 2 s' and a K m of 12.58 ± 1.1M were calculated by fitting the first order rate 
data against [cytochrome c] to a rectangular hyperbola on Origin software. To measure the 
rate of reoxidation of the reduced FLDR, the enzyme was reduced aerobically in the stopped-
flow apparatus by mixing with a sub-stoichiometric quantity of NADPH, and the subsequent 
increase in absorbance at 456nm was followed. At 30°C. FLDR (801.iM) was observed to 
reoxidise after rapid mixing with NADPH (601.iM) with a rate of (5.44 + 0.5) x 10.2 
(3.26min). To measure reoxidation of the FLD semiquinone, we initially attempted the same 
experiment as used for FLDR - employing 80tM FLD and 60p.M sodium dithionite as the 
reductant. However, it was found that reduction of FLD by the dithionite was very slow - with 
the semiquinone taking several minutes to form completely. Instead, the FLD was reduced 
with an excess of dithionite under anaerobic conditions - until the semiquinone formation was 
seen to be complete (maximal absorbance at 583nm). Thereafter, excess dithionite was 
removed from the FLD by gel filtration (G25) within the anaerobic glove box and the reduced 
FLD removed from the anaerobic environment. The reduced FLD was then diluted to 30p.M 
in oxygenated buffer, the buffer bubbled with air for 2 minutes and the rate of reoxidation of 
the semiquinone measured at 583 nm under steady-state conditions. The semiquinone was 
seen to be air stable, taking several hours to reoxidise completely. The reoxidation trace at 
583nm fitted accurately to a single exponential curve, with a rate of 3.85 ± 0.1 lhr' (0.642 
mind ). All stopped-flow data is tabulated (Table 3-5). 
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Table 3-5 
Stopped-flow parameters for oxidation/reduction reactions involving FLDR and FLD. Reaction 
rates were determined at 30 °C in 100mM sodium phosphate buffer (pH 7.5). Measurement of 
FLDR reduction was made at 456nm, FLD reduction to its semiquinone at 583nm and 
cytochrome c reduction at 550nm. Reoxidation of FLDR and FLD were monitored at the same 
?.s used to measure their reduction. 
Stopped-flow rate k (s') 
FLDR reduction (by NADPH) 15 ± 2(900 mind ) 
FLDR oxidation (5.44 ± 0.5) x 102  (-3.3 mind ) 
FLD reduction (by FLDR) (3.4 ± 0.2) x 102  (-2.0 min) 
FLD oxidation (1.07 ± 0.03) x 10-3 (3.85 hr- ') 
cytochrome c reduction (by FLDR) 29.0 + 2.0 (1740 min') 
It is worthy of note that E. coil FLDR is capable of reduction of cytochrome c in the absence 
of flavodoxin or alternative protein mediators (e.g. ferredoxin). This has not been reported 
previously. However, the rate is considerably elevated by the presence of E. coli FLD. In a 
recent publication, Jenkins and co-workers reported the kinetics of cytochrome c reduction 
with the Anabaena variabilis flavodoxin NADP reductase/flavodoxin system (161). In this 
system, there is negligible flavodox i n- independent cytochrome c reduction by the Anabaena 
FLDR. However, the cytochrome c turnover number of 1200mm' for the Anabaena 
FLDRIFLD system is much higher than that of its E. co/i homologue reported here. From 
stopped-flow studies, the first reduction of cytochrome c by reduced FLDR can occur at up to 
29s' (1740 min) compared with only 141.3 min' during steady state. Clearly, the reduction 
of cytochrome c by FLDR is rate-limited by processes other than its binding and the transfer 
of an electron to the ferric haem. 
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3.10 Potentiometric Titrations of FLDR and FLD 
To gain a clearer understanding of the energetics of FLDR and FLD a potentiometric titration 
was carried out on the FAD and FMN cofactors in these enzymes. In the following text, E , I 
represents the midpoint potential of the oxidised/semiquinone couple and E' 2 the midpoint 
potential of the semiquinone/reduced couple of the flavin. 
Figure 3-16a shows the redox titration of the E. co/i FLDR at ca 72MM monitored by UV/Vis 
spectrophotometry between 350 and 800nm. Figure 3-16b plots the proportion of FLDR 
oxidised based on the sum of the absorbance values between 440nm and 480nm against the 
potential of the enzyme solution. The 1 electron reduction of FLDR does not result in the 
accumulation of a stable semiquinone intermediate with long wavelength absorbance. Thus 
potentiometric data for both 1 and 2'' electron reductions are determined from the 
continuous decrease in absorbance between 440-480nm. The absorbance v. potential data was 
fitted to the following equation comprising the sum of one 2-electron redox function designed 
to model the absorbance of a flavin passing through 3 different oxidation states. 
a1O' -E1)/59 	+ ci 
Flavin absorbance 	
1+10 (E  - E1/59 + 10(E2-E 
)159 
Equation I 
a, b, c absorbance coefficients for oxidised, semiquinone and reduced flavin, respectively. E 
electrode potential; E'1, E'2 midpoint potentials for the oxidised/semiquinone couple and 
the semiquinone/reduced couple, respectively. 
In a subsequent experiment, the redox titration of FLDR was repeated in the presence of a 
saturating concentration (5mM) of 2' adenosine monophosphate (2' AMP), in order to 
investigate the effects of binding of a nucleotide analogue to the NADPH site on the redox 
properties of the FAD in FLDR. 2' AMP is non-redox active and thus can be used to in 
reductive titrations to mimic the effects of binding of NADP on the FAD redox properties. In 
preliminary experiments, the affinity of 2' AMP for FLDR was estimated by measurement of 
its IC (-j 1 mM) for FLDR-mediated cytochrome c reduction. The concentration of 5mM 
used in the titration was based on this result. An increase in the reduction potentials of both 
the oxidised/semiquinone (E' elevated by I 5mV to -293 + 6mV) and semiquinone/reduced 
(E 2  elevated by 38mV to -230 ± 7mV) couples of FLDR was observed in the presence of 2' 
AMP. 
73 












400 	 500 	 600 
Wavelength (nm) 
Figure 3-16a 
UV-visible spectra of E. coil FLDR (72tM) during redox titration. Reductive (sodium dithionite) 
and oxidative (potassium femcyanide) titrations were performed anaerobically as described in 
the previous section. The spectra shown in red are from the reductive titration and the flavin 
signals become less intense on reduction. The green spectra are from reoxidation of the 
reduced FLDR and become more intense with successive additions of potassium ferricyanide 









jO.4 	 I 
02 
o.o-i 
• 	 • 	 • 	 • 	I 
-500 	-400 	-300 	-200 	-100 	 0 
mV (vs NHE) 
Figure 3-16b 
Plot of proportion FLDR oxidised vs reduction potential (E, mV) during reductive and 
oxidative titrations, using absorbance between 440-480nm fitted to Equation 1. From these 
data E1 (oxlsq) = -308±4 mV and E2 (sq/red) = -268 ± 4 mV. 
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The chemical reduction of E. coli FLD (Ca 80p.M) was carried out using dithionite and the 
titration was monitored by visible spectrophotometry between 400nm and 800nm (Figure 3-
17a). In the spectrum of the initial fully oxidised sample (shown in magenta) the absorbance 
maxima at 466nm is obvious. The green spectra show the conversion of the oxidised flavin to 
its semiquinone form; (shown in blue). It can be seen that the absorbance in the 466nm region 
decreases as there is an increase in absorbance in the 600nm region (semiquinone region). 
The protein changed in colour from bright orange to blue showing that E.coli FLD has a 
stable neutral blue semiquinone form. The red spectra show the change from the semiquinone 
form to the fully reduced form or hydroquinone form (shown in cyan). Oxidative titrations 
with potassium ferricyanide gave essentially identical results to the reductive titrations, 
indicating reversibility of the redox protein. 
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Figure 3-17a 
UV-visible spectra of E. coli Flavodoxin (80.tM) during redox titration. Sodium dithionite 
reductive titrations were performed anaerobically. The fully oxidised spectrum is shown in 
magenta and the spectra shown by green lines are those representing the conversion from 
the oxidised to the semiquinone form; with decreasing absorbance in the 450nm region and 
increasing absorbance in the 600nm region (semiquinone region). The blue line shows the 
spectrum of the maximal semiquinone species (absorbance maximum at 583nm). Spectra 
shown by the red lines are those representing the conversion from the semiquinone to the 
hydroquinone (fully reduced) form; with decreasing absorbance in the 600nm region. The fully 
reduced spectrum is shown in cyan. Oxidative titrations with potassium ferncyanide gave 
essentially identical results to the reductive titrations. 
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The sum of absorbance values between 550-650nm was plotted against the potential of the 
enzyme solution (Figure 3-17b). The increase and decrease in absorbance in this 550 - 650nm 
region reflects the build up (0-1 electron reduced) and loss (1-2 electron reduced), 
respectively, of the flavodoxin neutral blue semiquinone. The FLD data was also fitted to 
equation 1. The experiment was done using a calomel electrode, so all data has been amended 
by the addition of 244mV to correct for the standard hydrogen electrode. 
-600 	 -400 	 -200 	 0 	 200 
E(mV) 
Figure 3-17b 
Plot of the sum of absorbance between 550nm and 650nm against electrode potential (E, 
my) during reductive and oxidative titrations, fitted to Eqn. 1. From these data, E'1 
(oxidised/semiquinone) = -254 ± 5 mV and E'2 (semiquinone/reduced) = -433 ± 6 mV. 
Values for the reduction potentials are collated in Table 3-6. Although the potentials for the 
two 1-electron couples of the FLD are very well separated (179mV), this is clearly not so for 
the FLDR. For the FLDR, the 1st  couple (ox i dised/sem iqu i none - E' j ) is calculated to be more 
negative than the 2 nd  (semiquinone/reduced - E' 2) by 40mV. In FLDR, the two I-electron 
reduction processes appear to occur simultaneously and the data can be represented 
reasonably accurately by a 2 electron function. The midpoint reduction values in Table 3-6 
are compared with those from the homologous domains of flavocytochrome P-450 BM3 and 
eukaryotic P-450 reductase, and with the potentials of free FAD and FMN. 
Analysis of the later data sets for the FLDR was complicated by the tendency of this enzyme 
to form a precipitate (very slowly) over the course of the experiment. For this reason the 
quality of these data is not as high as those obtained for FLD. However, correction of these 
data by subtraction of l/k from each spectrum (to compensate for the small increases in 
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turbidity) results in values that fit well to the 2 electron Nernst function used to derive the 
flavin reduction potentials for FLDR. 
Based on the wide separation of E 1 and E' 2 we calculated that a maximum of 94% blue 
semiquinone was formed during the reductive titration of FLD. As shown in Figure 3-17a the 
strongly absorbing semiquinone has a peak at approximately 583nm. The maximum 
absorbance reached by the semiquinone is 56.2% of that of the oxidised flavin band at 466nm. 
Based on this proportion and the known coefficient of 8250 M' cm' for the 466nm band 
(100), we calculated a coefficient of 4933 M' cm' for 100% of the semiquinone. 
Table 3-6 
Midpoint reduction potentials (E in mV) for the flavin cofactors in purified E. coil FLDR and 
FLD, calculated from electrode potential v. absorbance data. E12 refers to the midpoint 
potential for the 2-electron reduction of the flavins in each protein, while E'1 and E2 refer to 
the midpoint reduction potentials for the ox/sq and sq/hq couples, respectively, for FLD and 
FLDR. The values are compared with those of the FAD and FMN cofactors in the reductase 
domain of flavocytochrome P-450 BM3 from B. megaterium (BM3) (162) and mammalian P-
450 reductase (CPR) (163), and with the values for free FAD/FMN (164, 165). 
E'2 
FLDR FAD -288 ± 4 -308 ± 4 -268 ±4 
FLDR FAD (+2 AMP) -261 ± 6 -293 ± 6- 230+7 
FLD FMN -343 ± 6 -254 ± 5 -433 ± 6 
BM3 FAD -332 ±4 -292 ± 4 -372 ± 4 
BM3 FMN -203 ± 6 -213 ± 5 -193 + 6 
CPR FAD -327 -290 -365 
CPR FMN -190 -110 -270 
FREE FAD -207 
FREE FMN -205 -172 -238 
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3.11 Cytochrome P450 reduction 
To analyse the nature and kinetics of the reduction of cytochrome P-450 by the FLDR/FLD 
system, we examined the ability of these flavoproteins to support the oxidation of arachidonic 
acid by the haem domain of flavocytochrome P-450 BM3 (166). The FLDRIFLD system was 
able to transfer electrons to the P-450. At concentrations of 0.762p.M P-450, 0.25tM FLDR 
and 25.tM FLD, a rate of 5.48 ± 0.95 mol arachidonic acid oxidised/min was measured. Data 
were collected from three sets of fatty acid oxidation assays in which the P-450 was 
maintained at one of three different concentrations (0.76 j.tM, 2.54 jiM or 3.81 jiM), FLD was 
kept constant at 25jiM (4-fold in excess of its apparent K, for FLDR) and FLDR was varied 
between 0.25 jiM and lOjiM. The plots of the reciprocal rates of these data v. the reciprocals 
of the [FLDR] were used to generate the graph shown in Figure 3-16. The fact that the lines 
plotted are parallel (not convergent) indicates that the P-450 reduction mechanism is ping-
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Figure 3-18 
Reciprocal plot of P-450 BM3 haem-domain catalysed arachidonic acid oxidation versus 
concentration of FLDR. The three experimental data sets shown were performed as 
described in the Materials and Methods section, with P-450 BM3 haem-domain maintained 
constant at 0.76jiM, 2.54jiM Or 3.81jtM; FLD maintained at 25p.M throughout and FLDR 
varied between 0.254M and 10j.tM. The parallel data plots indicate that a ping-pong 
mechanism for FLDR/FLD-supported P-450 reduction is likely. 
78 
Chanter 3: Characterisation of FLDR and FLD 
3.12 Discussion 
FLDR and FLD are two flavoproteins which transfer electrons to E.coli biotin synthase, and 
which can support heterologously expressed cytochrome P-450 in E.coli (113). The 
characterisation of these proteins is central to our understanding of their role in electron 
transfer to these enzymes, and also to the multiple other redox enzymes with which 
FLDR/FLD communicates. These include as cobalamin-dependent methionine synthase, 
biotin synthase, ARR. and PFL. 
The quantities of pure FLDR and FLD are considerably higher than those previously reported 
(107, 113), and this is due to the high levels of expression achievable with the bacteriophage 
T7 promoter driven system, where expression is induced by providing a source of T7 RNA 
polymerase in the host cell, and with the efficient purification regimes (including a 2, 5-
ADP Sepharose affinity step for FLDR). Protein purification data indicate that the FLDR and 
FLD proteins can be overexpressed to at least 10% of total cell protein without notable 
detrimental effects on cell growth. However, it was noted that transformants of the fldr gene 
in the faster growing BL2I (DE3) strain yielded protein with considerably lower specific 
activity than that from HMS 174 (DE3). This is possibly due to failure of the cells to match 
FAD synthesis and/or incorporation to the production of FLDR apoenzyme with strong 
induction under the faster growth conditions. 
Both proteins had their masses determined by electrospray mass spectrometry and FLDR 
shows a discrepancy 2813a from that of the nucleotide sequence (109). The determined atomic 
structure of FLDR indicates the presence of an arginine as opposed to a glutamine residue at 
position 126 (110). This difference in mass between these two residues is precisely 2813a; 
thus these data indicate that the discrepancy is in the DNA sequence and not the atomic 
structure, and that residue 126 is an arginine. The mass of FLD is exactly that predicted from 
the amino acid sequence translated from the sequenced DNA (104). The masses determined 
for FLDR and FLD indicate that significant proportions of the purified proteins retain their 
initiator methionine residue, and that there are no covalent modifications of either 
flavoprotein in the homologous host. 
Spectroscopic characterisation was carried out on both flavoproteins. UV/visible spectroscopy 
showed that the two visible flavin absorption bands are shifted slightly to longer wavelengths 
when a protein matrix surrounds the flavin cofactors. It is obvious from the spectral data that 
when FMN is surrounded by a protein environment its spectra is significantly different to that 
of free FMN. This is due to the interaction of the FMN with various amino acid residues of 
the protein. 
Flourimetry was used to examine protein unfolding and the stability of the flavin cofactors on 
increasing exposure to GdnHCI. When FMN is bound to E.coli FLD its fluorescence is 
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severely quenched and this is due to the preferential energy transfer to the surrounding protein 
matrix. Denaturation studies were carried out to examine the stability of the FAD and FMN 
cofactors. Results from both tryptophan and flavin fluorescence experiments show that FLDR 
and FLD are very stable over a wide range of denaturation conditions and although their 
cofactors are non - covalently bound they bind very tightly to the protein. FLD in particular is 
extremely stable. 
Circular dichroism (CD) is the differential absorption of the left and right circularly polarised 
components of plane polarised radiation. It can be used to examine the structure, folding and 
stability of proteins. Three kinds of information are easily available from CD spectroscopy. 
Far-UV CD looks mainly at secondary structure, where the principal absorbing groups are the 
peptide bonds. This information can be quantitative, and estimates of secondary structure can 
be obtained. FLD and FLDR have distinctive CD spectra in this region and there are no major 
changes in secondary structure when the two proteins are mixed. Near-UV CD examines the 
environment of aromatic residues and disulfide bonds. Alterations in protein tertiary structure 
can be measured with near-UV CD. When FLDR and FLD are mixed there are measurable 
changes in the spectra when compared to that of the algebraic mix. This indicates that there 
are alterations of environments of the aromatic residues when a FLDR/FLD complex is 
formed. In the visible CD range bound chromophores, such as hemes, flavins and PLP, can be 
examined. When FLDR and FLD are mixed there are small reorientations of one or both 
flavins when a complex forms, and the alteration of spectra is due to changes in the chiral 
properties of the flavins. In the denaturation experiments it can be seen that there is a loss of 
FLDR's secondary structure (at concentrations of GdnHCI >1.5M) and that the chiral 
environment of FAD is lost (at concentrations of GdnHCI greater than 4M). FLD is extremely 
stable and shows no loss of FMN, even under extremely harsh denaturing conditions. 
Carbodiimides have often been used to covalently stabilise protein partners whose interaction 
is mainly electrostatic in nature. As there is currently no structural data on a complex of 
FLDR and FLD the two proteins were chemically crosslinked to examine electron transfer 
between the flavin cofactors. The fusion was catalytically active, although flavin-flavin 
interaction was sub-optimal. 
Analytical ultracentrifugation SE studies show that FLDR appears to be monomeric in 
solution, giving a whole-cell weight average mass at infinitive dilution of 29kDa. FLD, on the 
other hand, appears to undergo a monomer-dimer equilibrium (at 0.15M it has an apparent 
whole-cell weight average mass of 26kDa) with a Kd in the region of I LM. The crystal unit 
cell of FLD contains two polypeptide chains which appear to interact through an interface 
rich in polar residues. Thus dimerisation of the 19.7kDa species by a similar interaction in 
solution is not inconceivable. Preliminary SE studies of the FLDR/FLD mixture have been 
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performed, but at low protein concentrations interactions (if any) between FLDR and FLD are 
not detected. 
The electron transfer from FLDR to its physiological acceptor FLD was examined by both 
steady-state and stopped-flow kinetics. Steady-state studies show that FLDR is capable of 
reduction of cytochrome c in the absence of FLD or alternative protein mediators (e.g. 
ferredoxin). However, the rate is considerably elevated (6-fold) by the addition of FLD 
indicating that FLD must transfer electrons to cytochrome c at a greater rate than FLDR. 
Recently Jenkins and coworkers reported the kinetics of cytochrome c reduction with the 
Anabaena variabilis FLDRIFLD system. In this system there is negligible FLD-independent 
cytochrome c reduction by the Anabaena FLDR. The turnover number (1200mm 1 ) for the 
Anabaena FLDR/FLD system is much higher than that of its E. coil homologue. From 
stopped-flow studies it is impossible to determine a Kd of FLDR/FLD due to the slow rate of 
electron transfer which is 100,000 times slower than similar systems (167). The first reduction 
of cytochrome c by reduced FLDR can occur at up to 29s (I 740min 1 ) compared with only 
141.3mm' during steady-state. Clearly, the reduction of cytochrome c is rate-limited by 
processes other than its binding and the transfer of an electron to the ferric haem. The 
crosslinked complex was active in reducing cytochrome c and ferricyanide. The rate of 
reduction and affinity were lower for the complex when compared to FLDR on its own. This 
indicates that crosslinking of the proteins is probably holding them in a rigid conformation 
where they lack the ability to move free and to dock naturally. 
Redox reactions are essential to life and proteins allow electrons to travel great distances. The 
potentiometric data of FLD demonstrates clearly that it stabilises a neutral blue semiquinone 
form of FMN and that the FLD hydroquinone cannot be postulated as a realistic electron 
transferase to biological systems; since the midpoint reduction potential for the sq/hq couple 
is some lOOmV more negative than that of the NADPH/NADP couple (and 165mV and 
125mV more negative than those of the FLDR ox/sq and sq/hq couples, respectively). The 
midpoint reduction potential values for the FLD (-254mV [oxlsq] and -433mV [sq/red]) are 
similar to those obtained from non-recombinant E. coii FLD and flavodoxins from other 
species (168). The reduction potential of free FMN (E 1 -172mV and E 2 -238mV) is very 
different from that of FMN bound in flavoproteins (169). When FMN is bound in E.coli FLD 
its redox values are more negative than those of the FMN which is due to the cofactors 
interactions with the protein matrix. 
The reduction potential values of FLDR show that it does not stabilise a semiquinone, with 
the potential of the first electron reduction being more positive than that of the second. 
Repeats of the FLDR redox titration in the presence of a saturating concentration of 2' AMP 
indicated that the midpoint potentials of both the ox/sq and sq/red couples are elevated by 
binding this nucleotide analogue and that E' 12  is increased by 27mV from -288 ± 4 mV to - 
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261 ± 6 mV, respectively. The effect of bound nucleotide analogue is similar to that observed 
previously for the homologous FAD-containing enzymes adrenodoxin reductase (170) and 
cytochrome b 5 reductase (171) and indicates that the binding of NADP to FLDR may exert 
an important controlling influence on the catalytic properties of the enzyme. The pyridine 
nucleotide binding may influence the potentials of FLDR (increase them) bringing them 
closer to that of the oxlsq couple of FLD and this will decrease further the driving force for 
electron transfer to the FLD. This may at least partially explain the very slow rates of electron 
transfer measured between FLDR and FLD using stopped-flow spectrophotometry. 
The potentiometric data have important implications relative to the mechanism of the 
reduction of cytochromes P-450 (and other enzyme systems). They indicate that (unless there 
is a very large increase in the FLD sqfhq couple caused by binding of FLD to P-450) the 2 
electrons required for P-450 catalysis must be delivered through 2 consecutive single 
electron-transfers from FLD sq; as opposed to the I FMN-to-haem electron transfer being 
mediated by FMN hq and the 2 nd  by FMN sq. This raised the question as to whether these 
transfers occur in a ternary complex of FLDRIFLD/P-450 or through a ping-pong mechanism 
in which the FLD may interact firstly with the FLDR and secondly with the P-450. The fact 
that the flavins in both proteins are relatively exposed suggests that electron transfer between 
them is likely to be through close approach of the isoalloxazine rings, as opposed to involving 
a protein pathway (107, 109). The atomic structure of a eukaryotic P-450 reductase also 
indicates that the edges of the FAD and FMN ring systems in this protein are only 4A apart 
and that inter-flavin electron transfer must occur without mediation by any amino acid side 
chains (172). Thus, it appeared most likely that reduced FLDR and FLD would dock, an 
electron would be transferred to form the FLD sq and the FLD would then dissociate from the 
FLDR and associate with a P-450 to reduce this enzyme, again via the exposed FMN. The 
ping-pong kinetic properties of the FLDR/FLD/P-450 BM3 haem domain system are 
consistent with this model, suggesting that the FLD acts as a shuttle between FLDR and the 
P-450, as opposed to the three proteins forming a ternary complex for electron transfer. 
Double displacement/ping pong kinetics are a common mechanism for enzymes with 
prosthetic groups. 
The data presented here clearly define the electron-transfer route through this system as 
NADPH -> FLDR (FAD) --> FLD (FMN) and then onto other enzyme partners. This is a 
similar flavin electron-transfer path as that described previously for the E. coil sulfite 
reductase and for the diflavin reductases of cytochromes P-450 (P-450 reductase or CPR) and 
nitric oxide synthase (173). In fact, the FLDR and FLD proteins show structural homology to 
the FAD and FMN domains of CPR (174), and these domains have been expressed 
independently for both a eukaryotic P-450 reductase and the reductase of flavocytochrome P-
450 BM3 - a natural CPR/P-450 fatty acid hydroxylase fusion protein (175, 176). However, it 
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is of particular interest to note here that the FAD and FMN domains of P-450 BM3 show very 
different redox characteristics to FLDR and FLD: with the blue semiquinone being found on 
the FAD domain of P-450 BM3 (156). In P.450 BM3, the FAD hydroquinone is 
thermodynamically unfavourable, while it is the FMN of FLD in the E. coli system which 
stabilises a semiquinone. In all three systems the high and low potential flavins are the FMN 
and FAD, respectively. However, both theE' 1 and E' 2 values for FLDR are considerably less 
negative than those for the related reductases. Also, the ox/sq and sq/red couples for FLD are 
both more negative than those for the P-450 BM3 and CPR (163) systems. Indeed, the sq/red 
couple of FLD has a very negative potential (-433mV) which makes electron-transfer via an 
NADPH-driven system virtually impossible. The results indicate that the overall driving force 
(i.e. the difference in reduction potential) for single electron-transfer from NADPI-l-reduced 
FLDR to oxidised FLD is considerably less than those are for CPR and BM3. In addition, the 
binding of nucleotide (NADP) to FLDR may result in further increase in the flavin reduction 
potentials (as we have shown with 2' AMP) and decrease further the driving force for electron 
transfer to FLD. Our stopped-flow data are consistent with these findings. The rate of 
reduction of FLDR (15s 1 ) is markedly slower than that seen in the P-450 BM3 system (> 
700s) and the reduction of FLD by reduced FLDR is also very slow (0.034 s 1 ). Modelling 
studies in our lab have indicated that reduction of FLDR is slow because residue W248 has to 
move out of the way to let NADPH dock. This finding highlights an obvious target residue for 
future mechanistic studies of FLDR mutants.The systems that FLDR and FLD supply with 
electrons usually do not need fast turnover rates, so there may be no real evolutionary 
pressure to create a redox system with high electron transfer rates. 
Other work that was carried out to examine whether FLDR and FLD interact strongly did not 
lead to any conclusive results. Protein interaction studies were carried out by attaching FLD 
to Sephadex and passing FLDR over it. No binding occurred. The reverse was then attempted, 
in which thefldr gene was expressed with a N-terminal histidine tag, so that the protein could 
then be bound to a nickel column. Unfortunately the His 6 FLDR was not active and did not 
appear to fold properly. FLD did not bind to the His 6 FLDR. Preliminary Biacore experiments 
gave results which were inconclusive as it was unknown if the immobilised FLD was in a 
homogeneous layer on the Biacore chip surface. 
These results are published and a copy of the publication is to be found as Appendix 1(112). 
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Chapter 4: Characterisation of wild-type and mutant biotin synthases 
4.1 Introduction 
The aim of this work was to clone the bloB gene into a suitable vector to achieve a high level 
of protein expression and to develop a simple, efficient purification system to allow 
preparation of large amounts of homogeneous protein for characterisation. The 
characterisation of biotin synthase is essential to gain a clearer understanding into the 
mechanism of biotin production. In order to gain an insight into which protein residues are 
involved in the co-ordination of the Fe-S clusters of biotin synthase site-directed mutagenesis 
was carried out on five cysteine residues. The mutant proteins were then characterised using a 
variety of biophysical and chemical techniques. 
4.2 Cloning of the bloB Gene 
The vector p1JCl8/RBS (a modified version of pUC18 which contains a ribosome binding 
site and a NcoI site) was used for the initial cloning of bioB genes. A 1041 bp Ncol / BamHl 
fragment from pB030 (a gift from Lonza AG) containing the bioB gene was cloned into the 
same sites of pUC I 8/RBS and the resultant plasmid named pUC I 8/RBSIbioB (Figure 4-1 a). 
VO1(372ô) 	EcORI(1) 
I- - P(LAC) 
ORI 
bioB 	/7 
Apo LI (67 I) 
pUC-I8IRBSIbi0B 
3q43 bp 






Apa LI (1917) 
Figure 4-1a 
A diagram illustrating the plasmid pUC18/RBS/bioB (3743bp) which contains the bloB gene 
(1041 bp) and the pBR322A-derived ampicillin resistance gene and origin of replication. 
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We overproduced the protein using the pET system that is based on a T7 promoter driven 
system. The cloned gene is under control of strong bacteriophage T7 transcription and 
translation signals. IPTG induces protein expression. The bioB gene was cloned into the 
vector pET l6b (Novagen) using the Ncol and BamHI restriction sites. The resultant plasmid 




bloB 	 CIa 1(298) 
- 	 1(322) 
pa LI (648) 
d' AR 
- 	R: 1(1078) 
Apa L1(4832) Apa L1(1894) 




The plasmid pET16b/bioB (6681 bp) which contains the bloB gene under control of the T7 
promoter driven system. 
4.3 Overexpression and Purification of Wild-Type Biotin Synthase 
Wild-type biotin synthase was overexpressed in both B834 (DE3) and HMS 174 (DE3) cell 
lines. Expression levels were virtually identical but HMS 174 (DE3) gave a better control of 
expression and so was the cell line most frequently used. Optimal yields of protein was 
obtained by aerobic cell growth in 2YT at 37°C. The expressed protein was then purified 
using the method described by Sanyal et a! (66). In our hands we found this purification 
procedure both technically difficult and time consuming although the procedure provided ca 
80% pure biotin synthase. The protein contained some high molecular weight contaminants. 





Apa LI (3437) 
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as described by Marquet and coworkers (177). To overcome these problems we decided to 
express the protein with an N-terminal polyhistidine tag to allow it to be purified using 
immobilised metal affinity chromatography (IMAC). The bioB gene was cloned into the NcoI 
and BamHI sites of the vector pET6l-1 (a derivative of pETI Id). This fused the 5'-terminus of 
the gene to a sequence encoding a M1-IHHHUHA tag (Figure 4-2). 
10 
bloB 







Pst 1 (212 1) 
Apa LI (2937) 
Figure 4-2 
The plasmid pET6H/bioB (6705bp) which contains the bioB gene 
4.4 Overexpression and Purification of His 6-Tagged Biotin Synthase 
Overexpression of His 6-tagged biotin synthase was carried out in HMS 174 (DE3) and gave 
comparable expression levels compared to wild-type biotin synthase. Purification was carried 
out in a single step on a nickel column. We were routinely able to prepare 20mg of >95% 
pure His6-tagged biotin synthase per litre of transformed cell culture (Figure 4-3). 
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Figure 4-3 
SDS-polyacrylamide gel electrophoresis analysis of His6-tagged biotin synthase. Protein 
samples were applied to polyacrylamide gel electrophoresis (15%) in the presence of SDS 
(0.1%) as follows: lane 1, Cell free extract, lane 2, wild-type biotin synthase, lane 3, molecular 
weight markers (Mark 12, Novex) from the top 200kDa, 116.3kDa, 97.4kDa, 66.3kDa, 
55.4kDa, 365kDa, 31kDa, 21 .5kDa and 14.4kDa and lane 4, His6-tagged biotin synthase 
4.5 N-Terminal Protein Sequencing 
Both wild type and His 6-tagged biotin synthase were electroblotted and N-terminal protein 
sequencing was used to confirm their amino acid sequence. Occasionally the His 6-tagged 
biotin synthase was seen as a double band on SDS gels. These two bands were electroblotted 
and digested with trypsin before being sequenced. The higher band was His 6-tagged biotin 
synthase while the lower band was biotin synthase minus the first 63 amino acids 
(approximately 6000Da short of the complete protein). As there was no small molecular 
weight bands present on the gel it appears that this 6000Da peptide was being cleaved into 
fragments. It appears that this degradation is a consequence of oxidation during SDS PAGE 
as stronger reducing conditions (i.e. increased DTT concentrations) alleviates this double 
band effect. Electrospray mass spectrometry revealed that the protein was in fact 
homogeneous and does not appear to contain any small peptide fragments. 
On occasion, preparations of His 6-tagged biotin synthase exhibited two faint bands, which 
copurified on the nickel column. The impurities had molecular weights of approximately 
l4kDa and 20kDa according to SDS PAGE. These were electroblotted and sequenced. The 
l4kDa band was found to be superoxide dismutase (178) which is a metal binding protein and 
the 20kDa band to be the histidine rich protein SIyD (179). Both of these two impurities could 
be easily removed using gel exclusion chromatography. 
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4.6 Mass Spectrometry 
The molecular weights of wild type and l-lis 6-tagged biotin synthase were confirmed by 
electrospray mass spectrometry. The results were within 0.1% of the expected values for the 
polypeptide chains indicating that the Fe-S cluster is lost under the mass spectrometry 
conditions (Table 4-1). 
Table 4-1 
Molecular mass of both wild-type biotin synthase and His6-tagged biotin synthases measured 
by electrospray mass spectrometry. 
Protein Expected Actual 
(Da) (Da) 
Wild-type biotin 38648 38646 
synthase 
His6-tagged 39673 39666 
biotin synthase 
A 5.il sample of biotin synthase (20iM) in TFA/acetonitrile/water (0.1 %/50%/50%) solution 
was used in the measurement. The instrument was calibrated with a myoglobirt standard. The 
estimated error of the molecular mass for each protein is within 0.1%. 
4.7 In Vivo Assay for Biotin Production 
HMS 174 (DE3) cells did not produce detectable levels of biotin either on their own or when 
transformed with pET 16b or pET6H and so were used as a control. To examine whether or 
not the His 6-tag affected biotin synthase activity an in vivo assay was carried out using 
HMSI73 (DE3) cells transformed with either pETI6b/bioB or pET6HfbioB. All the cells 
grew in a similar fashion and both were active in that they produced biotin (Table 4-2). There 
was no difference in the cells transformed with pET16b/bioB when compared to those that 
were producing His 6-tagged protein indicating that the tag does not seem to affect the activity 
of wild-type biotin synthase. 
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Table 4-2 
In vivo production of biotin*. 
Protein Biotin produced 
Wild-type biotin + 
synthase 
l-lis6-tagged biotin + 
sy nthase 
Biotin production was measured using the Lactobacillus assay as described in the Materials 
and Methods section (+ = biotin produced and - = no biotin production). 
4.8 Elemental Analyses 
Analyses for iron, sulfur and nickel was carried out on both proteins using ICP-AES (150) 
and the ferrozine method (15 1 ) The protein concentrations were adjusted to ca 26iM (based 
on a monomeric weight of 38648Da for wild-type biotin synthase and 39673Da for I-us6-
tagged biotin synthase). The amount of sulfur (as S 2 ) in His6-tagged biotin synthase was 
virtually identical to that in the untagged protein and similar to the value previously reported 
by Sanyal et al (66). Analysis for nickel content proved that there was negligible nickel 
binding. ICP-AES iron analysis on the purified proteins revealed a 1:1 ratio between protein 
and iron in both wild type and His o-tagged biotin synthase (Table 4-3) in agreement with 
previously reported values (153) although it should be noted that Sanyal has reported a 1:2 
ratio (66). The ferrozine iron assay gave a slightly lower protein:Fe ratio than that obtained by 
ICP-AES (Table 4-4). 
Table 4-3 
ICP-AES iron analysis on wild-type biotin synthase and His64agged biotin synthase proteins. 
Protein Protein: Fe ratio 
Wild-type biotin I : 0.96 
synthase 
l-Iis6-tagged biotin I 	: 0.94 
synthase 
Protein samples (26p.M) and standards (Fe(NO3)3) were in 100mM sodium phosphate pH7.5 
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Table 4-4 
Results of the Ferrozine iron assay*. 
Protein Protein: Fe ratio 




Protein samples (26itM) and standards (Fe(NO3)3) were in 100mM sodium phosphate pH7.5 
4.9 Preparation of Wild-type and His 6-tagged Apoenzymes and the 
Reconstitution of [2Fe-2S] Cluster containing Holoenzymes 
in order to try to increase the iron content of wild-type biotin synthase and His,,-tagged biotin 
synthase the apoenzymes were prepared anaerobically using sodium dithionite and EDTA. 
The samples were then desalted using a G 1 gel filtration column. ICP-AES analysis and UV-
visible spectroscopy confirmed the absence of iron in both proteins. The Fe-S clusters were 
then reconstituted by incubation of the apoenzyme with FeCI 3 and Na2S. The reconstituted 
holoenzyme has an increased protein : Fe ratios which were comparable to those previously 
reported (Table 4-5) (153). 
Table 4-5 
ICP-AES iron analysis on wild-type biotin synthase and His64agged biotin synthase 





Wild-type 1:0.11 1:1.37 
biotin 
synthase 
His6-tagged 1: 0.11 1: 1.37 
biotin 
synthase 
* Protein samples (26tM) and standards (Fe(NO3)3) were in 100mM sodium phosphate pH7.5 
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4.10 Spectral Characteristics 
Solutions of wild type and EIis 6-tagged biotin synthase were both reddish brown in colour and 
they showed virtually identical UV-visible spectra with a maximum at 274nm, a shoulder at 
330nm and a distinctive peak at 420nm (Figure 4-4a). These spectra are similar to that of 
other 2Fe-2S] proteins. The apoenzymes lose their absorbance in the 420nm region. The 


















UV-visible spectra of wild type, His6-tagged biotin synthases - as purified, apoenzmes and 
reconstituted holoenzymes. The spectra are from samples of all proteins (1mg/mi) in 100mM 
sodium phosphate pH7.5. 
Biotin synthase exhibits absorption spectra with extinction coefficients indicative of a single 
[2Fe-2S] cluster in each subunit. Anaerobic reduction with excess sodium dithionite results in 
a decrease in the visible absorbance at all wavelengths >350nm (Figure 4-4b). The resulting 
spectrum is characteristic of proteins containing [4Fe-4S] clusters (83). To examine the 
reversibility of this reductive cluster conversion the [4Fe4S] sample was exposed to air. 
Gradual bleaching of the visible absorption occurred which indicates that there was cluster 
degradation of the sample. However, comparison of spectra taken during the oxidation 
indicates that some reformation of the [2Fe-2S] cluster occurs indicating that the presence of 
[2Fe-2S] clusters in biotin synthase is a result of aerobic purification. 
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Figure 4-4b 
Reduction and reoxidation of biotin synthase. The [4Fe-4S] form of biotin synthase (red) was 
prepared by anaerobic incubation of [2Fe-2S] biotin synthase (blue) was in the presence of 
excess sodium dithionite. The sample was then exposed to air for 5h at room temperature 
(green spectra). The spectra are from samples of all proteins (1mg/mi) in 100mM sodium 
phosphate pH7.5. 
4.11 In Vitro Assay for Biotin Production 
The in vitro activities or both proteins were determined using the Lactobacillus assay. Biotin 
was produced by all three forms of both the wild type and the l-lis 6-tagged proteins (Table 4-
6). The addition of pure A. vinelandii NifS (201.tM) to the assay mixture had no apparent 
effect on the amount of biotin produced. There was no difference in the levels of biotin 
produced when the samples were incubated aerobically or anaerobically. 
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Table 4-6 
In vitro biotin production. 
Protein As purified Apoenzyme Reconstituted 
holoenzyme 
Wild-type biotin + + + 
synthase 
His6-tagged biotin + + + 
sy nthase 
Biotin production was measured using the Lactobacillus assay in the presence of biotin 
synthase (5PM), potassium chloride (10mM), dethiobiotin (50iM), AdoMet (150.tM), 
Fe(NH4)2(SO4)2 (5mM), NADPH (1mM), fructose 1,6-bisphosphate (5mM), L-cysteine 
(5001tM), DII (10mM), PCOi cell free extract (1001.11), FLD (12.5j.iM) and FLDR (4iM). The 
reaction mixture was incubated for 2h at 37 C (+ = biotin produced and - = no biotin 
production). 
4.12 Crystallisation Studies 
Both PEG and ammonium sulphate crystallisation screens were set up using wild type and 
His6-taggged biotin synthase. Unfortunately no crystal forms were found in either screen. 
4.13 Amino Acid Sequence Analysis 
A sequence alignment search was carried out using the amino acid sequence of E. coli biotin 
synthase. Twenty-six sequences were found in the databases that were homologous to E. coli 
biotin synthase. A number of these sequences contained some very highly conserved residues 
and there were also two extended conserved motifs. Alignment of these twenty-four 
sequences can be seen in figure 4.5. 
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Figure 4-5 
Sequence alignment of twenty-four known biotin synthases. The 
conserved residues are boxed in red white lettering and the two 
extended conserved motifs outlined in black. Boxed in blue with white 
lettering is where one residue is present in at least 17 of the 
sequences. The black arrows show the residues mutated in this study 
and the residue numbering is that of the E.coIi sequence. (The 
Swissprot or Entrez accession numbers from the top are P12996, 
067104, P54967, P19206, P53557, P46396, Q9Z6L5, Q47862, 
P44987, 025956, Q9ZJK8, 027266, Q58692, P94966, P46715, 
006601, CAB56476, CAB491 38, P32451, 060050, 059778, P36569, 
P73538 AND AE001782_5). The sequence alignment was carried out 
using Expasy and Clustal Wand the data formatted using PJscript. 
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4.14 Essential Cysteine Residues of Biotin Synthase 
Spectroscopic studies on biotin synthase, PFL activase and LIPA (73, 78, 135) suggest that 
three cysteine residues from each monomer are required to co-ordinate the Fe in the [2Fe-2S] 
clusters of the oxidised dimer and that two of these are required ligands in the reduced 
catalytically active form. Five cysteine residues (C53, C57, C60, C188 and C288) were 
replaced separately with serine or threonine residues by site-directed mutagenesis (threonine 
was chosen as a replacement for C288 since it enabled us to engineer a Kpnl restriction site 
into the bioB gene to facilitate mutant selection). Each of the mutant proteins was 
overproduced in E.coli HMS 174 (DE3) and its catalytic activity determined. Since the His 6-
tagged biotin synthase showed identical in vitro spectroscopic parameters and catalytic 
activity to wild-type protein the mutant bioB genes were also expressed as histidine-fusion 
proteins. Each of the mutant proteins was purified using IMAC under identical conditions to 
the histidine-tagged wild-type biotin synthase except for mutant C  88S that despite numerous 
attempts (low temperature induction, IPTG concentrations <0.1 mM) remained intractably 






SDS-polyacrylamide gel electrophoresis analysis of His6-tagged biotin synthase and mutants 
C53S, C57S, C60S and C288T. Protein samples were applied to polyacrylamide gel 
electrophoresis (15%) in the presence of SDS (0.1%) as follows: lane 1, His-tagged, lane 2, 
C53S; lane 3, C57S; lane 4, C60S; lane 5, C288T and lane 6, low molecular weight markers 
in kDa - 140, 96, 64, 43, 30, 20 and 14.4 (Amersham Pharmacia). Coommassie Blue was 
used for staining. 
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4.15 Mass Spectrometry of the Cysteine Mutants 
All the mass spectrometry results were within 0.1% of the expected values for the mutant 
proteins (Table 4-7). 
Table 4-7 
Molecular mass of the E.coli biotin synthase cysteine mutants measured by electrospray 
mass spectrometry. 
Protein Expected Actual 
C53S 39657 39656 
C57S 39657 39658 
C60S 39657 39652 
C288T 39671 39670 
*5j samples of protein (20tM) in TFNacetonitrile/water (0.1%/50%150%) solution was used 
in the measurement. The instrument was calibrated with a myoglobin standard. The estimated 
error of the molecular mass for each protein is within 0.1%. 
4.16 In Vivo Assay for Biotin Production 
In vivo biotin production was carried out with the five mutant plasmids. All the clones grew 
as vigorously to those of the wild type and l-Iis 6-tagged biotin synthase but only the non-
conserved C288T mutant produced significant amounts of biotin. Cells expressing the C53S, 
C57S, C60S or Cl 88S mutants did not produce any detectable quantities of biotin (Table 4-
8). 
Table 4-8 
In vivo production of biotin 






*Bi oti n production was measured using the Lactobacillus assay (+ = biotin produced and - = 
no biotin production). 
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4.17 Elemental Analyses 
Analyses for iron and sulfur was carried out on all the mutant proteins using ICP-AES, the 
Beinert method and the ferrozine method. The protein concentrations were adjusted to ca 
26j.tM (based on a monomeric weight 39657Da). The amount of iron and sulfur in C53S. 
C57S and C60S was negligible but in C288T it was the same as that for wild type and His 6-
tagged biotin synthase (Table 4-9). 
Table 4-9 






C288T 1: 0.77 
* Protein samples (26iM) and standards (Fe(NO3)3) were in 100mM sodium phosphate pH7.5 
The protein : Fe ratio determined by the Ferrozine assay gave slightly lower results than that 
of the ICP-AES (Table 4-10). 
Table 4-10 
Results of the Ferrozine iron assay. 
Protein Protein : Fe ratio 
C53S 1: 0.09 
C57S 1: 0.07 
C60S 1:0.11 
C288T 1: 0.44 
* Protein samples (26M) and standards (Fe(NO3)3) were in 100mM sodium phosphate pH7.5 
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4.18 Preparation of Mutant Apoenzymes and the Reconstitution of [2Fe-
2S] Cluster containing Holoenzymes 
The mutant proteins were incubated with sodium dithionite and EDTA to remove their Fe-S 
clusters and to produce their apoenzymes. To try to increase their iron and sulfur content their 
holoenzymes were reconstituted by incubation with Fe 3+  and S2-.  Only C288T showed any 
increase in iron and sulfur. There was no change for the three conserved cysteine mutants 
(Table 4-11). 
Table 4-11 





C53S I : 0.07 1: 0.47 
C57S 1: 0.06 1: 0.27 
C60S I : 0.06 1: 0.44 
C288T 1 :0.04 1: 1.59 
* Protein samples (26iM) and standards (Fe(NO3)3) were in 100mM sodium phosphate pH7.5 
4.19 Spectral Characterisation 
The mutants (C53S, C57S and C60S) were colourless and their spectra showed no peaks 
indicative of the presence of an Fe-S cluster. Moreover, their spectra did not show any 
significant changes even after prolonged incubation with FeC 1 3 and Na2S. The spectra of the 
three forms of C288T were virtually identical to that of both the wild-type and the His 6-
tagged biotin synthases (Figure 4-7). 
99 
Chapter 4: Characterisation of wild-type and mutant biotin synthases 
0.5 
















UV-visible spectra of cysteine mutants. The spectra are from samples of all proteins (1mg/mi) 
in 100mM sodium phosphate pH7.5. Wild-type, His64aggged and C288T biotin synthases 
have almost identical adsorption spectra (green spectra). The three mutants (C53S, C57S 
and C60S) are very similar to each other (blue spectra). 
4.20 In Vitro Assay for Biotin Production 
The in vitro activities of the cysteine mutants were determined using the Lactobacillus assay. 
Biotin was produced by the C288T mutant but not by the three other cysteine mutants (Table 
4-12). There was no difference in biotin production between aerobic and anaerobic 
incubations. 
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Table 4-12 
In vitro biotin production. 
Protein As purified Apoenzyme Reconstituted 
holoenzyme 
C53S - - - 
C57S - - - 
C6OS - - - 
C288T + + + 
Biotin production was measured using the Lactobacillus assay in the presence of biotin 
synthase or mutant protein (51.iM), potassium chloride (10mM), dethiobiotin (50.tM), AdoMet 
(150tM), Fe(NH4)2(SO4)2 (5mM), NADPH (1mM), fructose 16-bisphosphate (5mM), L-
cysteine (5001tM), DII (10mM), PCOi cell free extract (lOOitl), FLD (12.5iM) and FLDR 
(21.tM). The reaction mixture was incubated for 2h at 37 C (+ = biotin produced and - = no 
biotin production). 
4.21 Discussion 
Biotin synthase has two dimeric forms that contain different types of Fe-S clusters. In its 
oxidised form the protein contains a single [2Fe-2S] cluster in each monomer unit but on 
reduction this converts to a single [4Fe-4S] cluster in the dimer. EPR and Raman 
spectroscopy studies have provided evidence that in the oxidised [2Fe-2S] form biotin 
synthase has one iron which is co-ordinated to two cysteines and one iron which is co-
ordinated to a cysteine and an oxygenic ligand (83, 180). In contrast, after dithionite reduction 
a [4Fe-45] cluster is formed in which each iron is co-ordinated to a single cysteine sulfur. A 
possible mechanism for this interconversion has been proposed by Johnson (180). It has been 
speculated that the cysteine residues of the highly conserved "cysteine box" 
GXCXXXCXXCXQ motif of these proteins are involved in Fe-S cluster binding. This is 
supported by the fact that an identical motif is found in other Fe-S cluster proteins such as 
LIPA (Swissprot accession number: P25845) (73), ARR-AE (P39329) (71), LAM (74), the 
nitrogen fixation B gene product (P1 1067) (75), pyrrolo-quinoline-quinone synthase 
(Q01060) (77), PFL-AE (P09374) (78), NARA protein (P39757) (81), FNR (P03019) (76) 5 
benzylsuccinate synthase activating enzyme (CAA05050) (72), spore photoproduct lyase 
(P37956) (79), molybdenum cofactor synthase (027593) (80) and the thiamine synthase H 
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gene product (P30140) (79). Mutational studies on PFL-AE have shown that the three 
cysteine residues of the 'cysteine box" are vital for its activity (141). 
Our attempts to purify wild-type biotin synthase from overexpressing clones using previously 
reported methods afforded protein that was Ca. 80% pure contaminated with several high 
molecular weight contaminants. To circumvent this problem we elected to clone the bioB 
gene with an N-terminal His 6-tag and to purify the fusion protein using Ni-bound affinity 
chromatography. This appeared to be a safe approach since E. co/i biotin synthase has a 
relatively long N-terminal sequence, which is either not present or unconserved in the ORF's 
of genes from other species, and the tag was unlikely to affect enzymatic activity. 
A further significant result was that the in vivo activity of the N-terminus Flis 6-tagged biotin 
synthase proved indistinguishable from that of the wild-type protein. The His 6 tag allowed 
purification of much larger quantities of homogeneous E. co/i biotin synthase than previously 
available. Typically, protein of >95% homogeneity could be isolated in a single 
chromatographic operation. 
N-terminal sequencing was used to check the amino acid sequence and mass spectrometry 
was used to verify the molecular weights and the homogeneity of the proteins. One small 
problem with the nickel affinity column was the copurification of superoxide dismutase and 
SIyD but this was easily resolved by the addition of a gel exclusion step. In vitro biotin 
production was very small (0.2mol biotin/mol protein/h) but was similar to reported values 
(66, 90, 122). Preliminary crystal trials were unsuccessful perhaps due to the pure enzyme 
being present in a number of different forms. 
Metal analyses on both the wild-type and the l-lis 6-tagged protein revealed that they contained 
the same amount of Fe as that reported by Marquet and her coworkers (1 53) but less than that 
reported by Sanyal (66). This is possibly a result of the high protein expression levels. 
Shortage of free intracellular Fe 2 ' and/or the fact that the enzyme involved in cluster 
formation in the cell is expressed at wild-type levels and would lead to a proportion of the 
biotin synthase population being formed with incomplete clusters. In order to increase the 
iron content of biotin synthase, the apoenzyme was prepared anaerobically by treatment of the 
proteins with sodium dithionite and EDTA and the [2Fe-2S] cluster was reconstituted by 
incubation with FeCl 3 and Na 2S. Although the concentration of biotin synthase with intact 
[2Fe-2S] clusters was significantly increased by this procedure both the apoenzyme and the 
reconstitute holoenzyme produced equal amounts of biotin which was virtually the same as 
wild type and l-lis 6-tagged biotin synthases. This suggests that there is sufficient iron and 
sulfur in the assay mixture to reconstitute the cluster in situ. Clearly, biotin synthase is not 
acting as a true catalyst and one reasonable explanation for this is that an unknown cofactor(s) 
(possibly the sulfur donor) is missing from the reaction mixture. Addition of pure A. 
vinelandii Nif'S did not seem to visibly affect the reaction. Although NifS has been shown to 
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regenerate Fe-S clusters in other enzymes it may be that a N ifS-like enzyme is not used by 
biotin synthase or that the A. vinelandii enzyme does not function with E. coil biotin synthase. 
Sequence similarity searches reveal that there at least twenty known species of bacteria, yeast 
and plants which contain a bloB gene sequence similar to that from E.coli. To date, biotin 
synthase from B. sphaericus (65), A. thaiiana (43), S. cerevisiae (44), and E. coil (66) have 
been cloned, overexpressed and purified. Sufficient complementation analysis has been 
carried out on Methylobacilius, B. flavum (67). B. subtiiis (68), E. herbicoia (69) and S. 
marcescens (70) to confirm that they also express active biotin synthases. Sequence alignment 
reveals a number of conserved regions. There are 25 completely conserved residues, four of 
which are cysteine. Three of these (C53, C57, C60) lie in the fifteen residue 'cysteine box' 
motif [K(S/T)GXCXE(D/N)CX(Y/F)CXQSJ and the fourth (C188 in the E. co/i sequence) is 
remote. 
To determine which of the cysteine residues are involved in stabilising the [2Fe-2S] and [4Fe-
4S] forms of biotin synthase single point mutations were made of five cysteine residues (C53, 
C57, C60, C 188 and C288) to either serine or threonine. The choice of cysteine substitution 
by hydroxylated residues was made to preserve as much as possible the I-I-bonding character 
and the side chain geometry of the original cysteine residues. All the mutant proteins were 
expressed as His6-tag fusions and purified using IMAC chromatography. The molecular 
weights of all the polypeptides were verified by mass spectrometry and the purified proteins 
were characterised by UV-visible spectrophotometry, Ni, Fe and S analyses and in vivo and in 
vitro assays for biotin production. 
Wild-type biotin synthase, His 6-tagged biotin synthase and the His 6-tagged non-conserved 
mutant C288T all had similar UV-visible spectrophotometric characteristics that were 
indicative of intact [2Fe-2S] cluster formation. All of these proteins, along with their 
apoproteins and reconstituted holoproteins, were active both in vivo and in vitro. In contrast, 
C53S, C57S and C60S were all colourless and their absorption spectra showed no indication 
of the presence of [2Fe-2S] clusters indicating that these residues are absolutely vital for Fe-S 
cluster formation which is in turn crucial for activity. C  88S proved to be insoluble and could 
only be characterised in vivo where it did not produce biotin. The fact that only three cysteine 
residues appear to be needed for [2Fe-2S] cluster binding (180) and that the C53S, C57S and 
C60S mutants are inactive suggest that C188 may be required for correct folding of the 
protein. Attempts to induce Fe-S cluster formation by incubation of these mutants with excess 
reagents did not result in any significant increase of iron binding. 
The only cysteine mutant of E. coli biotin synthase which was catalytically active and could 
support formation of a [2Fe-2S] cluster was C288T, the mutant of the non-conserved cysteine 
residue, showing that the presence of C288 is not essential for folding, [2Fe-2S] and [4Fe-4S] 
cluster formation or for activity. In contrast, all the conserved residues C53, C57 and C60 of 
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the 'cysteine-box' are proven to be absolutely crucial for both the formation of the [2Fe-2S] 
cluster and the activity of the enzyme. These results are consistent with recent mutational 
studies on PFL-AE where it was also found that mutations of cysteine residues in the 
'cysteine-box' abolish metal binding (141). 
Since the completion of these experiments, Hewitson and coworkers have published work on 
E. co/i biotin synthase mutants (181). In their paper they report the mutation of the residues 
C53, C57 and C60 to alanine. In contrast to our findings their alanine mutants still have the 
ability to bind the Fe-S cluster but they prove inactive in vitro which is in agreement with our 
results. They speculate that alternative residues could act as substitute ligands to the Fe-S 
cluster but that the mutant protein is unable to undergo the reductive 2Fe-2S to 4Fe-4S cluster 
rearrangement. 
In the absence of crystallographic evidence, this work is a step towards the definition of the 
essential protein residues involved in the mechanism of Fe-S cluster formation (180) in biotin 
synthase and the relevance of these to the catalytic action of the enzyme. The inference of 
spectroscopic studies on E. coli biotin synthase is that a hydroxylated residue is also involved 
in the initial [2Fe-2S] cluster formation and here the conserved cysteine-box' residues TIS50 
and S63 are obvious candidates. Another region in the protein that is almost completely 
conserved is the sequence Y150, N151,I-1152, N153 and L154 which is also found in lipoic 
acid synthase (84). Biotin synthase mutants at sites within these sequences are the subject of 
current studies. We have recently described the overexpression, purification and redox 
characteristics of the flavoprotein components of the E. coli biotin synthase system, FLD and 
FLDR (112), and the fact that it is now possible to obtain relatively large quantities of these 
and functional, homogeneous BioB protein should facilitate examination of the protein-
protein and protein-cofactor interactions involved the redox chemistry of the biotin synthase 
complex. Despite the enormous amount of research that has been carried out over the past 
thirty years a lot of work still has to be done to solve the problem that is the biotin synthase 
reaction. 
These results are published and a copy of the publication forms Appendix 11(182). 
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Characterisation of flavodoxin NADP oxidoreductase and flavodoxin; 
key components of electron transfer in Esclieric/iia coli 
Lisa McIVER. Claire LEADBEATER. Dominic J. CAMPOPIANO. Robert L. BAXTER. Simon N. 1)AFF. Stephen K. CHAPMAN 
and AndreA W. MtJNRO 
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(Received 19 May/19 June 1998) - EJB 98 0680/4 
The genes encoding the Eseherichia co/i flavodoxin NADP oxidoreductase (FLDR) and flavodoxin 
(FLD) have been overexpressed in E. co/i as the major cell proteins (at least 13.5 and 11.4/( of total 
soluble protein, respectively) and the gene products purified to homogeneity. The FLDR reduces potas-
sium ferricyanide with it k,, of 1610.3 mm and a K 0 of 23.6 ftM. and cytochrome c with a of 
141.3 min I and a K 17.6 riM. The cytochrome c reductase rate is increased sixfold by addition of 
FLD and an apparent K of 6.84 jiM was measured for the affinity of the two flavoproteins. The molecular 
masses of FLDR and FLD apoproteins were determined as 27648 Da and 19606 Da and the isolectric 
points as 4.8 and 3.5. respectively. The mass of the FLDR is precisely that predicted from the atomic 
structure and indicates that residue 126 is arginine. not glutamine as predicted from the gene sequence. 
FLDR and FLD were covalently crosslinked using I -ethyl-3(dimethylamino-propyl) carhodiiinide to gen-
erate a catalytically active heterodimer. The midpoint reduction potentials of the oxidised/semiquinone 
and semiquinoneIhydroquinone couples of both FLDR (-308 mV and —268 mV. respectively) and FLD 
( - 254 mV and —433 mV. respectively) were measured using redox potentiometry. This confirms the 
electron-transfer route as NADPH—.FLDR—.FLD. Binding of 2' adenosine monophosphate increases the 
Midpoint reduction potentials for both FLDR couples. These data highlight the strong stabilisation of the 
flavodoxin senliquinoile (absorption coefficient calculated as 4933 M cm at 583 nih) with respect to 
the hydroquinone state and indicate that FLD must act as a single electron shuttle from the semiquinone 
loriti in its support of cellular functions, and to facilitate catalytic activity of microsonial evtochromes 
P-450 heterologously expressed in E. co/i. Kinetic studies of electron transfer from FLDR/FLD to the 
fatty acid oxidase P-450 BM3 support this conclusion. indicating a ping-pong mechanism. This is the 
first report of the potent ionietric analysis of the full E. co/i NAD(P)H/FLDR/FLD electron-transfer chain; 
it complex critical to the function of a large number of E. to/i redox systems. 
Keviiords: Ilavodoxin; flavodoxin NADP oxidoreductase: redox potentiometry; enzyme kinetics: cyto-
chrome P-450. 
The E.rc/ieric/,ia cots flavodoxin NADP oxidoreductase 
.(FLDR or tiavodoxin reductase) and flavodoxin (FLD) are the 
two flavin-containing components of a short electron-transfer 
chain from NADPH. which provides electrons for the function 
of the biotin synthase Ill and cohalamin-dependent methionine 
synthase systems 121. The enzymes are also required during an-
aerobic growth of the organism. participating in the pyruvate 
forrnate/lyase system of E. co/i - it crucial mechanism for the 
anaerobic generation of l)yruvate  for glycolysis 131 and in the 
generation of deoxyrihonucleotides through the eni ne anaero-
bic ribonueleotide reductase 141. Recently, the FLDR/FLD sys-
tent has also been recognised as the E. colt 'reductase'. which 
can support the function of heterologously expressed eukarvotic 
cytochrornes P-450 151, even though no endogenous P-450s 
have yet been identified in the bacterium. 
Correspondence to A. W. Munro. Department of Chemistry. Joseph 
Black Building, The University of Edinburgh. The King's Buildings. 
West Mains Road, Edinburgh. EH') 31J. UK 
Fax: ±44 131 650 4760. 
E-mail: Andrew. Munro Cal ed.ac,uk 
Abhrei'iations. CPR. cyiochronie P-450 reductase: FLD. F. to/i ha-
vodoxjn; FLDR. F. co/i tiavodoxiTi NADP oxidoreductase: IPTG. iso-
propyl-fl. o-thiogalactopyranosidc: P-450, cytochronie P-450 nionooxy-
genase. 
We have overexpressed and purified the FLDR and FLD pro-
teins in order to investigate their function in biotin synthesis 
and cytochrome P-45() reduction. Of particular interest was the 
analysis of the interactions of the Fl_DR and FLD proteins and 
the redox characteristics of these enzymes, since it is known that 
the cytochromes P-450 require two successive single-electron 
transfers to perform their activation of molecular oxygen. While 
the flavodoxins have been considered to function as single-
electron donors by cycling between the hydroquinone and semi-
quinone states 161. it is by no means certain that the hydroqui-
none is a physiologically relevant species in electron-transport 
chains using NAD(P)H. FLDR and FLD, since the midpoint re-
duction potential of NAD( P)H ( - 320 mV) is likely to be con-
siderably higher (more positise) than that of the FLD semiqui-
none/hydroquinone couple. Indeed, there is evidence to support 
the utilisation of the hiavodoxin semiquinone as the electron do-
nor for methionine sytithetase 12. 71. It is known that hlavodox-
ins, in general, stabilise a seniiquinone- l -electron-reduced form 
as opposed to the 2-electron-reduced hydroquinone. In fact, 
potentiometric studies on non-recombinant F. co/i FL!), purified 
front large-scale cultures, indicated that this enzyme stabilises a 
blue neutral semiquinone form of FMN 181. 
In this paper, we report the results of biophysical studies of 
the E. co/i FLDR and FLD, analysing the interactions between 
McIver et al. (Eur J. Biochern. 257) 
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action rates were determined at 30°C in 100 mM sodium phos- 
phate. pH 7.5. and the reciprocals of the data plotted against the 
reciprocals of the IFLDRI for each concentration of P-45() used. 
Stopped-flow measurements of transient absorbance changes 
associated with reduction of FLDR and FLD flavins (decrease 
in absorbance at 456 nm and increase at 583 nm. respectively), 
reoxidation of the Ilavins (same wavelengths) and reduction of 
cytochronie c (550 rim) were made using an Applied Photophys-
ics SF. 17 MV stopped-flow kinetics spectrophotometer. Reac-
tions were performed at 30GC in 1(X) mM sodium phosphate. 
pH 7.5 (unless otherwise stated). Rates of FLDR-FLD electron 
transfer were measured after enzyme and buffer solutions hod 
been degassed and bubbled for 15 min with 0 1-free N 1 . Traces 
of 0 1 were subsequently removed from the enzyme solutions h 
passing the concentrated stock solutions of enzyme down a G25 
gel-filtration column (I X20 cm) within the anaerobic environ-
ment of a glove box (Belle Technology). The enzyme solutions 
were then diluted to the required concentrations, transferred to 
the stopped-flow syringes and sealed within the glove box be-
fore transferring to the stopped-flow apparatus. 
Analysis of stopped-flow data was performed using the 
SF17 MV software and Origin (Microcal). both of which use 
non-linear least-squares regression analysis. The reduction of 
FLDR by NADPH was measured by rapid mixing of NADPH 
(4 oM -2 mM) with FLDR (40 tM) and monitored at 456 nm 
(total flavin reduction). The electron transfer from FLDR to FLD 
was monitored at 583 nm (formation of FLI) blue seiniquinone) 
after mixing of 40 fIM FLDR (reduced with 2 mM NADPH or 
sodium dithionite) with FLD (20 jiM). When sodium dithionite 
was used. FLDR was reduced completely in an anaerobic envi-
ronment with excess reductant, then separated from the dithio-
nite by gel filtration under anaerobic conditions. Reoxidation of 
FLDR was measured after mixing of enzyme (80 pM) with a 
sub-stoichiometric quantity of reductant (40 pM NADPH) and 
monitoring the absorbance increase at 456 rim. Reoxidation of 
the FLD semiquinone (absorbance decrease at 583 nni) was 
measured after anaerobic reduction of the enzyme with excess 
sodium dithionite, isolation of the reduced enzyme by gel filtra-
tion and dilution of reduced FLDR into aerobic buffer. Reduc-
tion of cytochrome c was measured at 550 tim alter reaction 
of reduced FLDR (10-SO pM enzyme + 2 m NADPH) with 
cytochrome c (horse heart, type 1: 4 pM 
Chemical crosslinking of FLDR and FLD. Purified FLD 
(40 pM) and FLDR (8 pM) were covalently and specifically 
crosslinked using I -ethyl-3-(dimethvlamino-propyl) carbodi-
imide (EDC) (10 mM) in 10 mM Hepes buffer (2 nil. pH 7.0) at 
room temperature [ 1 51. 10-mI aliquots were withdrawn from the 
reaction at 15-nun intervals to assess the progress of the reaction 
by SDS/PAGE. After I h. the reaction was stopped by the addi-
tion of ammonium acetate (100 mM) and the protein mixture 
concentrated to approximately 0.5 ml by ultrafiltration jusing a 
10000 Da cut-off Centricon concentrator (Amicon)j. The cross-
linked complex was separated from the FLDR and FLD proteins 
by gel filtration on FPLC (Superdex 75 column. 1.6X60 cm) in 
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Fig. I. (a) SI)S/PAGE of E. cvii flavodoxin ADP oxidoreductase 
(FLI)R) purification steps. Lane I. low molecular mass standards 
(9400)). 67000. 43 000. 30000. 20 100. 14 400 Da) lane 2, uninduced 
cells; lane 3. induced cells: lane 4, cell lysate: lane 5. Q-Scpharose; 
lane 6. 2'. 5'-ADP Sepharose: lane 7. low molecular mass standards (as 
lane 1). (h) SDS/PAGE of E. rn/i flavodoxin (FLD) purification steps. 
Lane 1. low molecular mass standards (940(X), 67000. 43000.3000)). 
20 100. 14 400 Da): lane 2. unincfuced cell lysate : lane 3. induced cell 
lysate; lane 4. empty: lane 5. Q-Sepharose: lane 6. Resource-Q; lane 7. 
low molecular mass standards (as lane I). 
RESULTS 
Protein characterisation. Fin io(Iavm NADP o.vidoieluctase. 
FLDR is a monomeric (247 amino acids. M, 27620 Dal enzyme 
which contains FAD. E. roll HMSI74 (DE3)/pCL2I was used 
to overexpress FLDR. The protein was purified by sequential 
chromatography steps on Q-Sepharose and 2'.5'-ADP Sepliarose 
(Table 1). Samples were analysed at all steps by SDSIPAGE 
(Fig. I a) and ultraviolet-visible spectroscopy. The molecular 
mass of the expressed FLDR apoprotein was determined as 
27648 Da by electrospray mass spectroscopy. This is 28 Da 
higher than the predicted molecular mass of 27 620 Da. calcu-
lated from the amino acid sequence derived from the database 
gene sequence 1161 (less the N-terminal methionine). However, 
the recent solution of the atomic structure of the F. co/i FLDR 
indicates that an arginine is present at position 126, as opposed 
to a glutanuine predicted from the gene sequence 117]. The dif-
ference in niolecular mass of these two residues is exactly 
28 Da, corresponding to the apparent discrepancy. The isoelec-
Inc point of FLDR was measured as 4.8 by isolelectric focusing: 
rather more acidic than the theoretical value of 6.19 (SwissProt). 
FLDR is bright yellow in its oxidised form and it is con-
verted to a neutral blue semiquinone by the addition of one re-
ducing equivalent. FLDR has an absorption coefficient of 
Table 1. Purification table for E. coli NADP flavodoxin oxidoreductase (FLl)R. Total protein was estimated by absorbance at 280 nm. FLDR 
was estimated by measurement of absorbance (Abs) at the peak of the longer wavelength flavin band (456 nnu). 
Purification step Total volume V Total protein Total FLDR Abs.,JAhs 1 Purification 
ml VXAhs1.,,, VXAbs,, -fold 
Lysate 55 833.9 18.26 0.0207 
Q-Sepharose 80 119.1 9.28 0.0779 3.77 
2'.5'-ADP Sepharose 35 37.5 5.74 0.1531 7.41 
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Table 3. Steady-state kinetic parameters for FLDR. Rates of reduc-
tion 01 artificial electron acceptors were measured at 55() tim for cVtO-
chronic e 122 640 M cm and 420 nm for potassium terricyanide 
(1010M cm . Rates were measured at 30 5C in 100 mM sodium 
phosphate. pH 7.5. with saturating (200 pM) NADPH. The A',, for 
NADPH was determined tinder conditions of saturating cvtochrome c 
(150 pM). The K for the FLD was determined under conditions of satu-
rating cyrochrome c and NADPH. with the FLDR at 16.65 nM. 
Substrate A K,. 
min pM 
Potassium ferricyanide 1610.3 	50.1 23.6 	±3.2 
Cytochrome r 141.3 	5.3 17.6 	115 
NADPH - 3.85±0.5 
FLD - 6.94--0.69 
Table 4. Stead-state kinetic parameters 6r the EDU-linked com- 
plex of FLI)R/FLI). Experiments were performed as described above. 
Substrate A. K, 
mitt PM 
Potassium ferricyatiide 782.0 	35 33.2 ± 6.4 
Cytochrome r 109.2--4.5 87.4 ± 8.2 
Visible spectra of the complex showed absorbance maxima at 
3795 tim and 462 nm. with shoulders at 487 rim and 404 nm. 
These absorbance characteristics are different from those of the 
individual FLDR and FLD - with absorbance maxima located 
between the peaks of the isolated flavoprotcins. Addition of 
NADPH was seen to induce a decrease in the intensity of the 
tiavin spectrum. but not to induce the formation of a species 
absorbing in the 550-600 tim region. suggesting that there was 
no formation of the neutral blue semiquitlone form expected for 
the FMN in FLD. 
Enzyme activities. Purified FLDR has NADPH-dependent 
reductase activity towards a variety of electron acceptors 
(Table 3). Using cytochrome C (horse heart. Sigma) as the accep-
tor, a k,,, of 141.3 ±5.3 nun and a K of 17.6±2.15 pM were 
measured using homogeneous FLDR at 30 °C in 100 mM so-
dium phosphate. pH 7.5. With saturating cytochrome c. the K, 
for NADPH was estimated at 3.85 ±0.5 pM. Under similar con-
ditions. potassium ferricyanide was reduced, with a K, of 
23.6±3.2 pM and a of 1610.3±50.1 min '. Purified FLD 
acts as a single electron shuttle and is able to stimulate the rate 
of FLDR-dependent cytochronuc c reduction approximately six-
fold under the above conditions. With saturating cytochronie e 
(100 pM) and FLDR at 16.65 nM. a Michaelis curve was ob-
tained for the stimulation of cytochrome e reductase activity by 
FLD, indicating an apparent V,,,.. of 272 11.5 mm and an 
apparent K,,, of the FLD for the FLDR of 6.84 ± 0.68 pM. 
The purified EDC-linked complex of FLDR/FLD was also 
catalytically active (Table 4). With cytochrome c as the acceptor, 
a k,.,, of 109± 5 mm and a K of 87±8 pM were measured 
with the complex at 30 °C in 100 mM sodium phosphate. pH 7.5. 
With potassium ferricyanide, a k,, of 782 ± 4 mm and a K, of 
33 ± 6 (IM were measured. Both the rate of reduction and the 
affinity of these substrates for the complex were lower than 
those for FLDR on its own (Tables 3 and 4). 
Stopped-flow characterisation. Investigations of the rates of 
reduction of FLDR (40 l.tM) with NADPH (4 pM-2 mM) were 
Table 5. Stopped-flow parameters for oxidation/reduction reactions 
involving FI.I)R and FLD. Reaction rates were determined at 30'C in 
100 mM sodium phosphate. pH 7.5. as described in the Experimental 
Procedures section. Measurement of FLDR reduction was made at 
456 nm. FLD reduction to its semiquinone at 583 nm and cytochrome c 
reduction at 550 tim. Reoxidation of FLDR and FLD were monitored at 
the same wavelengths used to measure their reduction. 
Stopped-floss rate 	 A 
FLDR reduction i h's NADPH) 	15 2 (900 mm 
FLI)R oxidation 	 (5.44±0.5)X 102 (3.3 nun '1 
FLI) reduction thy FLDR 	 3.4 ± 0.2)X 102  12.0 tnin 
FLD oxidation 	 (1.07 ± 0.03) X 10 1 0.85h 
Cytocliromne c reduction (by FLDR) 	29.0 ± 2.0 (1740 nun ') 
performed with measurenietit of the rate of decrease ill absor-
bance at 456 nm. the oxidised FLDR absorbance maximum. The 
rate observed \\ as 15 ± 2 s ', regardless of the concentration of 
NADPI-1. A similar value was obtained when the concentration 
of FLDR was altered. 
Attempts to measure the rate of electron transfer between 
NADPH-reduced FLDR and FLD (following the formation of 
FLD setuuiquinone at 583 nm) proved difficult under aerobic 
conditions due to the slow rate of this process and the relatively 
rapid reoxidation of the FLDR. To soRe this problem, Solutions 
were degassed and made up anaerobically (as described in the 
Experimental Procedures section) prior to performing the 
stopped-flow experiments. The rate of formation of FLD semi-
quinone was seen to he very slow when reduced FLDR (40 pM 
was mixed with FLD (20 pM). regardless of whether NADPH 
(500 pM -2 mM) or sodium dithiotuite was used as the reduc-
tatit. Over the first 60s, a single exponential rate of only 
(3.4 ± 0.2) X ID s 1 was recorded in the presence of 2 mM 
NADPH. 
To compare the reduction of an artificial electron acceptor 
on stopped flow/steady-state time scales, the reduction of cyto-
chronic e by FLDR was investigated. NADPH (2 mM)- reduced 
FLDR (10 - 50 pM) was mixed with cytochrome c (4 pM) and 
absorbance monitored at 550 nm. A k, of 29 ± 2 s and a K, 
of 12.58 ± 1.1 pM were calculated by fitting the first-order rate 
data against [cytochronue c] to it rectangular hyperbola oil Origin 
software. All stopped-flow data is tabulated (Table 5). 
To measure the rate of reoxidation of the reduced FLDR, the 
enzyme was reduced aerobically in the stopped-flow apparatus 
by mixing with a sub-stoichionuetric quantity of NADPH and 
recording the increase in absorbance at 456 mum. At 30C. FLDR 
(80 pM) was observed to reoxidise after rapid mixing with 
NADPH (60 pM) with a rate of (5.44 ±0.5)< 10 ' s 
(3.26 min '. To measure reoxidation of the FLD senuiquinone, 
we initially attempted the same experiment as used for FLDR. 
employing 80 pM FLD and 60 pM sodium dithionite as the re-
ductant. However, it was found that reduction of FLD by the 
ilithionite was very slow, with the semiquinone taking several 
minutes to form completely. Instead, the FLD was reduced with 
an excess of dithionite under anaerobic conditions, until the 
senuiquinone formation was seen to be complete (maximal ab-
sorbance at 583 nm). Thereafter, excess dithionite was removed 
from the FLD by gel filtration (G25) within the anaerobic glove 
box and the reduced FLD removed from the anaerobic environ-
ment. The reduced FLD was then diluted to 30 pM in oxygen-
ated buffer, the buffer bubbled with air for 2 min and the rate of 
reoxidation of the setniquinone measured at 583 tim under 
steady-state conditions. The setniquinone was seen to he air sta- 
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Table 6. Midpoint reduction potentials (E' in mV for the flavin co-
factors in purified F. cvii FI.1)R NADP flaodoxin oxidoreductase) 
and F!.!) (flavodoxin (. Values oCI'C calculated from electrode potential 
ersus .Ebsorhuiice data as described in the Results section and in Figs 2 
and 3. E refers to the midpoint potential for the 2-electron reduction 
of the tiavins in each protein, while E and E refer to the midpoint 
reduction potentials for the oxidisedlsemiquinone and semiquinone/h - 
droquinone couples. respectively. for FLD and FLDR. The values arc 
compared with those of the FAD and FMN cofactors in the reductase 
domain of tlavocytochrome P-45() BM3 from Bacillus ozcgater000 
(BM3) 1291 and maninialian P450 rediictase (CPR) 1301. and with the 
values for free FAD/FMN F31 .321 
E', , E E 
FLDR FAD -2884 -308±4 -268±4 
FLI)R FAD (+2' AMP) -261±6 -293 ±6 -230±7 
Fl.l) FMN -343 	6 - 254 ± 5 -433 -6 
13M3 FAD -332±4 -292±4 -372±4 
BM3 FMN -203±6 -213±5 -193±6 
CPR FAD -327 -290 -365 
CPR FMN -190 -110 -270 
FREE FAD --207 - - 
FREE FMN -205 -172 -238 
5 mM used in the titration was based on this result. An increase 
in the reduction potentials of both the oxidised/semiquinone ( 
E elevated by 15 mV to - 293 ± 6 mV) and semiquinone/re-
duced (E elevated by 38 niV to -230±7 mV) couples of 
FLDR was observed in the presence of 2' AMP (Table 6). 
F. co/i .thnodovin. Fig. 5 a shows the redox titration of the 
F. co/i FLD at 8() pM monitored by visible spectrophotometry 
between 400 nni and 800 nm. Fig. Sb plots the sum of absor-
bance values between 600 nm and 650 nrn against the potential 
of the enzyme solution. The increase and decrease in absorbance 
in this region reflects the build up (0 I electron reduced) and 
loss (1 -2 electron reduced), respectively, of the flavodoxin tieu-
tral-blue senhiquinone. The FLD data was also fitted to Eqn (1). 
In this case. E represents the oxidised/serniquinone couple of 
FLD and E the semiquinone/reduced couple. 
Values for the reduction potentials of the FLDR and FLD 
flavins are collated in Table 6. Although the potentials for the 
two 1-electron couples of the FLD are very well separated 
(179 my). this is clearly not so for the FLDR. For the FLDR, 
the first couple (oxidized/semiquinone - E' ) is calculated to he 
more negative than the second (semiquinone/reduced - E) by 
40 mV. In FLDR, the two 1-electron-reduction processes appear 
to occur simultaneously and the data can he represented reason-
ably accurately by a 2-electron function. The midpoint reduction 
values in Table 6 are compared with those from the homologous 
domains of flavocytochrome P-450 BM3 and eukaryotic l'-450 
reductase, and with the potentials of free FAD and FMN. 
Analysis of the later data sets for the FLDR was complicated 
by the tendency of this enzyme to form a precipitate (very 
slowly) over the course of the experiment. For this reason, the 
quality of these data is not as high as those obtained for FLD. 
However, correction of these data by subtraction of 1I, from 
each spectrum (to compensate for the small increases in turbid-
ity) results in values that lit well to the 2-electron Nernst func-
tim] used to derive the flavin reduction potentials for FLDR. 
Based on the wide separation of the midpoint reduction po-
tentials of the oxidised/semiquinone and semiquinone/hydroqui-
none couples of the FLD: we calculate that a maximum of 94% 
blue semiquinone can he formed during the reductive titration 
of this protein. As shown in Fig. 5a. the strongly absorbing 
semiquinone has a peak at approximately 583 nm. The maxi- 
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Fig. 5. (a) Ultraviolet-visible spectra of F. cvii FLI) (811) pM) during 
redox titration. Reductis c sodium diihion i Ic ) ii rations Acre performed 
anaerobically as described in the Experimental Procedures section. The 
spectra shown by solid lines are those representing the conversion from 
the oxidised to the scmiquinone form: with decreasing absorbance in the 
450-run region and increasing absorbance in the 600-nni region (semi-
quinone region). The (lashed line shows the spectrum of the maximal 
semiqulnone species (absorbance maximum at 583 nm) Spectra shown 
by dotted lines are those representing the conversion from the seiniqlii-
none to the hydroquinone (fully reduced) form: with decreasing absor-
bance in the 6(X)-nm region. Oxidative titrations with potassium fcrricya-
nide give essentially identical results to the reductive titrations. (h) Plot 
of the sum of absorhance between 600 nni and 65)) nm against electrode 
potential W. mV) during reductive and oxidative titration. fitted to 
Eqn. I. as described in Results. From these data. E (oxidised/semiqui-
none) = -254 ±5 mV and E (scmtquinone/rcduced) = -433±6 niV. 
mum absorbance reached by the semiquinone is 56.2% of that 
of the oxidised flavin band at 466 nm. Based on this proportion 
and the known coefficient of 8250 M cm for the 466-nm 
hand 121. we calculate a coefficient of 4933 M cm for 100% 
of the semiquinone. 
DISCUSSION 
This is the first report of the determination of all of the re-
duction potentials for the flavins in the FLDR and FLD system, 
the liavoprotein electron-transfer chain of the F. co/i biotin (vita-
min H)-synthase system. which also supports the function of 
heterologously expressed cytochrome P-450 in F. coli 151. The 
knowledge of these values is central to our understanding of the 
roles of these flavoprotetns in electron transfer to these en- 
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transfer via a NADPH-driven system virtually impossible. The 
results indicate that the overall driving force. i.e. the difference 
in reduction potential. for single electron transfer from NADPH-
reduced FLDR to oxidised FLD is considerably less than that 
for CPR and P-450 BM3. In addition, the binding of nucleotide 
(NADP ) to FLDR may result in further increase in the Ilavin 
reduction potentials (as we have shown with 2' AMP) and 
decrease further the driving force for electron transfer to FLD. 
Our stopped-flow data are consistent with these findings. The 
rate of reduction of FLDR (15 s ') is markedly slower than that 
seen in the P-450 BM3 system (>7()O s') and the reduction of 
FLD by reduced FLDR is also very slow (0.034s '). 
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The gene encoding Escherichia coli biotin synthase 
(bioB) has been expressed as a histidine fusion protein, 
and the protein was purified in a single step using im-
mobilized metal affinity chromatography. The His,-
tagged protein was fully functional in in vitro and in 
vivo biotin production assays. Analysis of all the pub-
lished bioB sequences identified a number of conserved 
residues. Single point mutations, to either serine or 
threonine, were carried out on the four conserved (Cys-
53, Cys-57, Cys-60, and Cys-188) and one non-conserved 
(Cys-288) cysteine residues, and the purified mutant 
proteins were tested both for ability to reconstitute the 
[2Fe-2S] clusters of the native (oxidized) dimer and en-
zymatic activity. The C188S mutant was insoluble. The 
wild-type and four of the mutant proteins were charac-
terized by UV-visible spectroscopy, metal and sulfide 
analysis, and both in vitro and in vivo biotin production 
assays. The molecular masses of all proteins were veri-
fied using electrospray mass spectrometry. The results 
indicate that the His 6 tag and the C288T mutation have 
no effect on the activity of biotin synthase when com-
pared with the wild-type protein. The C53S, C57S, and 
C60S mutant proteins, both as prepared and reconsti-
tuted, were unable to covert dethiobiotin to biotin in 
vitro and in vivo. We conclude that three of the con-
served cysteine residues (Cys-53, Cys-57, and Cys-60), all 
of which lie in the highly conserved "cysteine box" mo-
tif, are crucial for [Fe-S] cluster binding, whereas Cys-
188 plays a hitherto unknown structural role in biotin 
synthase. 
The biotin operon of Escherichia coli contains six open read-
ing frames that encode at least four of the proteins essential for 
the conversion of pimeloyl-CoA to biotin (1). The recent deter-
ruination of the structure of three of these enzymes, 8-amino-
7-oxononanoate synthase (2), 7,8-diaminononanoate synthase 
(3), and dethiobiotin synthase (4), encoded by the bioF, bioA, 
and bioD genes respectively, has shed light on the mechanism 
of the steps involved in the conversion of alanine to dethiobi- 
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otin. However, the mechanism of the final step, the conversion 
of dethiobiotin to biotin catalyzed by biotin synthase (see 
Scheme 1), remains unresolved. 
Numerous studies have shown that a fully functional in vitro 
system for conversion of dethiobiotin to biotin requires not only 
the product of the bloB gene but also several other proteins and 
low molecular weight molecules. Although the exact compo-
nents of this system vary between different laboratories, S. 
adenosylmethionine (AdoMet), 1 NADPH, cysteine, DTT, Fe 2-, 
and a reducing system (5) are common to all. The reducing 
system we and others use consists of flavodoxin (FLD) (6) and 
flavodoxin (ferredoxin) NADP ° oxidoreductase (FLDR) (7) 
(which we believe to be the physiological system) which Mar-
quet and co-workers (8) have found can be replaced by a pho-
toreduced deazaflavin. Both systems appear to be equally ef-
fective in providing reducing equivalents for the reaction. 
There is, however, conflicting evidence that other proteins, 
cofactors, and allosteric activators may also be required for 
competence of the biotin synthase complex. There is no doubt 
that addition of extracts derived from E. coil bloB - strains can 
enhance activity of biotin synthase, but whether this is due to 
the presence of a thiamine pyrophosphate-stabilized protein 
(7), high levels of constitutive low molecular weight cellular 
components such as fructose 1,6-biphosphate and the labile 
(and as yet uncharacterized) AdoMet-derived product of the 
7,8-dianiinononanoate synthase reaction (5), or indeed to a 
combination of several of these factors is still open to question. 
Recent results indicate that the sulfur incorporated in the 
tetrahydrothiophene ring of biotin is ultimately derived from 
cysteine (7) and that 9-mercaptodethiobiotin (but not 6-mer-
captodethiobiotin) can act as an intermediate (9). The interme-
diacy of 9-mercaptodethiobiotin, racemization at C-9 (10) (but 
not at C-6 (11)), and the requirement for at least two molecules 
of AdoMet for each ring formation step provides clues to the 
mechanism of C-S bond formation (12). Taken together these 
results suggest that the mechanism involves the following: (a) 
initial AdoMet-dependent radical formation at C-9; (b) capture 
of sulfur by the C-9 radical to form a 9-mercaptodethiobiotin 
derivative; and (c) a second AdoMet-initiated radical formation 
by abstraction of the pro-S hydrogen at C-6 to generate a 
conformationally restrained radical that subsequently cap-
tures the C-9 thiol resulting in tetrahydrothiophene ring do- 
'The abbreviations used are: AdoMet, S.adenosylmethionine; CV, 
column volume; DTT. dithiothreitol: FLD. E. co/i Flavodoxin; FLDR, E. 
co/i flavodoxin (ferredoxin) NADP' oxidoreductase: Ills,,, six consecu-
tive histidine residues: ICP-AES, inductively coupled plasma-atomic 
emission spectroscopy; IMAC, immobilized metal affinity chromatogra-
phy; IPTG. isopropyl-$,o-thiogalactopyranoside; LAM, lysine 2.3-amin-
omutase: LIPA, lipoic acid synthase; PFL-AE, pyruvate formate lyase-
activating enzyme; ARR-AE, ribonucleotide reductase-activating 
enzyme: PAGE. polyacrylamide gel electrophoresis: Bis-Tris, 2-1bis(2-
hydroxyethyl )aminol-2-(hvdroxymethyl )propane- 1,3-diol: PCR, polym-
erase chair, reaction. 
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sure (13). Recent studies indicate that a sulfur atom of the 
[Fe-S] cluster of biotin synthase, rather than cysteine itself, 
may act as the actual sulfur donor, suggesting that the [Fe-S] 
cluster of the enzyme must be regenerated prior to the next 
reaction (14). Thus biotin synthase could be regarded as both a 
reagent and a catalyst. It has been suggested that a NiIS-like 
enzyme, similar to the Azotobacter vinelandii NilS (15), may be 
required for construction of the [Fe-S] cluster in vivo and re-
generation in vitro but such an activity has still to be identified. 
NifS is a pyridoxal phosphate-dependent enzyme that cata-
lyzes the desulfuration of i-cysteine to yield L-alanine and 
sulfide that has been shown to catalyze [Fe-S] cluster forma-
tion in vitro and in vivo. 
The fact that E. co/i biotin synthase is based on a core 
[2Fe-2S] protein with a requirement for a FLD/'FLDR redox 
couple and AdoMet as a radical generator suggests that it 
belongs to the family of enzymes that include anaerobic ribo-
nucleotide reductase-activating enzyme (ARR-AE) (16), pyru-
vate formate-lyase-activating enzyme (PFL-AE) (17), lysine 
2,3-aminomutase (LAM) (18), and lipoic acid synthase (LIPA) 
Even within this small group there already appears to be 
differences with regard to subunit composition and chemical 
function; biotin synthase, LIPA, and ARR-AE are dimers; LAM 
is a hexamer, and PFL-AE is a monomer. Biotin synthase, 
LIPA, and LAM generate a radical on a small molecule, 
whereas ARR-AE and PFL-AE generate a protein glycyl 
radical. 
Characterization of the E. co/i biotin synthase has been 
complicated by the fact that most preparations of the protein 
contain variable amounts of polymeric forms (mainly dimers 
and tetramers) with variable [Fe-S] content. The major native 
form of the core biotin synthaae, however, appears to be a 
76-kDa dimer, each monomer containing an [2Fe-2S] cluster 
Spectroscopic studies suggest that reduction of the two 
[2Fe-2S] clusters in the oxidized protein dimer, an obligatory 
step in the mechanism, results in formation of a biotin syn-
thase dimer containing a single [4Fe-4S] cluster in which each 
of the iron centers is coordinated to a thiol ligand(s) of the 
protein (21-23). 
However, almost nothing is known about the protein resi-
dues involved in coordination to the [Fe-S] clusters of biotin 
synthase. Whereas the active sites have been proposed to in-
volve the cysteine thiols of the common GXCXXXCXXCXQ 
motif as a 'cysteine ([Fe-S] coordination) box" motif, there has 
been as yet no experimental evidence to support this contention 
(20). In this paper we describe studies on mutants of the biotin 
synthase protein that uniquely identify the key protein cys-
teine residues involved in formation of the [Fe-S] cluster. 
EXPERIMENTAL PROCEDURES 
Materials--Electrophoresis was carried out using a Blo-Rad Protean 
II minigel system (protein) and a Life Technologies, Inc., H5 system 
(DNA). PCR and sequencing reactions were done on a Perkin-Elmer 480 
thermal cycler, and automated DNA sequencing was carried out using 
an ABI prism 377 DNA sequencer. An Amersham Pbarmacia Biotech 
FPLC system and columns were used for chromatographic separations 
of proteins. Electrospray mass spectrometry was performed on a Micro- 
mass Platform 11 quadrupole mass spectrometer. UV-visible spectra- 
photometry was done on a Unicam UV4. Determination of metal ion 
concentrations were carried out using a Thermo Jarrell Ash IRIS in- 
ductively coupled plasma atomic emission spectrometer. Primers were 
purchased from Life Tedmologies, Inc., and Ready to Go PCR'ra beads  
from Ainersham Pharmacia Biotech. Pre-cast SDS-PAGE gels (10% 
Bis-Tha) were purchased from Novex and were used according to the 
manufacturer's instructions. 
E. coli Strains and Plosmids—The E. coli strain Top 10 One ShotTM 
cells (F'mcrA D(mri-hsdRMS-mcrBC) F80IacZDMI5 DlacX74 deoR 
recAl araD139 X(ara-ku)7697 galU galE rpsb endAl mpG, Invitro-
gen) were used for the maintenance of plasmids and also for the initial 
transformation of ligation products. HMS174 (DE3) cells (F -  recA 
hsdR(r 12 Th1Kl2) Rif (DE3). Novagen) were used for the overexpres-
sion of genes cloned into pET plasmids. PCOi (bw (attA, bin uvrB) thr, 
leu, thi, plan) was used to prepare a biotin minus cell-free extract. The 
biotin auxotroph Lactobacillusplantarum ( ATCC 8014)was used in the 
microbial biotin assay (24). A 1041-base pair NcoI/RamHl fragment 
from p8030 (a gift from Lonza AG) containing the bioB gene was cloned 
into the same sites of pET lfib (Novagen), and the resultant plasmid was 
called pETlilbibioB. 
Mutagenesis—Site-directed mutagenesis was performed using the 
"mega-primer" PCR method using vector forward (BlOB PCR) and 
reverse (M 13) oligonucleotides and the mutagenic primers (C538, C57S. 
C60S. C 1888 and C288T) (25). The typical PCR reaction volume was 50 
tl and consisted of template DNA (1 zl), forward primer (1 AM), reverse 
primer (1 /M), water (39 ii)), and two Tag beads. The primers for the 
cvsteine mutations used were C53S (5' AAG ACC GGA GCT TCC CCG 
GAA GAT 3'), C57S (5' CCG GAA CAT TCT AAA TAC TGC CCG 3. 
C60S (5' AAA TAC Tel' CCG CAA AGO TCG CGC 3), C 1888(5' GGG 
ATC AAA GTC TCT TCT CCC 3'), and C288T (5 GOT CAG CAG '111' 
GGT ACC GTA 3'). The bases underlined in each primer indicate the 
position where the cysteine codon is replaced by one encoding a serine 
or in the case of C288T a threonine. The bases in bold indicate a Kpnl 
restriction site. All clones were sequenced, and the data were analyzed 
using ABI Prism editview software. 
Preparation of Biotin Syn those Cell-free Extracts—Wild-type biotin 
synthase, W8 e tug1 biotin synthase (from HMS174 (DE3YpETI6b/ 
bioB and pET6H/bioB), and mutant proteins (from HMS174 (DE3)/ 
pHC53S, pHC57S, pHC60S. pHC 1888, and pFIC288T) were prepared 
from cultures grown in 2-10 liters of 2YT media (tryptone (16 g/Iiter), 
yeast extract (10 glliter), sodium chloride (5 g/liter), pH 7.5) containing 
ampicillin (100 pg/mI). Transformed cells were grown at 37 'C (shaking 
250 rpm) until the Aan,,,,  1.0 and biotin synthase was produced by 
addition of IPTO to a final concentration of 1 mm. Cells (-2.5 g/liter wet 
weight) were harvested (5,000 x g for 20 mm, 4 'C) after a further 4 h 
of growth. The cells pellets were washed by resuspension in ice-cold 
buffer A (20 mm Tris-HCI, pH 7.9, 0.5 M sodium chloride, 5 mm imid-
azole). All other cell pellets were washed in buffer B (100 mM sodium 
phosphate, pH 7.5). The cell pellets were lysed by intermittent sonica-
tion (30 a on, 30 a off) 4 'C for 15 mm. Cellular debris was removed by 
centrifugation (15,000 X g for 30 mm, 4 'C), and the supernatants were 
stored frozen (-20 'C) in glycerol (15%). The PCOi (bioB ) strain was 
grown in 2YT, and the cells washed with buffer A and cell extracts, used 
for augmentation in the in vitro assay, were prepared in a similar 
fashion to that described above. 
Purification of Wild-type Biotin Synthase—Protamine sulfate 0%, 
0.5 ml per 10 ml) was added to the cell-free extract to remove nucleic 
acids. After ammonium sulfate (45%) precipitation, precipitated pro-
teins were collected by centrifugation. resuspended in buffer B, and 
filtered (0.45 gin) prior to being loaded onto a Q-Sepharose 26/10 high 
load anion exchange column (2.5 X 10 cm) which had been equilibrated 
with buffer B. The proteins were eluted with an increasing gradient of 
potassium chloride (0-1 M, 20 CV) in buffer B. The deep red fractions 
containing biotin synthase eluted at 300 mm salt. These were combined, 
brought to a final concentration of 10% ammonium sulfate, and loaded 
onto a phenyl-Sepharose hydrophobic interaction column (1 X 30 cm) 
that had been equilibrated with buffer B containing ammonium sulfate 
(10%). Biotin synthase was eluted with a decreasing gradient of buffer 
B containing ammonium sulfate (10-0%, 20 CV). Biotin synthase 
eluted at the end of the gradient, and these fractions were combined and 
filtration concentrated (Amicon PM 10 membrane). The protein was 
purified by gel filtration on Sephacryl 8-200 HR eluting with buffer B. 
Protein samples were diluted with glycerol (15%) and stored (-80 'C). 
Purification of His6-tagged Biotin Synthase and Mutants—Cell-free 
extracts were loaded directly onto a Hi.Trapra.chelating  column (5 ml, 
Amersham Pharmacia Biotech) that had been charged with NiSO 4 (100 
mm) and prewashed with buffer A. Proteins were eluted with a linear 
gradient of (5 ma to 1 M) imidazole in buffer A. Biotin synthase-
containing fractions typically eluted between 120 and 150 mm imidaz-
ole. These were combined and exhaustively dialyzed against buffer B to 
remove imidazole and nickel salts and concentrated by ultrafiltration. 
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The purity and integrity of wild-type, His 6-tagged, and mutant biotin 
synthase forms were assessed by SE)S-PAGE, mass spectrometry, and 
IJV-visible spectrophotometry. Protein concentrations were determined 
by the Bradford method using bovine serum albumin as a reference (26) 
and by spectrophotometry using reported extinction coefficients (e 274 
M I cm, e4,, 	7.1 X 103 M' cm 1 , 	3.5 X iO M 1 cm 
(20). 
Mass Spectrometry—Prior to mass spectrometry all protein samples 
were passed through an Aquapure reverse phase C.-4 column at a 
constant trifluoroacetic acid concentration of 0.1% using a linear gra-
dient of 10-100% acetenitrile in water over 40 min at a flow rate of I 
ml/min and the separation monitored at 280 nm. The total ion count of 
all the ions in the m/z range 600-2.000 was recorded. The mass 
spectrometer was scanned at intervals of 0.1 a, the scans accumulated, 
spectra combined, and the average molecular mass determined using 
MaxEnt and Transform algorithms of MassLyns software. 
Sequence Aiignments—Swis&-Prot and the Genomes Representation 
Organization data bases were used to search for amino acid sequences 
that were then aligned using Expasy. Clustal W, and Alscript (27). 
Preparation of Apo and Halo Wild-type Biotin Synth.aae and Mu -
tants—This was curried out using methods previously described (14, 
20). 
In Vitro Assay for Biotin Synthase Activity-In vitro biotin production 
was determined using the Lactobacillus assay (24). Incubations were 
carried out both aerobically and anaerobically in buffer B. A typical 
assay mixture contained biotin synt.haae or mutant protein (5 tiM), 
potassium chloride (10 mm), dethiobiotin (50 tiM), AdoMet (150 mm), 
Fe(NH4 )2(SO4)2  (5 mm), NADPH (1 mm), fructose 1,6-biphoaphate (5 
mm). L-cysteine (5W um), DT'l' (10 mM). PCOi cell-free extract (100 uI), 
FLD (12.5 /LM), and FLDR (2 Am). The final reaction volume was 
typically 1 ml. The reaction was incubated at 37 C for 2 h and then 
stopped by adding 100 jul of 10% trichloroacetic acid. The resulting 
precipitate was centrifuged, and 5 1d of the supernatant was used for 
bioassay. 
In Vivo Assays for Biotin Synthase Activity—Transformants of 
HMS174 (DE3) with pET16b. pET6H, pET16b/bioB, pET6HIbioB, 
pHC53S, pHC57S, pHC60S, pHC188S, and pHC288T were grown in 
M9CA media containing dethiobiotin (5 zglml). glucose (0.4%), thia-
mine (0.8 g/ml), MgSO4 (2 mm), CaCl2 (0.1 mM), and ampicillin (100 
g/ml). At A __ 1.0 the cells were equally divided, and one sample 
was kept as a control and the other was induced with IPTG (1 mm). 
Aliquots (1 ml) of cells were removed from both control and induced 
samples at various time intervals. The cells were pelleted by centrifu-
gation, and 5 jul of the supernatants were used in the bioassay as above. 
Supernatant from HMS174 (DE3) cells were grown in the same media 
minus ampicillin and used as the control. 
Elemental Analyses—Inductively coupled plasma atomic emission 
spectroscopy (ICP.AES) was used for metal analyses. All data were 
interpreted using thermoapec/CID software. The radiofrequency power 
was 1150 watts, the nebulizer flow was 30 pounds/square inch, the 
pump rate was 100 rpm, and the purge time was 90 a. Fe/NO 3)3 
(0.01-100 ppm; 180 nM to 1.8 mm) and Ni(NO3 )2 (0.0001-1.0 ppm; 1.7 
rIM to 17 mm) solutions were used as standards. All biotin synthase 
samples (27 um) and standard solutions were made up in buffer B (28). 
Chemical analysis for iron was carried out using the ferrozine assay as 
described by Stookey (29) using the standard described above. Labile 
sulfide analysis was determined as previously reported (20). 
RESULTS 
Over-expression of Biotin Synthase—To study the molecular 
properties of wild-type and mutant forms of biotin synthase, we 
overproduced the protein using the pET system. In our hands 
we found the purification procedure described by Sanyal et al.  
(20) both technically difficult and time-consuming, although 
the procedure provided --80% pure biotin synthase. We found it 
impossible to reproduce the purification of biotin synthase us-
ing a cobalt column, as described by Marquet and co-workers 
(30). To overcome these problems, we decided to express the 
protein with an N-terminal polyhistidine tag. The bioB gene 
was cloned into pET6H which fused the 5' terminus of the gene 
to a sequence encoding a MHHIHI{HHA tag. Overexpression of 
His6-tagged biotin synthase was carried out in HMS174 (DE3) 
and gave comparable expression levels when compared with 
wild-type biotin aynthase. Optimal yields of both proteins were 
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Fv. 1 . SDS-polyacrylamide gel electrophoresis analysis of 
Ris5-tsgged biotin synthase and mutants C53S, C57S, C808, and 
C288T. Protein samples were applied to a polyacrylamide gel (10% 
Bis-Tris, Novex) in the presence of SOS (0.1%) as follows: 1st lane, 
wild-type biotin synthase; 2nd lane, C53S; 3rd lane, C57S; 4th lane, 
C60S; 5th lone, C288T; and 6th lane, low molecular mass markers in 
kDa, 96, 64, 43. 30, 20, and 14.4 (Amersbam Pharmacia Biotech). 
Coomassie Blue was used for staining. 
obtained by aerobic cell growth in 2YT at 37 C. By using the 
[MAC purification system, we were able to routinely prepare 
100-mg quantities of >95% pure Hi8 6-tagged biotin synthase 
from 5 liters of transformed cell culture. 
Essential Cysteine Residues of Biotin Synthase—Spectro-
scopic studies on biotin synthase, PFL activase, and LIPA (17, 
19,31) suggest that three cysteine residues from each monomer 
are required to coordinate the iron in the [2Fe-2S] clusters of 
the oxidized dixner and that two of these are required ligands in 
the reduced catalytically active form. Five cysteine residues of 
biotin synthase (Cys-53, Cys-57, Cys-60, Cys-188, and Cys-288) 
were replaced separately with serine or threonine residues by 
site-directed mutagenesis (threonine was chosen as a replace-
ment for Cys-288 since it enabled us to engineer a RonI restric-
tion site into the bwB gene to facilitate mutant selection). Each 
of the mutant proteins was overproduced in E. colt HMS 174 
(DE3), and its catalytic activity was determined. Since the 
His5-tagged biotin synthase showed identical in vitro spectro-
scopic parameters and catalytic activity to wild-type protein, 
the mutant bioB genes were also expressed as histidine fusion 
proteins. Each of the mutant proteins was purified using IMAC 
under identical conditions to the histidine-tagged wild-type 
biotin synthase except for mutant C188S, which despite nu-
merous attempts (low temperature induction and IPTG concen-
trations <0.1 mm), remained intractably insoluble. Protein pu-
rity was estimated by SDS-PAGE (Fig. 1). 
Preparation of Wild-type and Hiss lagged Apoenzymes and 
the Reconstitution of 12Fe-2S1 Cluster Containing Holoen-
zyrnes—The apoenzymes of each of wild-type biotin synthase, 
Ilis6-tagged biotin synthase, and mutants were prepared 
anaerobically using sodium dithionite and EDTA. The samples 
were then desalted using a GlO gel filtration column. ICP-AES 
analysis and LTV-visible spectroscopy confirmed the absence of 
iron in the proteins. The samples were then reconstituted by 
incubation with FeC1 3 and Na2S under similar conditions to 
those described previously (14, 20). 
Spectral Characteristics—Solutions of wild-type, Hiss-
tagged, and C288T biotin synthase were all reddish brown in 
color, and they showed virtually identical UV-visible spectra 
with a maximum at 274 nm, a shoulder at 330 urn, and a 
distinctive peak at 420 mu (see Fig. 2). The spectra of the spa 
forms of each of these proteins were colorless and showed no 
peaks at 330 or 420 nm. Upon incubation with FeC13 and Na2S 
for 2 h, their spectra were identical to that of the wild-type 
isolate. 




Molecular masses of the wild-type, His 6 tagged, and mutant E. coli 
biotin synthases measured by decirospray mass spectrometry 
- -  
5-pt samples of proteins (20 pee) in tnfluoroacetic acidlacetonitrile/ 
water (0.1:50:50%) solution were used in the measurements. The in-
strument was calibrated with a myogiobin standard. The estimated 
error of the molecular mass for each protein is within 0.1%. 
Protein lxpected Actual 
Wild-type biotin synthase 38,648 38,646 
His6 tagged biotin synthase 39,673 39.666 
C53S 39,657 39,656 
C57S 39,657 39,658 
C60S 39,657 39.652 
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FIG. 2. UV-visible spectra of wild-type, flis5-tagged, and mu-
tent biotin synthases The spectra are from samples of all proteins (1 
mg/mi) in 100 nfl sodium phosphate. pH 7.5. Wild-type, Hiss-tagged, 
and C288T biotin synthases have almost identical adsorption spectra 
(upper trace, solid lines). The three mutants (C53S, C57S, and C608) 
are very similar to each other (lower trace, dashed lines). 
The mutants (C53S, C57S, and C60S) were colorless, and 
their spectra showed no peaks indicative of the presence of an 
[Fe-S] cluster. Moreover, their spectra did not show any signif-
icant changes even after prolonged incubation with FeC1 3 and 
Na2S. 
All the mass spectrometry results were within 0.1% of the 
expected values for the polypeptide chains (Table I) indicating 
that the [Fe-S] cluster is lost under the MS conditions. 
Elemental Analyses—Analyses for iron, sulfur, and nickel 
were carried out on all proteins using ICP-AES, the Bemert 
method, and the ferrozine method (29). The protein concentra-
tions were adjusted to –27 Am (based on a monomeric mass of 
39,673 Da for Hiss-tagged proteins and 38,648 Da for wild-type 
biotin synthase). The amount of sulfur (as S 2 ) in Hiss-tagged 
biotin synthase was virtually identical to that in the untagged 
protein and similar to the value previously reported by Sanyal 
et al. (20) for wild type. Analysis for nickel content proved that 
there was negligible nickel binding. Iron analysis (Table II) on 
the purified proteins revealed a 1:1 ratio between iron and 
sulfide in both unmodified and His 6-tagged biotin synthnse in 
agreement with previously reported values (14), although it 
should be noted that Sanyal (20) has reported a 2:1 ratio. In 
order to try to increase the iron/protein ratio, the proteins were 
converted to their apoenzymes by incubation with sodium di-
thionite and EDTA, and the [Fe-S] clusters were reconstituted 
by incubation with FeC13 and Na2S. In the case of the wild-
type, the Hiss-tagged, and C288T proteins, the protein/iron 
ratios increased to values comparable with those previously 
reported (20). The ferrozine assay gave a slightly lower iron/ 
protein ratio than that obtained by ICP-AES (Table III). 
In Vitro Assay for Biotin Production—The in vitro activities 
of all proteins were determined using the Lactobacillus assay. 
Biotin was produced by the wild-type, the His 6-tagged, and the 
C288T mutant but not by the three other cysteine mutants 
(Table M. There was no difference in biotin production be-
tween aerobic and anaerobic incubations. 
In Vivo Assay for Biotin Production—HMS174 (DE3) cells 
did not produce detectable levels of biotin either on their own or 
when transformed with pET16b and pET6H and were used as 
a control. To examine whether or not the His6 tag affected 
biotin synthase activity, an in vivo assay was carried out using 
HMS 174 (DE3) cells transformed with either pET16b/BioB or 
pET6H/bioB. All the cells grew in a similar fashion, and pro-
duction of biotin was found to increase with cell growth. There  
was no difference in the cells transformed with pET 16WBioB 
when compared with those that were producing His 6-tagged 
protein indicating that the tag does not seem to affect the 
activity of wild-type biotin synthase. Similar experiments were 
carried out with the five mutant plasmids, all the clones grew 
as vigorously to those of the wild-type, but only the non-con-
served C288T mutant produced significant amounts of biotin. 
Cells expressing the C53S, C57S, C605, or C 1888 mutants 
did not produce any detectable quantities of biotin (Table V). 
DISCUSSION 
Biotin synthase has two dimeric forms that contain different 
types of [Fe-S] clusters. In its oxidized form the protein con-
tains a single [2Fe-2S] cluster in each monomer unit, but on 
reduction this converts to a single [4Fe-4S] cluster in the dimer. 
EPR and Raman spectroscopy studies have provided evidence 
that in the oxidized [2Fe-2S] form biotin synthase has one Fe"  
that is coordinated to two cysteines and one Fe" that is coor-
dinated to a cysteine and an oxygenic ligand (21, 22). In con-
trast, after dithionite reduction a [4Fe-4S] cluster is formed in 
which each iron is coordinated to a single cysteine sulfur. A 
possible mechanism for this interconversion has been proposed 
by Johnson ci al. (22) (Fig. 3). It has been speculated that the 
cysteine residues of the highly conserved °cysteine box" GX-
CXXXCXXCXQ motif of these proteins are involved in [Fe-S] 
cluster binding. This is supported by the fact that an identical 
motif is found in other [Fe-S] cluster proteins such as LIPA 
(Swiss-Prot accession number P25845) (19), ARR-AE (P39329) 
(32). LAM (33), the nitrogen fixation B gene product (P11067) 
(34), pyrrolo-quinoline-quinone synthase (Q01060) (35), 
PFL-AE (P09374) (17), NARA protein (P39757) (36), FNR 
(P03019) (37), benzylsuccinate synthase-activating enzyme 
(CAA05050) (38), spore photoproduct lyase (P37956) (39), mo-
lybdenum cofactor synthase (027593) (40), and the thiamine 
synthase H gene product (P30140) (39). Mutational studies on 
PFL-AE have shown that the three cysteine residues of the 
cysteine box are vital for its activity (41). 
Our attempts to purify wild-type biotin synthase from over-
expressing clones using previously reported methods afforded 
protein that was –90% pure contaminated with several high 
molecular weight contaminants. To circumvent this problem 
we elected to clone the bioB gene with an N-terminal His 6 tag 
and to purify the fusion using nickel-bound a ffi nity chromatog-
raphy. This appeared to be a safe approach since E. coli biotin 
synthase has a relatively long N-terminal sequence, which is 
either not present or unconserved in the ORFs of genes from 
other species, and the tag was unlikely to affect enzymatic 
activity. 
A further significant result was that the activity of the N 
terminus Hi86-tagged biotin synthaae proved indistinguishable 
from that of the wild-type protein. The His6 tag allows purifi-
cation of much larger quantities of homogeneous E. coli biotin 
synthase than previously available. Typically, protein of >95% 
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TABLE II 
JCP-A&'3 analysis on wild-type biotin synthase. His6-tagged biotin syntho.se, and the mutant proteins 
Protein samples (27 M) and standards (Fe(NO3)3) were in 100 mm sodium phosphate, pH 7.5. 
Protein [Fe) in Pt*ei" Protein/iron [Fe) in Apoenzyme: [Fe) in ratio apoenzyme° iron ratio holoenzynid 
.001 
Wild-type 26.0 1:096 2.9 1:0.11 37.0 
Hise-taed 26.0 1:0.96 2.9 1:0.11 37.0 
C538 3.6 10.13 1.8 1-0.07 12.8 
C57S 57 10.21 1.7 1.11.06 7.4 
C60S 5.8 1.11.21 1.7 1.11.06 12.0 
C288T 20.8 1:0.77 1.2 10.04 43.0 
Total concentration of iron in as-purified protein. 
' Total concentration of iron in the apoenzyme. 










Results of the ferrozine iron assay 
Protein samples (27 cst) and standards (Fe(NO 3)3) were in 100 mm 
sodium phosphate, pH 7.5. 
Protein Iron concentration Protein/iron ratio 
/001 
Wild-type biotin synthase 18.5 1:0.68 
Hiss-tagged biotin syntase 19.3 1:0.72 
C53S 2.6 1:0.09 
C578 2.0 1:0.07 
C60S 2.9 1:0.11 
C288T 11.9 1:0.44 
TABLE IV 
In vitro biotin production 
Biotin production was measured using the Lactobacillus assay in the 
presence of biotin synthase or mutant protein (5 am), potassium chlo-
ride (10 mm), dethiobiotin (50 ,um), AdoMet (150 ,am), Fe(NH4 )2(SO4)2 (5 
mm), NADPH 0 mm), fructose 1,6-biphosphate ( 5 mm), L-cysteine ( 500 
gM). DT1 (10 ram), PCO 1 cell free extract (100 51), FLD (12.5 um), and 
FLDR (2 am). The reaction mixture was incubated for 2 h at 37 'C. 
biotin produced, , no biotin production. 
Protein 	Biotin produced Siotiri produced 	Biotin produced 
	
by apoenzyme by holoenzyme 
(in vitro) 
Wild-type 	+ 	 + 	 4- 
His6-t.agged -4- ± + 
C53S 	 - 	 - 
C57S - 
C608 	 - 
C288T -. 	 4- 	 + 
TABLE V 
In vivo production of biotin 
Biotin production was measured using the Lactobacillus assay as 
described under 'Experimental Procedures." +, biotin produced, , no 
biotin production. 
Protein 	 Biotin produced 
(in vice) 
Wild-type 	 + 
His6-tagged -4- 
C538 




homogeneity can be isolated in a single chromatographic 
operation. 
Metal analyses on both the wild-type and the Hiss-tagged 
protein revealed that they contained the same amount of iron 
as that reported by Marquet and co-workers (14) but less than 
that reported by Sanyal et at. (20). This is possibly a result of 
the high protein expression levels. Shortage of free intracellu-
lar Fe" and/or the fact that the enzyme involved in cluster 
5L Ale 
S -4k -esi- .(aØ$e 	. 
HS4CVtI 	 - 
(IL?PI 	1N4,..seL) 	 P 
 CW 
- i4 'cs 
Fic. 3. Proposed mechanism for [Fe-S] cluster interconver-
sion. Modified from Johnson et al. (22). 
formation in the cell is expressed at wild-type levels would lead 
to a proportion of the biotin synthase population being formed 
with incomplete clusters. In order to increase the iron content 
of biotin synthase, the apo-enzyme was prepared anaerobically 
by treatment of the proteins with sodium dithiomte and EDTA, 
and the [2Fe-2S] cluster was reconstituted by incubation with 
FeC!3 and Na2S. Although the concentration of biotin synthase 
with intact [2Fe-2S] clusters was significantly increased by this 
procedure, both forms produced equal amounts of biotin (0.2 
mol biotin/mol protein/h) which is in agreement with reported 
values (8, 12, 20). This suggests that there is sufficient iron and 
sulfide in the assay mixture to reconstitute the cluster in situ. 
Clearly, biotin synthase is not acting as a true catalyst, and one 
reasonable explanation for this is that an unknown cofactor(s) 
(possible sulfur donor) is missing from the reaction mixture. 
Sequence similarity searches reveal that there at least 20 
known species of bacteria, yeasts, and plants that contain a 
bioB gene sequence similar to that from E. coli. To date, biotin 
synthase from Bacillus sphaericus (42), Arabid.opsis thaliana 
(43), Saccharomyces ceret'isiae (44), and E. coli (20) have been 
cloned, overexpressed, and purified. Sufficient complements-
tion analysis has been carried out on Met hylobadilus, Bacillus 
flavum (45), Bacillus subtilis (46), Eru'inia herbicola (47), and 
Serratia marcescens (48) to confirm that they also express 
active biotin syntheses. Sequence alignment reveals a number 
of conserved regions (Fig. 4). There are 25 completely conserved 
residues, four of which are cysteine. Three of these (Cys-53, 
Cys-57, and Cys-60) he in the 15-residue cysteine box motif 
(K(SIT)GXCXE(D/N)CX(Y/F)CXQS), and the fourth (Cys-188 in 
the E. coli sequence) is remote. 
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FIG. 4. Sequence alignment of 17 known biotin synthases. The conserved residues are boxed in gray and the two extended conserved motifs 
outlined in black. The black arrows show the residues mutated in this study, and the residue numbering is that of the E. cole sequence. (The 
Swiss-Prot accession numbers from the top are P12996. 067104, P54967, P19206, P53557, P46396, Q9Z6L5, Q47862, P44987, 025956, P94966, 
P46715, 00660 1, P32451,060050, P36569, and P73538). The sequence alignment was carried out using Expasy and Clust.alW, and the data were 
formatted using Aiscript. 
To determine which of the cysteme residues are involved in 
stabilizing the [2Fe-2S] and [4Fe-4S] forms of biotin synthase, 
single point mutations were made of all five cysteine residues 
(Cys-53, Cys-57, Cys"60, Cys-188, and Cys-288) to either serine 
or threonine. The choice of cysteine substitution by hydroxy-
lated residues was made to preserve as much as possible the 
H-bonding character and the side chain geometry of the origi-
nal cysteine residues. All the mutant proteins were expressed 
as His6 tag fusions and purified using INAC. The molecular 
weights of all the polypeptides were verified by mass spectrom-
etry (Table I), and the purified proteins were characterized by 
UV-visible spectrophotometry (Fig. 2), nickel, iron, and sulfur 
analyses (Tables II and Ill), and in viva and in vitro assays for 
biotin production (Tables IV and V). 
Native biotin synthase, His6-tagged biotin synthase, and the 
Hiss-tagged non-conserved mutant C288T all had similar UV-
visible spectrophotometric characteristics that were indicative 
of intact [2Fe-2S] cluster formation. All of these proteins, along 
with their apo-proteins and reconstituted holo-proteins, were 
active both in vitro (Table IV) and in vivo (Table V). In contrast, 
C53S, C57S, and C60S were all colorless, and their absorption 
spectra showed no indication of the presence of [M-2S] clus-
ters (Fig. 2) indicating that these residues are absolutely vital 
for [Fe-S] cluster formation which is in turn crucial for activity. 
C 1888 proved to be insoluble and could only be characterized in 
viva. The fact that only three cysteine residues appear to be 
needed for [2Fe-2S1 cluster binding (22) and that the C53S, 
C57S, and C60S mutants are inactive suggest that Cys-188 
may be required for correct folding of the protein. Attempts to 
induce [Fe-S] cluster formation by incubation of these mutants 
with excess reagents did not result in any significant increase  
of iron binding. 
The only cysteine mutant of E. coli biotin synthase that was 
catalytically active and could support formation of a [2Fe-2S] 
cluster was C2888, the mutant of the non-conserved cysteine 
residue, showing that the presence of C288 is not essential for 
folding, [2Fe-2S] and [4Fe-4S] cluster formation, or for activity. 
In contrast, all the conserved residues Cys-53, Cys-57, and 
Cys-60 of the cysteine box are proven to be absolutely crucial 
for both the formation of the [2Fe-2S] cluster and the activity of 
the enzyme. These results are consistent with recent muta-
tional studies on PFL-AE where it was also found that muta-
tions of cysteine residues in the cysteine box abolish metal 
binding (41). 
In the absence of crystallographic evidence, this work is a 
step toward the definition of the essential protein residues 
involved in the mechanism of [Fe-S] cluster formation in biotin 
svnthase and the relevance of these to the catalytic action of 
the enzyme. The inference of spectroscopic studies on E. coli 
biotin synthase is that a hydroxylated residue is also involved 
in the initial [2Fe-2S] cluster formation (22) and here the 
conserved cysteine box residues Thr-50 and Ser-63 are obvious 
candidates. Another region in the protein that is completely 
conserved is the sequence Tyr-150, Asn-151, Hie-152, Asn-153, 
and Leu- 164 which is also found in lipoic acid synthase (13) (see 
Fig. 4). Biotin synthase mutants at sites within these se-
quences are the subject of current studies. We have recently 
described the overexpression, purification, and redox charac-
teristics of the fiavoprotein components of the E. coli biotin 
synthase system. FLD, and FLDR (49) and the fact that it is 
now possible to obtain relatively large quantities of these, and 
functional, homogeneous BioB protein should facilitate exam- 
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ination of the protein-protein and protein-cofactor interactions 
involved in the redox chemistry of the biotin synthase complex. 
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Addendum—Since the acceptance of this manuscript Hewitson et al. 
(Hewitson, K. S., Baldwin. J. E., Shaw. N. M., and Roach, P. L. (2000) 
FEBS Left, 466, 372-376) have published the results of a similar study 
on E. cdi biotin synthase. They describe the characterization of three 
biotin synthase mutant enzymes C53A. C57A. and C6OA. All three 
mutant enzymes were inactive in in vitro dethiobiotin to biotin conver-
sion assays but are reported to exhibit the characteristic UV-visible 
spectrum of a [2Fe-2S] 2 cluster, in contrast to the C53S. C57S, and 
C608 mutants described here. The exact nature of these differences 
awaits further structural investigation and highlights the complexity of 
the biotin synthase system. 
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Conferences and Courses Attended 
1995 
Radiation Protection Course 
First Aid Course 
Departmental Postgraduate Lectures (1995) 
24th Royal Society of Chemistry - Perkin Division (Glasgow 18.12.95) 
1996 
Departmental Postgraduate Lectures (1996) 
Perkin Symposium (26.03.96) 
Structures - form and function (12.03.96) 
Promega Conference (12.06.96) 
European Peptide Symposium (8 - 13.09.96) 
Romanes Lecture 
Walker Memorial Lecture 
Ames Symposium 
25th Royal Society of Chemistry - Perkin Division (Edinburgh 12.96) 
1997 
Departmental Postgraduate Lectures (1997) 
Oxidases (2 5.03.97) 
Firbush (04.06.06.97) 
17th International Congress of Biochemistry and Molecular Biology including American 
Society for Biochemistry and Molecular Biology 
(San Francisco 24-29.08.97) Poster presented 
261h Royal Society of Chemistry - Perkin Division (Strathclyde 12.97) 
Walker Memorial Lecture 
Ames Symposium 
SET Mentoring Programme 
Scottish Protein Structure Group Meeting (Edinburgh 15.11.97) 
1998 
Departmental Postgraduate Lectures (1998) Oral presentation given (27.04.98) 
Biochemistry Meeting (Southampton 31 .03.98 - 03 .04.98) Poster presented 
Bio-inorganic Firbush Meeting (10-12.06.98) Oral presentation given 
Walker Memorial Lecture (John- Marie Lehn) 
Presentation skills workshop 
Presenting a positive image 
Thesis writing workshop 
Biochemistry Society Meeting (Leicester 21- 23.09.98) 
27th Royal Society of Chemistry - Perkin Division (St. Andrews 12.98) Poster presented 
1999 
Departmental Postgraduate Lectures (1999) 
Scottish Protein Meeting (Glasgow 13.3.99) 
13th International Flavins Conference (Constance 28.8 —4.9.99) Poster presented 
RSC Bio-Organic Meeting (Oxford 16-18.12.99) Oral presentation given. Prize received for 
Best Oral Presentation 
2000 
Scottish Protein Meeting (Dundee 26.02.00) Oral presentation given 
